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Innate immune molecules direct microglia-mediated developmental synaptic
refinementMicroglia, the brain’s resident immune cells and phagocytes, are emerging as criticalregulators of developing synaptic circuits in the healthy brain after having long beenthought to function primarily during central nervous system (CNS) injury or disease.Recent work indicates that microglia engulf synapses in the developing brain; however,how microglia know which synapses to target for removal remains a major open question.For my dissertation research, I studied microglia-mediated pruning in the retinogeniculatesystem and sought to identify the molecules regulating microglial engulfment of synapticinputs. I discovered that “eat me” and “don’t eat me” signals, immune molecules known foreither promoting or inhibiting macrophage phagocytosis of cells or debris, localize to thedorsal lateral geniculate nucleus of the thalamus (dLGN) and direct retinogeniculaterefinement. We found that “eat me” signal C3 and its microglial receptor, CR3, are requiredfor normal engulfment, and that loss of either of these molecules leads to a reduction inphagocytosis and sustained deficits in refinement. These data suggest that microglia-mediated pruning may be analogous to the removal of non-self material by phagocytes inthe immune system.  To test this hypothesis, I examined whether protective signals arerequired to prevent excess microglial engulfment, as they prevent phagocytosis of self cellsin the immune system.  I found that protective “don’t eat me” signal CD47 is required toprevent excess microglial engulfment and retinogeniculate pruning during development.Moreover, another “don’t eat me signal”, CD200, also prevents overpruning. Together,
iv
these findings indicate that immune molecules instruct microglia as to which synapses toengulf and present a model in which a balance of stimulatory and inhibitory cues isnecessary to guide remodeling of immature synaptic circuits. These data shed new light onmechanisms regulating synaptic refinement and microglial function in the healthy,developing CNS, and may have implications for disorders characterized by immunedysregulation and circuit disconnectivity, such as autism spectrum disorder (ASD) andschizophrenia.
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Chapter 1:
Introduction
2Microglia, the brain’s resident immune cells and phagocytes, have long been thoughtto execute their primary functions during nervous system disease and injury, where theyare known to transform into an activated state capable of phagocytosis and cytokinesecretion (Hanisch and Kettenmann, 2007; Ransohoff and Perry, 2009). As defenders ofthe central nervous system (CNS), they have been considered to be in a “resting” statewhen the brain is healthy, a state characterized by monitoring the environment andwaiting for a call to action. However, a number of studies conducted over the last decadehave begun to alter this view.  New data indicate that microglia are vital for thedevelopment and function of the healthy brain and that genetic disruption of these cellsproduces defects in neural circuitry and behavior (Eyo and Wu, 2013; Schafer et al., 2013;Wake et al., 2013). Recent work indicates that microglia are required for normal synapticcircuit remodeling and that they phagocytose synaptic elements, demonstrating thatmicroglial engulfment can occur in a non-pathological context (Paolicelli et al., 2011). Thisimportant finding actually raises more questions than it answers, and chief among these ishowmicroglia know which synapses to engulf. Synaptic refinement involves the removalof unnecessary or inappropriate connections and the strengthening and maintenance ofthose that remain (Hua and Smith, 2004; Katz and Shatz, 1996; Sanes and Lichtman, 1999).As this process calls for the removal of specific synapses, signaling mechanisms must beemployed to instruct microglia as to which inputs to engulf.In the immune system, phagocytosis is a carefully orchestrated process, governedby a large array of both pro- and anti-phagocytosis molecular cues (Brown and Neher,2012; Griffiths et al., 2007; Hochreiter-Hufford and Ravichandran, 2013). Intriguingly,some of these cues are required for synaptic refinement in the developing retinogeniculate
3system, although how these immune molecules could mediate the removal of synapticconnections remains largely unknown (Boulanger, 2009; Huberman et al., 2008; Shatz,2009).  The newfound knowledge that microglia phagocytose synaptic connections duringbrain development may provide the answer. For my dissertation research, I haveinvestigated how immune molecules guide microglial engulfment during retinogeniculaterefinement based on the hypothesis that these molecules serve similar functions in theimmune and nervous systems. This work provides insight into the mechanisms underlyingboth synaptic pruning and microglial phagocytosis in the developing CNS and reveals thatimmune mechanisms are utilized to sculpt the developing nervous system. The insightsprovided by these data can serve as the basis for future investigation of immune moleculesand microglia in disorders involving abnormalities in circuit connectivity, such as autismspectrum disorder (ASD) and schizophrenia, as well as in neurodegenerative disease.
Synaptic refinement is a key event in CNS developmentDuring early nervous system development, neurons send out exuberant processesand form an excess of synaptic connections. These overlapping and redundant connectionsare unique to the immature vertebrate nervous system, and while the reason for theemergence of this redundancy is unknown, the creation of specific, mature circuits frominitially redundant connections could enable information storage and plasticity, perhapsencoding memories or underlying learning (Lichtman and Colman, 2000).  To achieve themore precise and organized circuitry that characterizes the adult nervous system, a periodof pruning must occur during development to remove inappropriate or unsuccessfulconnections, leaving only those that are necessary for the mature circuit (Guido, 2008;Huberman et al., 2008; Jaubert-Miazza et al., 2005; Shatz and Kirkwood, 1984). This period
4of removal occurs concurrently with a period of arborization, which is thought to establishand strengthen the remaining connections (Dhande et al., 2011; Hahm et al., 1999; Hongand Chen, 2011; Snider et al., 1999). While the molecular mechanisms underlying synapticrefinement in the CNS remain largely unknown, it is well established that neural activityplays a key role (Chen and Regehr, 2000; Del Rio and Feller, 2006; Penn et al., 1998; Shatz,1990; Stellwagen and Shatz, 2002; Torborg and Feller, 2005), and synapse elimination isoften conceptualized as a competition for postsynaptic territory among presynaptic inputsin which the “winning” input is stronger and somehow capable of destabilizing competingweaker inputs (Nguyen and Lichtman, 1996; Wyatt and Balice-Gordon, 2003). Synapticrefinement is a fundamental feature of nervous system development, and has beenobserved in a variety of regions in both the central and peripheral nervous systems (Hongand Chen, 2011; Kano and Hashimoto, 2009; Sanes and Lichtman, 1999).Much of our knowledge about synapse refinement has come from pioneering workat the neuromuscular junction (NMJ).  In this system, motor neurons innervate musclefibers, forming relatively simple circuits with large synaptic terminals that are easilyvisualized using microscopy. Initially, individual muscle fibers are innervated by manymotor axons that form synapses in the same location.  Over a period of days, all but oneinput in a synaptic location will lose territory, detach, and withdraw, with the remaininginput expanding into the newly vacated territory and transitioning into a more maturemorphology (Sanes and Lichtman, 1999). The outcome of this process seems to beregulated, at least in part, by neuronal activity, as synapse elimination accelerates as thedisparity in synaptic strength between competing inputs grows, and the remaining motoraxon generally has a greater synaptic strength than its competitors (Colman et al., 1997).  If
5two inputs are equally effective in driving the postsynaptic muscle fiber, both might remain(Herrera and Werle, 1990). The activity-dependent nature of this competition has led to amodel describing the types of signals that might mediate this process (Lichtman andColman, 2000).  This model proposes that synapse elimination is dependent upon twosignals: 1) a secreted punishment signal capable of destabilizing weak synapses and 2) alocal protective signal that shields strong inputs from the punishment signal (Figure 1.1).It is not yet known whether this model is correct or applies to CNS synaptic refinement,and the elusive ‘protective’ and ‘punishment’ signals have not been identified. I hypothesizethat molecules that normally protect against the inappropriate removal of self cells in theimmune system, such as CD47, could act as protective signals to prevent the elimination ofappropriate synapses during CNS development (Chapter 4).Synaptic refinement in the CNS has proven harder to study.  Much of this difficultystems from the fact that CNS synapses are both more complex and harder to visualize thanNMJ synapses.  The regions that undergo pruning in the CNS are diverse and contain avariety of synapses, and many of these synaptic connections are small, dense, and difficultto resolve individually using microscopy.  Additionally, many regions that undergo well-characterized pruning are in deeper brain structures that are not amenable to chronic liveimaging.  In the CNS, a great deal of what is known about pruning has been elucidatedelectrophysiologically and supplemented with anatomical tracing and imaging of fixedtissue. While many brain areas are now known to undergo pruning, including thebrainstem, cerebellum, and somatosensory system (Kano and Hashimoto, 2009; Lu andTrussell, 2007; Wang and Zhang, 2008), synaptic refinement has been most extensively
6Figure 1.1. The punishment model of synapse elimination. Two signals havebeen proposed as mediators of activity-dependent synapse elimination: 1) Asecreted punishment signal (orange) that binds to and destabilizes weak orasynchronously firing neurons, and 2) A local protective signal (blue) that shieldsmore active neurons from the punishment signal.
7characterized in the visual system, making it a good model for further investigation of themolecular mechanisms underlying this process (Feller, 1999; Huberman et al., 2008; Shatzand Kirkwood, 1984).
The retinogeniculate systemSynaptic refinement in the visual system has been primarily studied at theretinogeniculate synapse, which exhibits remarkably precise connectivity in the matureCNS.  In this system, retinal ganglion cells (RGCs) that reside at the back of the eye projectto relay neurons in the dorsal lateral geniculate nucleus (dLGN) of the thalamus.  In theadult CNS, RGCs exhibit retinotopic mapping and eye-specific segregation, meaning thatRGCs in specific retinal locations project to defined areas of the dLGN and that RGCs fromthe left and right eyes send inputs to distinct, non-overlapping territories within thethalamus (Guido, 2008; Hong and Chen, 2011; Huberman et al., 2008; Sretavan and Shatz,1986).  Additionally, RGC-relay neuron connectivity is between one-to-one or three-to-onein the mature circuit, indicating that a single relay neuron obtains all of its visualinformation from only one to a few RGCs (Chen and Regehr, 2000; Hooks and Chen, 2006;Ziburkus and Guido, 2006).The immature circuit, however, contains a great deal of redundancy.  During earlydevelopment, RGCs from the two eyes project to overlapping regions in the dLGN and relayneurons are multiply innervated by as many as ten or more weak inputs.  The maturecircuitry is obtained following two phases of synaptic refinement.  The first phase involvesthe pruning of overlapping connections and the establishment of a retinotopic map, whilethe second phase is characterized by the elimination of supernumerary inputs (Hong andChen, 2011; Huberman et al., 2008; O'Leary and McLaughlin, 2005). Although synaptic
8refinement in the dLGN is often described in terms of the removal of excess or incorrectconnections, it is important to note that this is also a period during which extensivearborization and bouton formation occurs to strengthen the remaining inputs (Dhande etal., 2011; Hahm et al., 1999; Snider et al., 1999).The first phase of pruning occurs after birth but before eye-opening in the mouseand is largely complete by postnatal day 10 (P10) (Jaubert-Miazza et al., 2005). This periodof pruning is driven by spontaneous retinal waves caused by correlated bursts of actionpotential firing in the retina (Feller, 1999; Stellwagen and Shatz, 2002; Torborg and Feller,2005).  During this period, eye-specific territories are formed such that RGCs from the twoeyes project to stereotyped, non-overlapping regions within the dLGN (Figure 1.2).  Theresolution of overlapping inputs into distinct territories is thought to occur via theweakening and removal of incorrectly targeted inputs and the strengthening andmaintenance of correctly targeted projections (Penn et al., 1998; Shatz, 1990).  For thisprocess to occur normally, inputs from the two eyes must be able to compete, as removingone eye prevents the pruning of incorrectly targeted connections sent from the remainingeye (Sretavan and Shatz, 1986).  Additionally, disrupting retinal activity either geneticallyor pharmacologically impairs eye-specific segregation, highlighting the necessity ofspontaneous activity for this process (Bansal et al., 2000; Demas et al., 2006; Grubb et al.,2003; Shatz and Stryker, 1988; Stellwagen and Shatz, 2002).The second phase of pruning involves the removal of excess connections from thenow primarily monocularly innervated dLGN relay neurons (Figure 1.2).  The first part ofthis phase is thought to occur from P8-P16 and depend on spontaneous retinal activity,including both retinal waves and RGC spiking (Hong and Chen, 2011). During this period,
9Figure 1.2. Synaptic refinement in the retinogeniculate system. In the maturedLGN, left and right eyes project to distinct, eye-specific territories that can bevisualized using anterograde tracers (left).  Most RGCs project contralaterally,crossing the optic chiasm, while a small number project ipsilaterally and form adefined patch.  During early development (P5), RGC inputs from left and right eyesproject overlapping inputs onto relay neurons in the dLGN (right, yellow).  By P10,the first phase of pruning has led to the removal of nearly all overlapping inputs tocreate eye-specific territories.  Relay neurons are still multiply innervated at thisstage.  Over the next few weeks, spontaneous and visually evoked activity drive theremoval of supernumerary inputs so that each relay neuron ultimately receivesinput from only 1-3 RGCs.
10
the number of inputs received by each relay neuron goes down by half while the strength ofeach input increases 8-fold (Chen and Regehr, 2000; Hooks and Chen, 2006; Ziburkus andGuido, 2006). After this point, inputs continue to strengthen and the number of innervatinginputs declines until approximately P32 (Figure 1.2). While this latter phase of refinementwas also thought to rely exclusively on spontaneous activity, recent research hasuncovered a role for visual experience in maintaining the mature circuitry (Hooks andChen, 2008). Visual deprivation via late dark rearing after P16 can increase RGC inputnumber and weaken synaptic strength, however, this change is plastic and can be reversedby re-exposure to light. Ongoing study continues to enhance our understanding of synapticrefinement in this system, and the body of work performed to characterize this circuitenables investigation of the molecules that direct and regulate the refinement process.
Mechanisms underlying retinogeniculate refinementWhile the developmental timing and connectivity changes that occur duringretinogeniculate pruning are fairly well understood, knowledge of the molecularmechanisms underlying this process is limited. Given the clear importance of retinalactivity for proper refinement, some of the first molecules implicated in retinogeniculatepruning were those required for normal retinal waves, such as the 2 subunit of thenicotinic acetylcholine receptor (Grubb et al., 2003; Muir-Robinson et al., 2002; Rossi et al.,2001).  The no b-wave (nob) mouse, a mouse with prolonged retinal wave activity, alsodisplays pruning defects, although, in this case, eye-specific territories initially developonly to desegregate as waves persist abnormally beyond eye opening (Demas et al., 2006).Additionally, disruption of axon guidance cues known to direct retinotopy impairs eye-specific segregation and causes other wiring defects (Pfeiffenberger et al., 2005;
11
Pfeiffenberger et al., 2006).  The identification of these molecules as critical forretinogeniculate refinement aligns with electrophysiological and axon guidance studies ofthe retinogeniculate system.More recently, an unexpected class of molecules has been implicated in synapticrefinement in the retinogeniculate system. A number of immune molecules and their CNShomologs have been found to be required for proper pruning in the dLGN, including class Imajor histocompatibility complex (MHCI) molecules, complement cascade components C1qand C3, and neuronal pentraxins 1 and 2 (NP1, NP2), CNS relatives of immune moleculelong pentraxin 3 (PTX3) (Hong and Chen, 2011; Huberman et al., 2008). In the immunesystem, these molecules help phagocytes identify pathogens or debris in need of removal,and it appears that they may perform a similar function in the brain, in this case, denotingsynapses in need of pruning.  Mice deficient in MHCI molecules or complement cascadecomponents C1q or C3 do not properly form eye-specific territories; instead, relay neuronsin knockout mice receive input from both eyes, indicating a failure to prune overlappingconnections (Datwani et al., 2009; Huh et al., 2000; Stevens et al., 2007). Double NP1/2knockouts experience delayed pruning, as eye-specific segregation takes longer to reachcompletion in these animals (Bjartmar et al., 2006). The discovery that these immunemolecules regulate retinogeniculate refinement is quite intriguing, and begs the question ofhow exactly they execute this function.  If immune molecules normally signal to phagocyticcells in the immune system, could they be doing something similar in the brain?
Microglia play critical roles in the developing brainMicroglia are the resident phagocytes and immune cells of the CNS.  Due to theirmacrophage-like properties, much of the work on microglia has focused on their reactive
12
role in CNS diseases, however, recent studies indicate that microglia regulate a variety ofprocesses that occur throughout the life of an organism (Cronk and Kipnis, 2013; Eyo andWu, 2013; Hanisch and Kettenmann, 2007).  These multifunctional cells may even actprenatally, as fate mapping has shown that microglia enter the brain as early as embryonicday 9 (E9) (Ginhoux et al., 2010).  Microglia are therefore present as the brain develops,and are important cellular mediators, and possibly instigators, of programmed cell death(PCD) (Marin-Teva et al., 2004; Wakselman et al., 2008).  Microglia may also regulate cellnumbers in the developing brain via effects on neurogenesis and neural progenitor cells,although more work is necessary to confirm these findings (Morgan et al., 2004; Sierra etal., 2010; Sultan et al., 2013). Importantly, as we learn more about microglial function inthe developing and adult CNS, it becomes increasingly clear how many parallels existbetween their function in the brain and macrophage function in the immune system.  Thissuggests that many molecular mechanisms may be shared between the CNS and immunesystem, and that a great deal can be learned by taking advantage of this conservation.
Microglia: specialized CNS “macrophages”A key to understanding microglia may be their high degree of similarity tomacrophages.  Microglia can be considered the tissue-resident macrophages of the CNS andthey share a common origin with other tissue-resident macrophages: the embryonic yolksac (Cronk and Kipnis, 2013). Microglia are also functionally similar to macrophages, asthey play an important role in the development and maintenance of healthy tissue, buthave a reactive phenotype involving phagocytosis and cytokine secretion during disease orinjury (Prinz et al., 2014; Ransohoff and Cardona, 2010). These cells can even berecognized by many of the same markers (Saijo and Glass, 2011), which is sometimes
13
problematic as commonly used microglial markers, such as Iba-1, cannot distinguishbetween resident microglia and infiltrating peripheral immune cells during disease.Due to these many commonalities, it is unsurprising that mechanisms regulatingmicroglia and functions executed by microglia are comparable to those involvingmacrophages in the immune system.  A number of molecules and signaling pathways havealready been found to behave analogously in these two systems. For instance, CX3CL1, orfractalkine, regulates monocyte chemoattraction in the immune system via CX3CR1(Ravichandran, 2011), and mice lacking this receptor exhibit fewer microglia during braindevelopment and a decrease in synaptic pruning (Paolicelli et al., 2011).  In the immunesystem, toll-like receptors on macrophages initiate an inflammatory response, and theirmicroglial counterparts perform the same function, particularly during neurodegenerativedisease (Ransohoff and Brown, 2012; Wyss-Coray and Rogers, 2012).  Complementmolecules tag pathogens or debris for removal by macrophages in the immune system, andthey also appear to tag debris, such as amyloid plaques and apoptotic cellular material formicroglial engulfment during neurodegenerative disease or injury (Afagh et al., 1996;Fonseca et al., 2004; Lambris and Tsokos, 1986; van Lookeren Campagne et al., 2007).Microglia also secrete many of the same pro-inflammatory cytokines as macrophages, suchas TNF- and interleukin family members, that may play a role in neurodegenerativediseases or other instances of neuroinflammation (Perry et al., 2010; Ransohoff and Perry,2009; Wyss-Coray and Rogers, 2012).However, microglia are specialized cells and exhibit notable differences frommacrophages.  Unlike macrophages, microglia appear to be a self-renewing population,with little contribution from bone marrow-derived monocytes except after irradiation
14
(Prinz et al., 2014). They have also recently been found to carry a unique genetic signature,for, although they share many common genes and signaling pathways with macrophages, arecent profiling study found that resident microglia express genes not found in immunecells or tissue resident macrophages, including Fcrls, Olfml3, Tmem119, P2ry12, Hexb and
Tgfbr1 among others (Butovsky et al., 2014).  These genes can be used to differentiateresident microglia from peripheral cells that enter the brain during disease, a property oftremendous utility to the field. Furthermore, as microglia participate in a variety ofprocesses in the CNS, they may use some of their shared signaling molecules in a way thatdoes not mimic macrophage function.  One example of this is the ability of pro-inflammatory molecule TNF- to regulate homeostatic synaptic scaling (Beattie et al., 2002;Stellwagen and Malenka, 2006). Yet, the overwhelming similarities between microglia andmacrophages allow the immune system to serve as a foundation for understandingpotential microglial functions and signaling pathways.
Microglia influence synapse development and functionPart of the reason that microglia in the healthy brain went overlooked for so longmay have to do with terminology and perception.  Microglia in the healthy, adult brain areoften referred to as “resting” cells and possess a small cell body and numerous fine,branched processes (Ransohoff and Perry, 2009).  During CNS disease, microglia retracttheir processes, adopt an ameboid morphology, and become highly phagocytic, a state thatis controversially and ambiguously referred to as “activated.” Advances in live imagingtechnologies have enabled improved visualization of resting microglia, and exciting newdata obtained using two-photon live imaging challenge the existing nomenclature.  Restingmicroglia are actually quite dynamic, continuously extending and retracting processes to
15
sample the brain parenchyma (Davalos et al., 2005; Nimmerjahn et al., 2005).  While thissurveillance behavior allows them to rapidly detect and respond to injury, process motilitymay have other functions, as it changes in response to neuronal activity (Li et al., 2012;Wake et al., 2009).  Intriguingly, resting microglia also make contact with dendritic spines,raising the question of what microglia-synapse contact might signify (Tremblay et al., 2010;Wake et al., 2009).Recent work has unveiled numerous types of microglia-synapse interactions in theCNS.  In the developing brain, microglia phagocytose synaptic material, participating insynaptic refinement and shaping circuit function. Mice deficient in fractalkine receptorCX3CR1, a microglia-specific receptor in the healthy CNS, have fewer microglia during CNSdevelopment as well as reduced synaptic pruning and functionally immature synapses inthe hippocampus (Paolicelli et al., 2011).  These defects resolve as microglia numbersnormalize during adulthood. Microglia-synapse interactions also appear to be experience-dependent, as changes in light exposure alter microglia process motility, spine contact, andphagocytosis in visual cortex (Tremblay et al., 2010).  Some of the effects of microglia onsynapse development may even occur prenatally, as loss of DAP12, a microglial signalingadaptor, impairs synapse maturation in vivo and in cultured neurons isolated from P0DAP12-deficient pups (Roumier et al., 2004; Roumier et al., 2008). Neuronal activity alsoinfluences microglia-synapse interactions, likely due to the many neurotransmitterreceptors expressed by microglia (Kettenmann et al., 2011). While early studies arecontradictory, as some demonstrate increased process motility and synapse contact withincreased activity and others show the reverse, it is clear that microglia can sense andrespond to changes in activity (Eyo and Wu, 2013).
16
Given increasing evidence that microglia shape synaptic connectivity and function,recent work has begun to focus on the behavioral consequences of disrupting microglia-synapse interactions.  Multiple studies using CX3CR1-deficient mice indicate that loss ofthis microglia-specific gene may have behavioral consequences.  Heterozygous micedisplay deficits in memory, motor learning, and contextual fear conditioning, as well asimpaired LTP induction (Rogers et al., 2011).  Homozygotes exhibit reduced functionalbrain connectivity by functional magnetic resonance imaging (fMRI) and decreased socialinteraction and increased grooming behaviors (Zhan et al., 2014). Pathological grooming inthe hoxb8mutant mouse has also been linked to microglial defects, as the hoxb8mutantphenotype can be rescued by bone marrow transplant, which allows wild type microglia toinfiltrate into the mutant brain (Chen et al., 2010). Another study used bone marrowchimerism to introduce wild type microglia into a mouse model for Rett syndrome, whichseemed to rescue some of the more severe deficits (Derecki et al., 2012). Additionally,recent work demonstrates that mice lacking microglia exhibit impaired motor learning aswell as spine alterations, suggesting that microglia can influence synaptic changes thataffect circuit function (Parkhurst et al., 2013).
Microglia in CNS diseaseWhile much of this work has been done in mouse, it appears that microgliadysfunction can produce similar behavioral deficits to those recognized as hallmarks ofneurodevelopmental and neuropsychiatric disorders, including autism spectrum disorder(ASD, impairments in social behavior) and obsessive compulsive disorder (OCD,pathological grooming). Various genome wide association studies (GWAS) conducted onhuman patients with these disorders have begun to identify immune molecules known to
17
regulate microglia directly or to regulate microglia-associated signaling cascades aspotential risk factors (Voineagu et al., 2011). Furthermore, mouse models for psychiatricdisorders based on maternal immune activation (MIA) often exhibit synaptic and/ormicroglial abnormalities (Giovanoli et al., 2013).  The recent studies implicating microgliain synaptic circuit development and function could indicate a role for microglia in multipleneurodevelopmental and neuropsychiatric disorders, as defects in developmental circuitformation and wiring in humans are becoming increasingly associated withneurodevelopmental and neuropsychiatric impairments (Belmonte et al., 2004;Courchesne et al., 2007; Keshavan et al., 1994; Tye and Bolton, 2013). Moreover,dysregulated microglia and immune molecules are beginning to be observed in humanpatients with these disorders (Frick et al., 2013; Morgan et al., 2010; Tetreault et al., 2012;Vargas et al., 2005).Many CNS neurodegenerative diseases are also associated with microglialdysfunction (Wyss-Coray and Rogers, 2012). Postmortem analysis of human tissue oftenreveals morphologically abnormal cells; however, it remains to be determined whethermicroglial dysfunction plays a causal role in pathogenesis or is a consequence of theneuroinflammation that occurs during disease progression (Napoli and Neumann, 2009;Schafer and Stevens, 2010; Tansey et al., 2008). Current studies on neurodegenerativediseases, including Alzheimer’s disease (AD) and Huntington’s disease (HD), indicate thatsynapse loss or dysfunction begins long before symptom onset (DiProspero et al., 2004;Scheff and Price, 2003; Selkoe, 2002), and one hypothesis is that microglia may be involved(Stephan et al., 2012). This appears to be a possibility in a mouse model of tauopathy(P301S), in which hippocampal synapse loss and microglial activation can be observed as
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early as 3 months, while significant atrophy does not occur until at least 9-12 months of age(Yoshiyama et al., 2007).  Although data are only correlative at this stage, aberrant re-activation of developmental microglial pruning programs may be one mechanismunderlying neurodegenerative disease; and the implication of microglia in bothneurodevelopmental and neurodegenerative diseases underscores their importance fornormal brain development and function.
Tools for studying microgliaOne reason the study of microglial function has lagged behind the study of otherCNS cell types is due to issues of accessibility.  To assay normal microglial behavior andfunction, work must be performed in vivo or ex vivo, as cultured microglia typicallytransform into an activated state and behave as they would during injury or disease. Forthis reason, most early studies relied on inferences made based on observations ofmicroglial cell numbers, morphology, and markers of activation in immunostained, fixedtissue. As high-resolution in vivo imaging technologies have improved, this has begun tochange. When used with a microglial reporter line, the CX3CR1-GFP mouse (Jung et al.,2000), microglia can be imaged through cranial windows or thin skull preparations inanesthetized or awake mice.  This approach can be used to visualize microglial movementand dynamics basally and in response to various stimuli, and if mice are crossed to otherreporter lines, this approach can be applied to examine microglial interactions with othercell types (Davalos et al., 2005; Nimmerjahn et al., 2005; Tremblay et al., 2010; Wake et al.,2009). Studies using these approaches have greatly enhanced our understanding of howmicroglia behave in the healthy brain, although they are limited to imaging brain regionsnear the skull.
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New tools have also vastly improved our ability to regulate microglial function.  Inthe past, to determine the effects of altering microglial function, broad anti-inflammatoryagents such as minocycline were used, which would affect microglia in addition to a varietyof other cells and inflammatory signaling cascades throughout the animal. Knockout micecould be used, but, to claim microglia-specific effects, the gene in question could not beexpressed by other cell types.  Recently, mice have been generated that will enablemicroglia-specific genetic deletion. Two mice make use of the CD11b promoter, which isspecific to microglia in the brain, to drive the expression of the herpes simplex virusthymidine kinase (HSVTK) or the diptheria toxin receptor (DTR), which will lead tomicroglial death when mice are treated with ganciclovir or diptheria toxin, respectively(Duffield et al., 2005; Heppner et al., 2005).  There are also mice that completely lackmicroglia, including the PU.1 null mice and CSF1R knockouts, although neither line lives toadulthood (Erblich et al., 2011; McKercher et al., 1996). New cre lines, the CX3CR1-Creand –CreER mice, use the fractalkine receptor promoter to excise floxed genes of interestfrom microglia to assay cell-specific effects (Parkhurst et al., 2013; Yona et al., 2013).Additionally, these lines can be used to ablate microglia, as new work indicates that drivingmicroglia-specific expression of the diptheria toxin receptor in CX3CR1-CreER mice leadsto microglial ablation when diptheria toxin is administered (Parkhurst et al., 2013).Finally, new tools are also being used to deplete microglia, such as delivery of clodronateliposomes, although these will affect other CNS phagocytes as well (Faustino et al., 2011).These and other technical advances have already contributed greatly to our understandingof microglia, and will facilitate and quicken the pace of knowledge acquisition regardingmicroglia-specific functions in the years to come.
20
“Eat me” and “Don't eat me” signals regulate engulfment by phagocytesMicroglia are clearly integral to normal CNS development and function.  Althoughthe molecular mechanisms underlying their myriad roles in the brain are still beingexplored, one of their cellular properties features prominently during both CNSdevelopment and disease, that of phagocytosis (Prinz et al., 2014). This is an ability theyshare with their immune system counterpart, the macrophage, so understanding howphagocytosis is regulated in macrophages may provide insight into genes necessary fornormal microglial function.  The engulfment of apoptotic cells, debris, and pathogens is akey function of macrophages, and microglia similarly engulf material in the CNS (Ransohoffand Cardona, 2010; Ransohoff and Perry, 2009).  To effectively perform this function,macrophages must differentiate between foreign or harmful material and healthy “self”cells that must remain in the body. They make this distinction via extracellular signalsfound on self and non-self material (Figure 1.3), commonly known as “eat me” and “don’teat me” signals (Griffiths et al., 2007).
“Eat me” and “don’t eat me” signals regulate macrophage phagocytosis“Eat me signals” are molecules or modifications on apoptotic or infected cells thatallow for identification by phagocytes.  There are many such signals, and they can take theform of previously internalized molecules that become exposed on the cell surface,modifications to existing surface molecules, or the binding of new molecules to the cell(Elward and Gasque, 2003; Gardai et al., 2006; Grimsley and Ravichandran, 2003; Lauber etal., 2004).  Some classic examples of “eat me signals” are the phospholipidphosphatidylserine, which translocates from the inner to the outer surface of apoptoticcells, and members of the classical complement cascade, which can bind to or opsonize
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Figure 1.3. “Eat me” and “don’t eat me” signals regulate phagocytosis in the
immune system. Normal, healthy self cells (light blue, right) express “don’t eatme” signals, such as CD47 and CD200, to instruct phagocytes (green) carryingreceptors for these molecules, such as SIRP and CD200R, not to engulf them.However, when cells become injured, infected, or apoptotic (dark blue, left), theydownregulate or re-localize “don’t eat me” signals, and express or are bound by“eat me” signals.  Complement molecules such as C1q and C3 are classic “eat me”signals that encourage phagocytosis by signaling to receptors, such as CR3, onmacrophages.
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dying cells and debris.  Phagocytes express a variety of cell surface receptors to detectthese signals and may only need a subset of these receptors to function efficiently.While it is important that phagocytes engulf apoptotic cells or pathogenic materialto prevent harm to the organism, uncontrolled engulfment or an overactive immuneresponse can be harmful. Therefore, mechanisms exist to protect “self” cells and inhibitphagocytic activity. Just as phagocytes are instructed to remove specific cells or materialvia “eat me” signals, they must be told which cells to avoid by “don’t eat me” signals. “Don’teat me” signals are membrane bound or secreted molecules normally expressed by “self”cells and not by pathogens that are recognized by receptors on phagocytes (Elward andGasque, 2003; Griffiths et al., 2007; Grimsley and Ravichandran, 2003). Many of these actas negative regulators of phagocyte function and can inhibit phagocytic activity. Classicexamples of “don’t eat me” signals are CD200 and CD47, which interact with receptorsCD200R and SIRPα respectively to directly or indirectly inhibit engulfment by phagocytes.My dissertation research investigates the role of CD47 and CD200 in CNS synapticrefinement (Chapter 4). In the immune system, CD47 directly protects self cells frominappropriate removal, as binding to its receptor, SIRPα, on phagocytes causes receptortyrosine phosphorylation, which recruits SHP1 or SHP2 to inhibit phagocytosis (Barclayand Van den Berg, 2014; Matozaki et al., 2009).  Red blood cells (RBCs) lacking CD47exhibit a markedly increased rate of clearance compared to WT RBCs, and mice lacking thecytoplasmic tail of SIRPα also display increased RBC clearance, indicating that the CD47-SIRPα interaction is critical for inhibiting excess phagocytosis (Ishikawa-Sekigami et al.,2006; Oldenborg et al., 2000). Additionally, red blood cells opsonized with “eat me” signals,
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such as C3b, are cleared much more effectively when they lack protective signal CD47(Oldenborg et al., 2001).CD200 plays a slightly different protective role.  Its ligation to CD200R onphagocytes leads to receptor interaction with Dok2 and activation of RasGAP, whichdecreases synthesis of many pro-inflammatory cytokines including TNF-, IFN-, and IL-1,and promotes synthesis of anti-inflammatory cytokines such as IL-10 and TGF- (Barclay etal., 2002; Minas and Liversidge, 2006; Walker and Lue, 2013).  CD200 is therefore thoughtto be primarily responsible for preventing macrophage activation and inflammatorysignaling.  CD200 deficient mice exhibit an increased number of activated myeloid cells andincreased susceptibility to autoimmune disease development (Hoek et al., 2000; Wright etal., 2000). As microglial phagocytosis appears to be in important mechanism for sculptingdeveloping synaptic circuits (Schafer and Stevens, 2013), I chose to focus on these two“don’t eat me” signals to determine whether removing inhibition of phagocytosis orinflammation would have consequences for developmental synaptic refinement.
“Eat me” and “don’t eat me” signals in the brainAlthough “eat me” and “don’t eat me” signals have been studied primarily in theimmune system, it is becoming increasingly clear that they are utilized in the CNS as well(Figure 1.4) (Elward and Gasque, 2003). “Eat me” signals are often exposed on or bound tocells in the immune system in response to pathogens and inflammation, and they have beenobserved in the CNS under similar circumstances.  Diseases characterized by inflammation,such as Alzheimer’s disease, exhibit increased complement activation in both human tissueand mouse models, as well as complement localization to plaques and to the neuropil(Afagh et al., 1996; Fonseca et al., 2004; Wyss-Coray and Rogers, 2012).  Whether this is
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Figure 1.4. “Don’t eat me” signals communicate with microglia in the CNS. Inthe immune system (left), “don’t eat me” signals are expressed by healthy self cells(blue) and communicate with receptors on phagocytes (green).  The samemolecules have a similar distribution in the CNS (right), where “don’t eat me”signals are expressed by neurons in addition to other self cells and communicatewith receptors on microglia (green).
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harmful, beneficial, or simply a hallmark of inflammation remains to be determined, assome argue that complement activation may lead to increased neurodegeneration, whileothers suggest that complement deposition on plaques enhances clearance by microglia.Complement activation has also been observed following acute injury, such as in cerebralischemia, head trauma, and stroke, and in other chronic CNS diseases such as AmyotrophicLateral Sclerosis (ALS) and Huntington’s disease (HD) (Chiu et al., 2009; Gasque et al.,2000; van Beek et al., 2003; Yanamadala and Friedlander, 2010).Just as “eat me” signals are increased during CNS disease and injury, “don’t eat me”signals may be necessary to help protect the brain from excessive harm. Profiling datafrom human multiple sclerosis (MS) lesions indicate that CD47 is downregulated indiseased tissue (Koning et al., 2007). In mouse models for MS, known as experimentalautoimmune encephalomyelitis (EAE), blocking CD47 with an antibody during the height ofthe disease worsens disease progression (Han et al., 2012).  CD200-deficiency leads to aworsening of EAE symptoms in mouse models (Wright et al., 2000), and antibody blockadeof this molecule promotes microglial activation and dopaminergic neuron loss in a ratmodel of Parkinson’s disease (PD) (Zhang et al., 2011).  A reduction in CD200 has also beenobserved in affected areas of human AD brains (Walker et al., 2009), and the CD200-CD200R interaction appears dysregulated in cells from PD patients (Walker and Lue,2013). These data suggest that “don’t eat me” signals play an important role in dampeninginflammation and microglial activation and phagocytosis during CNS disease.The involvement of “eat me” and “don’t eat me” signals in CNS disease mirrors theirfunction in the immune system.  Unexpectedly, some of these same signals have been foundto be critical for normal CNS development. Recent work has identified a role for the classic
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“eat me” signals of the complement cascade, C1q and C3, in nervous system development.Mice deficient in either molecule fail to complete proper retinogeniculate pruning andexhibit overlapping ipsilateral and contralateral territories and multiply innervated relayneurons into adulthood (Stevens et al., 2007). There is also some evidence that thesepruning defects occur throughout the brain, as juvenile C1q knockout mice have a greaterdensity of axonal boutons on layer V neocortical pyramidal neurons as well as hyper-excitability and behavioral seizure activity (Chu et al., 2010). Defects in pruning mayactually be beneficial once mice age, as C3KO mice exhibit enhanced LTP and cognitioncompared to aged WT mice, and aged C1qKO mice exhibit less cognitive memory decline(Shi et al., 2012; Stephan et al., 2013). The role of “don’t eat me” signals in braindevelopment is relatively unexplored, however, a recent study suggests that loss of theCD47 receptor, SIRPα, during a specific developmental time window influences synapticmaturation (Toth et al., 2013).  Whether this is due to changes in “don’t eat me” signaling ormicroglial phagocytosis is unknown.
SignificanceWhile scientists have known about the existence of synaptic refinement for over 20years, there is still little known about the molecular mechanisms that direct this process.Recent studies have begun to identify key molecules, and, intriguingly, many of them areshared with the immune system (Boulanger, 2009; Huberman et al., 2008; Shatz, 2009).Discovering additional molecules that regulate pruning and the cellular interactionsunderlying this process will greatly contribute to understanding a fundamental aspect ofbrain development.  While we use the retinogeniculate system as a model, many of themolecules identified in this system have been found to regulate pruning in other areas and
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to be involved in a variety of CNS diseases (Stephan et al., 2012).  This highlights the powerof the retinogeniculate system and the likelihood that new molecular discoveries will beapplicable across brain regions and potentially disease relevant.Another conceptual advance that could arise from this work is the notion thatimmune molecules and microglia are critical for the development of a normal, healthybrain. For many years, these molecules and cells were thought to be active only duringinjury or disease, but this idea is becoming outdated (Ransohoff and Perry, 2009). Recentwork has shown that microglia survey their environment, contact spines, and shapesynaptic circuits and behavior in healthy animals, and immune molecules have beenimplicated in synaptic refinement and circuit formation as well (Eyo and Wu, 2013;Huberman et al., 2008; Saijo and Glass, 2011). The work discussed in this dissertationascribes a new function to microglia in developmental synaptic refinement and furtherchallenges the idea that microglia are quiescent when not reacting to an insult.Additionally, this work is the first to describe an analogous immune-like function for “don’teat me” signals in the developing CNS, and demonstrates that immune molecules in thedeveloping brain serve a regulatory role, keeping microglial phagocytic activity within anappropriate range.Finally, identifying molecules and cells that play a critical role in brain developmentprovides candidates to examine in a variety of CNS disorders and diseases.  Manymolecules previously shown to regulate nervous system development, including synapseformation and pruning, have since been implicated in various neurodevelopmental andneuropsychiatric disorders (van Beek et al., 2003).  For instance, a number of moleculesrequired for synapse formation, including Neuroligins and Shanks, have also been
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implicated in autism and the generation of autistic-like behaviors (Kumar and Christian,2009). Some of the same immune molecules that have been linked to developmentalsynaptic pruning have appeared, along with their regulators, in Genome Wide AssociationStudies (GWAS) of autism and schizophrenia and many of these molecules are alsoaberrantly expressed in neurodegenerative disease (Gasque et al., 2000; Voineagu et al.,2011). Microglial abnormalities have been associated with neurodevelopmental andneurodegenerative disease as well, making it likely that molecules that affect microglialfunction will be disease relevant (Dheen et al., 2007; Frick et al., 2013; Morgan et al., 2010).The molecules described in this work regulate synaptic refinement and microglialphagocytosis during development, and alterations in these molecules have already beenobserved in neurodegenerative disease. As defects in synaptic connectivity and brainwiring appear to be a common thread in a variety of CNS diseases, these molecules arelikely to be implicated in additional neurodevelopmental and neurodegenerative diseasesonce their function in synaptic refinement in the healthy brain is revealed.
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MiceC57BL/6 mice were obtained from Charles River.  CX3CR1::EGFP, C3KO, CR3 KO, Chx10-Cre, Rosa26-STOP-tdTomato, and CD47KO mice were obtained from Jackson Labs. CD200knockout mice were generously provided by Dr. Agnes Vignery.  SIRPα; Actin-CreER micewere provided by Dr. Hisashi Umemori. CX3CR1+/GFP;CCR2+/RFP tissue was obtainedfrom Dr. Richard Ransohoff. For engulfment experiments, CR3 KO or C3 KO mice werecrossed with CX3CR1::EGFP. All experiments using CX3CR1::EGFP, Chx10-cre, or Rosa26-STOP-tdTomato mice were performed with heterozygotes. For minocycline experiments,C57BL/6 or CX3CR1::EGFP mice were injected daily with minocycline (Sigma; 75mg/kg) orvehicle (saline) subcutaneously from P4-P8. Experiments were approved by theinstitutional care and use committee of Boston Children’s Hospital in accordance with NIHguidelines for the humane treatment of animals.
ImmunohistochemistryBrains and eyes were harvested from mice following transcardial perfusion with PBS and4% paraformaldehyde (PFA).  Tissue was postfixed in 4% PFA for two hours afterperfusion, and then washed 3X with phosphate buffered saline (PBS) and transferred to30% sucrose for cryoprotection. For whole mount retinas, eyes were transferred to PBSfollowing postfix and PBS wash.
If used for cryosectioning, tissue was embedded in a 2:1 mixture of 20% sucrose: OCT andstored at -80° C until use. Fourteen micron sections were collected, and then dried, washedwith PBS, and blocked with a 5% bovine serum albumin (BSA) + .2% Triton-X 100 solution
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for 1 or 2 hours (2hrs if sections were to be used for SIM imaging). Primary antibodiesdiluted in antibody buffer were applied to sections for overnight (O/N) incubation at 4° C,with the exception of Iba-1, in which slides were incubated O/N at room temperature (RT).After 3 PBS washes, secondary antibodies diluted 1:250 in antibody buffer were added toslides and incubated for 2hrs at RT. Slides were then washed 3X in PBS and mounted withVectashield + DAPI (Vector Labs).
If used to make sliding microtome sections, brains were flash frozen and then mounted inOCT on the freezing stage of a sliding microtome.  Forty micron floating sections werecollected from the microtome blade using a paintbrush and placed in 24-well platescontaining PBS.  For staining, sections were washed with PBS, blocked with a 10% normalgoat serum solution (NGS), and incubated O/N with primary antibodies diluted in 10% NGS+.3% Triton-X 100. The next day, sections were washed 3X in PBS, incubated for 2hrs at RTwith secondary antibodies diluted 1:250 in the antibody diluent, and then washed 3X inPBS and applied to slides using a paintbrush.  Sections were allowed to dry and thenmounted with Vectashield + DAPI. For retina whole mount staining, retinas were dissectedand incubated O/N at 4° C in primary antibody diluted in 1% NGS and 2% Triton-X 100. Allother steps are identical to those described above.
All images were acquired using either an UltraView Vox spinning disk confocal microscopeequipped with diode lasers (405nm, 445nm, 488nm, 514nm, 561nm, and 640nm) andVolocity image acquisition software (Perkin Elmer), an Imager.M2 microscope equippedwith diode lasers (405, 488, 555 and 639nm) and Zen 2009 image acquisition software
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(Carl Zeiss), or an Imager.Z1 microscope equipped with Axiovision software (Carl Zeiss).
Antibody dilutions used: CD47 (BD Pharmingen, 1:500), SIRPα (BD Pharmingen, 1:500),CD200 (R+D systems, 1:250), Homer (Synaptic systems, 1:200), Vglut2 (Millipore, 1:2000IHC; 1:1000 ImmunoEM, 1:200 AT), Iba-1 (Wako, 1:400 O/N at room temperature IHC,1:1000 ImmunoEM), SV2 (DSHB, 1:20), CD68 (Serotec, 1:200, clone FA-11), CR3 (CD11b,Serotec, 1:200, clone 5C6), DsRed2 (Clontech), C3 (MP Biomedicals, 1:200), TUJ1 (Covance,1:400), GFAP (Sigma, 1:1000), Cleaved caspase (Asp175, Cell Signaling, 1:200), GluR1(Millipore, 1:100 AT), GFP (rabbit, Millipore, 1:500), GFP (chicken, Abcam, 1:500)
Eye-specific segregation analysisMice were anesthetized with inhalant isofluorane and given intraocular injections ofcholera toxin-beta subunit (CTB) conjugated to Alexa 488 (green) in the right eye and Alexa594 (red) in the left eye as described in (Bjartmar et al., 2006).  Mice were sacrificed theday after injection and tissue was processed and analyzed as previously described (Jaubert-Miazza et al., 2005, Stevens et al., 2007). Images were selected for analysis and thresholdedblind to genotype, and only age-matched littermate controls were used.
Engulfment analysisMice were injected with anterograde tracers (CTB-594 and CTB-647) at P4 and perfused 24hours later using the same methods as for immunohistochemistry.  Brains were sectionedon the sliding microtome and 40m sections were stained for Iba-1 if not already labeledby CX3CR1::EGFP.  For each animal, two sections of medial dLGN were imaged and only
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dLGNs with good dye fills were used for analysis.  Images were acquired on a spinning diskconfocal microscope at 63x with .2m z-steps.  For each dLGN, at least 4 cells were imagedin the ipsilateral territory and at least 4 cells were imaged in the contralateral territory(minimum 8 cells per dLGN, 16 cells per animal). For P5 regional analysis, optic tractmicroglia were imaged as well (2 fields per dLGN). Images were processed using ImageJ(NIH) and Imaris (Bitplane) software.  ImageJ was used to subtract background from z-stacks of CTB channels (rolling ball radius = 10) and the microglia channel (rolling ballradius = 50) and a mean filter of 1.5 was applied to the microglia channel.  Images werecropped such that only one microglia cell would be in each image to prepare for surfacerendering.  Imaris software was used to surface render each channel and obtain volumemeasurements.  Internalized material was visualized by masking CTB channels with themicroglia channel to subtract all material not contained within the microglia cell volume.The remaining engulfed input fluorescence was surface rendered using parameterspreviously determined for total RGC inputs and total volume of engulfed inputs wascalculated. To determine % engulfment, the following calculation was used: Volume ofinternalized RGC inputs (μm3)/Volume microglial cell (μm3). For experiments involvingnormal development n=3 mice per condition. For experiments involving pharmacologicalmanipulation of neuronal activity n=4 (TTX) or 5 (forskolin). For experiments involving KOor minocycline-treated mice n= 3 (CR3 KO) or 4 (C3 KO and minocycline) mice pergenotype/condition. For all C3 and CR3KO engulfment experiments, littermates were alsosex matched. For CD47KO and CD200KO experiments, percent engulfment was furthernormalized to ensure that variations in axon outgrowth did not affect engulfmentcalculations by dividing % engulfment by the input density for each field (input density =
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total volume CTB-labeled inputs/total volume field of view).  All experiments involvingknockout animals were performed blind to genotype.
Quantitative PCR (qPCR)Whole brains and retinas from PBS perfused mice were flash frozen on dry ice.  RGCs andmicroglia were collected as described below. Whole brain tissue was manuallyhomogenized and RNA was isolated using phenol chloroform extraction, while other celland tissue RNA was collected after lysis in RLT buffer.  The RNeasy mini kit (QIAGEN) wasused to isolate and purify all RNA samples.  After cDNA synthesis, qPCR was performedusing the Applied Biosystems Cells to Ct Power SYBR green kit.  QPCR reactions wereassembled for the genes of interest (cd47, sirpα) using .5μl of cDNA per reaction andsamples were run on the Rotogene qPCR machine (QIAGEN).  Expression levels werecompared using the ddCt method normalized to GAPDH.  All samples were normalized toP5 and only males were used for whole brain, retina, and microglia isolation.
Microglia activation analysisMice were perfused as described for immunohistochemistry  and 2-4 40m free floatingsections containing dLGN were stained from each brain (for Iba-1 and CD68).  Sectionswere mounted as described above, and then imaged using a spinning disk confocalmicroscope.  Two medial dLGNs per animal were imaged, and two 20x z-stacks wereacquired to fully capture each dLGN using 2m z-steps. Maximum intensity projectionswere created, and each microglia cell was given a score of 0-5 based on morphology andCD68 abundance. The activation state of microglia was categorized from 0 (lowest
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activation) to 5 (highest activation) depending on the following criteria. First, the processesmorphology was scored as 0 (>15 thin processes with multiple branches), 1 (5-15 thickprocesses with branches), 2 (1-5 thick processes with few branches), 3 (no clearprocesses). Second, the expression pattern of CD68 was analyzed and scored as 0(no/scarce expression), 1(punctate expression), 2 (aggregated expression or punctateexpression all over the cell). Finally, for each cell analyzed, morphology and CD68 scoreswere summed and a final score of microglia activation state (0–5) was assigned. For eachcondition/age dLGN from 3 mice were analyzed (n=3). All analyses were performed blindand littermates were sex matched whenever possible.
Microglia density quantificationThe same sections used for activation analysis were also used for cell densityquantification. For quantification of cell density, 2 dLGN were imaged per animal (n=3 pertreatment condition or genotype). To capture the entire dLGN, a 10x field was acquired.Microglia were subsequently counted from each 10x field. To calculate the density ofmicroglia, the area of the dLGN was measured using ImageJ software (NIH). All analyseswere performed blind to genotype or drug treatment.
Structured Illumination Microscopy (SIM)For synaptic colocalization, 14m sections were imaged at 100x magnification using theZeiss Elyra S.1 system. A 3nm z stack with an interval of 0.101nm was captured withbrightfield illumination and Zen software (Zeiss) was used to generate the structuredillumination microscopy image. Three dimensional reconstructions of these images were
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subsequently generated and annotated with Zen and Photoshop software (Adobe). Formicroglial engulfment of Vglut2, 16m cryosections of CX3CR1+/EGFP dLGN wereimmunolabeled. Images were acquired with an Elyra PS.1 Combi with LSM 780 Confocal onan Axio Observer inverted microscope equipped with a 63x Plan Apo objective (Zeiss). Z-stacks were collected using 5 rotations and 5 phase shifts of a grid specific to the objectivewith a 1K X 1K EMCCD camera. Laser lines included on the system were 405, 488, 561 and642. ZEN 2010 software (Zeiss) was used for acquisition and image processing for superresolution.
Western blot analysisFrozen brain samples from PBS perfused mice were transferred into lysis buffercontaining SDS (25mM Hepes pH 7.5, 95mM NaCl, 10mM EDTA, 2% SDS and proteaseinhibitor cocktail (Roche 05 892 970 001)). Samples were homogenized using the TissueLyser II system (Qiagen) for 2 minutes at speed setting 20 1/s. Subsequently, sampleswere centrifuged for 2 minutes at 10000rpm at 4 C. Supernatants were extracted andcentrifuged again for a further 2 minutes at the same speed after which the resultingsupernatants were collected. Twenty milligrams of each protein sample were loaded andseparated by SDS-PAGE on 10% tris-glycine gels under denaturing conditions with the miniProtean II gel electrophoresis apparatus (Biorad, USA). Kaleidoscope pre-stained standardmolecular weight markers (Biorad, USA) were run alongside samples to enableidentification of band sizes. Separated proteins were then transferred to a nitrocellulosemembrane, Hybond-ECL (Amersham RPN 3032D), in a mini gel tank (Biorad, USA) at 4 C.
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Membranes were incubated in 5% fat free milk powder in tris-buffered saline (TBS) for 1hour to block non-specific binding sites. Primary antibodies diluted in 5% fat free milkpowder in TBS were then added and membranes incubated O/N at 4 C on a slow rotator.Membranes were washed 3 times every 15 minutes for 30 minutes at RT with TBS andsubsequently incubated with horse radish peroxidase (HRP) conjugated secondaryantibody diluted in 5% milk in TBS for 1 hour at RT and again washed in TBS 3 times every15 minutes for 1 hour. Membranes were then treated with ECL reagents from the SuperSignal detection kit (Perbio). Specific protein complexes were revealed by placingmembranes in autoradiography cassettes (Appligene, USA) and developed by briefexposure (5 seconds to 10 minutes) to Thermo Scientific CL-XPosure film. Quantificationwas performed using the gel function in ImageJ (NIH).Antibodies used: Vglut 2 (Millipore) and Homer (Synaptic systems) 1:20000, Actin 1:1000.
In situ hybridizationCryosections were collected as described for immunohistochemistry (14m) and dried at65° C for 30 minutes.  Tissue was subsequently fixed in methanol at -20° C for 20 minutesbefore being washed 3X with PBS. Sections were then incubated in a proteinase K solution(proteinase K 1μg/ml in 50mM Tris pH 7.5 and 5mM EDTA) for 10 minutes at RT beforecarrying out another PBS wash. Tissue was then re-fixed in 4% PFA for 5 minutes at RTbefore again washing with PBS. An acetylation step was subsequently carried out byincubating the sections in a solution containing acetic anhydride (triethanolamine 0.09M,HCl 0.09M, 0.2% acetic anhydride) for 10 minutes at RT before a further washing step.
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Endogenous peroxidase activity was then blocked by incubating in a 0.3% hydrogenperoxide solution before a final wash in PBS.
Before continuing, a hybridization chamber was humidified by adding 5XSSC to thereservoir chamber. Slides were subsequently placed into the chamber and hybridizationsolution (1x pre-hybridization solution (Sigma P-1415), 25mg yeast tRNA (Roche), and50% formamide (American Bioanalytical)) was applied to the sections for 1hr at RT.Relevant probes were then diluted in hybridization solution and heat denatured at 80° Cfor 15 minutes before being applied to the sections. A glass coverslip was mounted on topof the sections, which then incubated O/N at 62° C.
Coverslips were removed by washing in 2XSSC (Sigma) at 62° C and sections were placed ina fresh 2XSSC solution for a further 5 minutes. Sections were subsequently transferred to a0.2XSSC solution at 55° C before being washed with the same solution over a 3hr period.Sections were then placed at RT and washed a further two times with TBS. Antibodyblocking solution was applied to sections for 1hr before adding Sheep anti-DIG:POD(Roche) at 1:2000 in blocking solution alongside relevant primary antibodies for IHC andincubating O/N at 4° C.
Sections were washed 3X for 10 minutes with TBS and then a further 2X with TBST (TBSand 0.3%Triton X-100). TSA staining solution with an appropriate fluorophore was thenapplied to sections according to the manufacturers instructions (PerkinElmer) for 1hr atRT before again washing with TBS. For double labeling with two in situ probes, sections
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were first incubated in 0.3% hydrogen peroxide to kill the 1st POD before repeating thestaining with a sheep anti-fluorescein POD.
For double in-situ staining alongside an antibody for IHC, sections were washed again inTBS before incubating with a conjugated secondary antibody against the species in whichthe primary antibody was made for 2hrs at RT. After washing again with TBS, coverslipswere mounted on top of the sections with Vectashield +DAPI (Vector labs).The CD47 probe was designed using an Open Biosystems plasmid, NSE was obtained fromthe Greenberg lab (HMS) and SIRP plasmid was provided by Hisashi Umemori.
Microglia isolationMicroglia were isolated from male, C57BL/6 mice as described in (Pino and Cardona 2011).Briefly, mice were transcardially perfused with cold HBSS and whole brains were manuallyhomogenized in RPMI.  Samples were applied to a percoll gradient, and after a 30min spinat 500G, cells were collected from the 30%-70% interphase, pelleted and washed.Microglia isolation was followed immediately by RNA isolation using the RNeasy mini kit(QIAGEN) and cDNA synthesis.
Neuron culturesRetinal ganglion cells (RGCs) were acutely isolated from P5 C57BL/6 mice after serialimmunopanning steps to yield >99.5% purity as described in (Barres et al., 1998).  Cellswere lysed at the end of immunopaning and RNA and cDNA were isolated using the AppliedBiosystems Cells to Ct kit.
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Synaptosome fractionationThe fractionation protocol was adapted from a previous report (Hahn et al., 2009) . Cortex(300–350mg) from P21 mice was homogenized in 1.5ml of homogenization buffer (0.32Msucrose, 1mM NaHCO3, 1mM MgCl2, 0.5mM CaCl2, protease inhibitor). Homogenate wasthen adjusted to 1.25M sucrose and 0.1mM CaCl2 in a total of 5ml. Homogenate wasoverlaid on 5ml of 1M sucrose and spun at 100,000G (SW41-Ti rotor, Beckman) for 3hrs at4° C. Interface was collected and designated as synaptic membrane fraction (SPM). SPM(500μl) was then added to 2ml of 0.1mM CaCl2 and 2.5ml of 40mM Tris, pH 6, with 2%Triton X-100, and placed on rocking platform for 20 min at 4° C. The sample was then spunat 35,000G (SS-34 rotor, Sorvall) for 20 min at 4° C and supernatant was collected as theextrajunctional fraction. The pellet was air-dried and resuspended in 1ml of 0.1mM CaCl2and 1ml of 40mM Tris, pH 8, with 2% Triton X-100, and placed on rocking platform for 60min. Resuspended pellets were then spun at 140,000G (SW41-Ti rotor, Beckman) for 30min at 4° C, and supernatant was collected as presynaptic fraction. The insoluble fractionwas resuspended in 1ml of 20mM Tris pH 7.4 with 1% SDS and designated as thepostsynaptic fraction. Extrajunctional and presynaptic fractions were acetone-precipitatedand resuspended in 1ml of 2 mM Tris, pH 7.4, with 1% SDS. Synaptic membrane fractionand equivalent volumes of extrajunctional, presynaptic and postsynaptic membranefractions were then transferred to PVDF membrane and probed with CD47 (BDPharmingen 1:500).
Minocycline injectionWT or CX3CR1::EGFP heterozygote mice were injected daily with minocycline (Sigma;
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75mg/kg) or vehicle (saline) subcutaneously from P4-P8. The dose, route, and frequencyof injections were determined based on earlier work (Buller et al., 2009) and on our ownobservations. All subsequent analyses were performed blind to treatment condition.
Intraocular injection of TTX or forskolinP4 CX3CR1::EGFP heterozygotes were anesthetized with isofluorane and given anintraocular injection of drug (0.5µM TTX  or 10mM forskolin) and vehicle (saline or DMSO)into the left and right eyes, respectively.  Injection volume was approximately 200 nL. 4-5hrs after first injection, mice received a second intraocular injection of CTB-594 and 647into the left and right eyes, respectively. Mice were sacrificed at P5 for analysis.
Cell death quantificationFor experiments to quantify cell death, P4 WT mice were given an intraocular injection ofdrug (0.5μM TTX or 10μM forskolin) and vehicle (saline or DMSO) into the left and righteyes, respectively. 4-5hrs after first injection, mice received a second intraocular injectionof CTB 594 and 647 into the left and right eyes, respectively. Mice were subsequentlysacrificed at P5. Only retinas from those mice in which dye tracing resulted in complete fillsof RGC axons were analyzed. Retina were subsequently embedded, cryosectioned (14μm),and immunolabeled for cleaved caspase-3 (Asp175) and total nuclei were stained withDAPI. The percent of cleaved-caspase-positive cells was calculated from the RGC layer. Foreach condition (2 animals per condition), four retinas were quantified, two 20x fields ofview per retina. n=16 fields of view/condition.
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Retinal ganglion cell quantificationFor each retina (1 retina per animal; n=3 mice per treatment condition or genotype), 12images of peripheral retina and 8 images of central retina were collected at 63x. For eachfield of view collected (20 per retina), Macbiophotonics ImageJ software (NIH) was used toquantify the total number of DAPI using the nuclei counter plugin and TUJ1-positive cellswere counted using the cell counter plugin. All analyses were performed blind to genotypeor drug treatment.
Electron MicroscopyEM was performed in collaboration with the J. Lichtman laboratory. For EM, 30nm sectionswere sliced using a Diatome 45 diamond knife and a Leica UM-6 ultramicrotome. Thesections were collected on kapton tape as described by Hayworth et al. (2006). Aftercollection, the tapes were adhered to silicon wafers using double-sided carbon tape. Thesections were then post stained with uranyl acetate and lead citrate for 3 minutes. Theentire wafer assembly was then coated with 10nm of carbon. The sections were thenimaged using a Zeiss Sigma field emission scanning electron microscope (FESEM)operating in backscattered electron mode.
For double immunoEM experiments, primary antibodies and secondary antibodies wereincubated together. For immunogold labeling, tissue was prepared identically with minormodifications. 1.4nm nanogold conjugated to appropriate species-specific antibodies wasused for secondary labeling (Nanoprobes). Following all secondary antibody incubationsteps, tissue was processed to increase the size of the nanogold with HQ silver
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enhancement for 5 min (Nanoprobes). Tissue was then post-fixed in 1% osmium tetroxideand embedded as previously described (Tremblay et al., 2010). Images were acquired on aJEOL 1200EX-80kV.
Quantification of EMFour fields of view (10,000x) of dLGN containing microglia (4 independent experiments)were imaged. Statistics were calculated per cell, n=20. The % frequency of engulfedmaterial was subsequently calculated per dLGN. To calculate cumulative probability ofVGlut2 localization, 4 fields of view (10,000x) of dLGN containing microglia and/or RGCterminals (2 independent experiments) were imaged. Neuropil measurements wereperformed from views containing either microglia or RGC terminals. A total of 10measurements were made for each structure (microglia, RGC terminal, or neuropil, n=10).The total area of VGlut2 versus neuropil, microglia, or RGC terminal was subsequentlycalculated by measuring the area of the neuropil, microglia, or RGC terminal followed bymanual thresholding of VGlut2 immunoreactivity and measurement of the thresholdedarea with ImageJ software.
Array TomographyArray Tomography was performed as previously described with minor modifications(Greer et al., 2010; Margolis et al., 2010; Micheva and Smith, 2007; Ross et al., 2010;Stevens et al., 2007). Briefly, acute dLGN slices (300μm thick) were fixed in 4%paraformaldyhde for 1.5hrs at RT and embedded in LR White resin using the benchtopprotocol. Ribbons of between 20-30 serial 100nm thick sections of both WT and KO
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littermates were mounted side by side on subbed glass coverslips and immunostained withanti-VGlut2 and anti-GluR1. Serial sections were imaged using a Zeiss Imager.Z1microscope, 63x objective and subsequent volumes were aligned using ImageJ (NIH) withthe multistackreg plugin (Brad Busse). Fields of view (3-4 per animal, 3 animals pergenotype) were analyzed in Bitplane Imaris and custom software to count synapses. Asynapse was counted if the distance between the center point of a VGlut2 puncta and aGluR1 puncta was equal to or less than the sum of the radii of the two puncta plus anempirically determined scaling factor of 0.1μm. All data were subsequently normalized toWT values. All experiments were carried out and analyzed blind to genotype.
Statistical AnalysisFor all statistical analyses, GraphPad Prism 5 software (La Jolla, CA) was used. Analysesused include one-way ANOVA, unpaired or paired, two-tailed or one-tailed, Student’s t-test,95% confidence or Mann-Whitney U test. All p values are indicated in figure legends.
Chapter 3:
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent
Manner
Contributions: All experiments were designed by Dorothy Schafer and Beth Stevens.Dorothy Schafer and Emily Kate Lehrman developed engulfment analysis.  All experimentsand data analysis were performed by Dorothy Schafer with the exception of the following:wild type developmental engulfment analysis, CR3KO engulfment analysis, minocyclineengulfment analysis, regional engulfment analysis, and microglia cell density counts wereperformed and analyzed by Emily Kate Lehrman, microglia activation assay was performedby Ryuta Koyama, array tomography was performed by Amanda Kautzman.
Publication: Most of this chapter has been published in Neuron 74 (4): 691-705.
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IntroductionEarly in development neurons make far more synaptic connections than aremaintained in the mature brain. Synaptic pruning is an activity-dependent developmentalprogram in which a large number of synapses that form in early development areeliminated while a subset of synapses is maintained and strengthened (Hua and Smith,2004; Katz and Shatz, 1996; Sanes and Lichtman, 1999). While it is clear that neuronalactivity plays a role, the precise cellular and molecular mechanisms underlying thisdevelopmental process remain to be elucidated.Microglia are the resident CNS immune cells which have long been recognized asrapid responders to injury and disease, playing a role in a broad range of processes such astissue inflammation and clearance of cellular debris (Hanisch and Kettenmann, 2007;Kreutzberg, 1996; Ransohoff and Perry, 2009). In contrast to disease pathology, thefunction of microglia in the normal, healthy brain is far less understood. However, recentstudies suggest that microglia may play a role in synaptic remodeling and plasticity in thehealthy brain (Davalos et al., 2005; Nimmerjahn et al., 2005; Paolicelli et al., 2011;Tremblay et al., 2010a; Wake et al., 2009). For example, microglia within the juvenile visualcortex modify their association with dendritic spines in response to changes in visualsensory experience (Tremblay et al., 2010a). A more recent study provides evidence thatdisruptions in microglia function result in delayed maturation of hippocampal synapticcircuits (Paolicelli et al., 2011). Moreover, data from these studies suggest that microgliamay be phagocytosing dendritic spines. These intriguing studies raise several interestingand important questions. The precise function of microglia at synaptic sites, the molecular
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mechanism(s) underlying microglia-mediated synaptic engulfment, and the long termconsequence(s) of disrupting microglia function on synaptic circuits remain a mystery.A candidate mechanism by which microglia could be interacting with developingsynapses is the classical complement cascade. Complement cascade components C1q and C3localize to immature synapses and are necessary for the developmental pruning ofretinogeniculate synapses (Stevens et al., 2007). While provocative, the mechanism by whichcomplement mediates synaptic pruning has remained completely unknown. Complementcomponents function in the immune system by binding and targeting unwanted cells and cellulardebris for rapid elimination through several different pathways. These molecules are classic “eatme” signals, which are known to communicate with receptors on immune cells (Elward andGasque, 2003; Lauber et al., 2004). Among the many mechanisms by which complement maymediate synaptic pruning is phagocytosis, which makes microglia, the resident CNS phagocyte, acandidate.Given the questions that have now emerged regarding the role of microglia at CNSsynapses, we sought to address precisely how microglia are interacting with developingsynaptic circuits and determine the long-term consequences of disrupting microgliafunction on neural circuit development. In the current study, we demonstrate thatmicroglia engulf presynaptic retinal inputs undergoing synaptic pruning in the postnatalbrain and determine that this process is regulated by neuronal activity. Furthermore, weidentify signaling through a phagocytic receptor, complement receptor 3 (CR3/CD11b-CD18/Mac-1), expressed on the surface of microglia and its ligand, complement componentC3 localized to synaptically-enriched regions, as a key molecular mechanism underlyingengulfment of developing synapses. Importantly, disruption of CR3/C3 signaling was
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specific to microglia in the CNS and resulted in sustained deficits in brain wiring. Takentogether, these observations provide a role for microglia in the healthy, developing brain,and provide a cellular and molecular mechanism by which microglia are physicallyinteracting with synaptic elements.
Results
Microglia engulf RGC inputs during a period of active synaptic pruningTo investigate the functional role of microglia in developmental synapticremodeling, we used the mouse retinogeniculate system, a classic model for studyingactivity-dependent developmental synaptic pruning (Feller, 1999; Huberman et al., 2008;Shatz and Kirkwood, 1984). Early in development, retinal ganglion cells (RGCs) formexuberant synaptic connections with relay neurons throughout the dorsal lateralgeniculate nucleus (dLGN) of the thalamus. During the pruning period, RGC synaptic inputsoriginating from the same eye as well as between eyes compete for territory throughoutthe dLGN (Chen and Regehr, 2000; Hooks and Chen, 2006; Jaubert-Miazza et al., 2005;Ziburkus and Guido, 2006). Spontaneous retinal activity plays critical role in thisrefinement process, however the underlying cellular and molecular mechanisms remainpoorly understood. (Del Rio and Feller, 2006; Feller, 1999; Penn et al., 1998; Shatz, 1990;Torborg and Feller, 2005).During this robust pruning period (P5 in mouse), we used high resolution confocalimaging to assess the interactions between microglia and synaptic inputs throughout thedLGN.  Contralateral and ipsilateral presynaptic inputs from RGCs were visualized in thedLGN by intraocular injection of anterograde tracers, cholera toxin β subunit conjugated toAlexa 594 (CTB-594) and Alexa 647 (CTB-647), respectively (Figure 3.1A). Microglia were
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labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under thecontrol of fractalkine receptor, CX3CR1, expression (Figure 3.1, Figure 3.2, Figure 3.11)(Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).At an age consistent with robust synaptic pruning (P5), microglial processes were inclose association with RGC presynaptic inputs (Figure 3.1B, Figure 3.3A). Upon closerexamination, we detected numerous fluorescently labeled RGC inputs within the processesand soma of microglia (Figure 3.1B). Internalization was further confirmed by assessingconfocal z-stacks through individual microglia. This specific example is a microglia sampledfrom a region containing similar densities of overlapping ipsilateral (blue) andcontralateral (red) RGC inputs (Figure 3.1A) which are undergoing active synapticremodeling to establish non-overlapping eye specific territories (Figure 3.4A) (Godementet al., 1984; Guido, 2008; Huberman et al., 2008; Sretavan and Shatz, 1986; Ziburkus andGuido, 2006). Consistent with simultaneous pruning of inputs from both eyes, contralateral(red) and ipsilateral (blue) RGC inputs were engulfed and localized within the microglia(Figure 3.1B). In addition, consistent with widespread pruning of RGC inputs throughoutthe P5 dLGN, we observed engulfment of RGC inputs in all synaptic regions (monocular andbinocular). These data suggest that microglia engulf RGC inputs undergoing active synapticremodeling.To confirm that inputs are phagocytosed by microglia, RGC inputs from both eyeswere labeled with CTB-594 and colocalization with CD68, a marker of lysosomes specific tomicroglia, was assessed in P5 dLGN. As suggested by previous dye-labeling experiments,
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Figure 3.1. Microglia engulf RGC inputs undergoing active synaptic pruning in
the dLGN. A, A representative low magnification image of P5 dLGN. Ipsilateral inputsare labeled with CTB-647 (blue) and contralateral inputs are labeled with CTB-594(red). Scale bar = 100 µm. Bi, A microglia (EGFP, green) sampled from the borderregion of ipsilateral (blue) and contralateral (red) projections (inset in A). Bii, AllCTB fluorescence outside the microglial volume has been subtracted revealing RGCinputs (red and blue) that have been engulfed (arrows, enlarged in inset). Grid lineincrements = 5 µm. Ci, A representative microglia (green, EGFP) from P5 dLGN. RGCinputs from both eyes are labeled with CTB-594 (red) and lysosomes are labeledwith anti-CD68 (blue). Cii, The same microglia in which all CTB fluorescence outsidethe microglia volume has been removed revealing lysosomes (blue) and engulfedRGC inputs (red). Ciii, The same cell in which only the lysosomes (blue) and RGCinputs (red) are visualized in which most inputs (red) are localized within CD68-positive lysosomes (blue; white arrows). There are few instances in which CTB is notlocalized to lysosomes (yellow asterisks). Inset is enlarged region of Ciii. Civ-v, TheCD68 (Civ) and CTB (Cv) channels alone. Scale bar = 10 µm. D, Quantification of %volume of microglia occupied by CD68-positive lysosomes (white bar) and RGCinputs (black bar), n=3 P5 mice. E, There are significantly more engulfed inputslocalized to lysosomal compartments (white bars) versus non-lysosomalcompartments (black bars). *P<0.001 by Student’s t-test, n=3 P5 mice. All error barsrepresent s.e.m.
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Figure 3.2. Microglia engulf RGC synaptic inputs within the P5 dLGN into
lysosomal compartments. A, Schematic of strategy used to further assessphagocytosis using pHrodo. Bi, Microglia (green) within the dLGN engulf RGCinputs (pHrodo, red, Biii) into lysosomal compartments (CD68, blue, Bii) duringpeak retinogeniculate pruning (P5). Scale bar = 10 µm. .C-F, The reporter line Rosa26-Stop-tdTomato was crossed with Chx10-cre to specifically label RGC inputs inthe dLGN (CHX10-cre::tdTomato). dLGN from P5 tdTomato-expressing mice wereimmunolabeled for CR3 alpha subunit, CD11b (green) to label microglia, CD68(blue) to label lysosomes within microglia, and dsRed2 (red) to amplify thetdTomato expressed in RGC inputs. C, CR3/CD68-positive microglia that hasengulfed RGC inputs (arrow). D, The same cell in which any RGC inputs that are notwithin the microglia have been subtracted. Ei-iii, An enlarged region of D. Similar toCTB-labeled inputs, tdTomato-labeled RGC inputs are within lysosomalcompartments of microglia (arrows; white arrow denotes region shownorthogonally in F). C,D Scale bar = 15 µm. Ei-iii, Scale bar = 5 µm. F, Orthogonalviews of engulfed RGC inputs designated by the white arrow in E. Anyuncolocalized tdTomato labeling are inputs that have not been engulfed and areoutside of the microglia volume (see C).
64
the majority of engulfed RGC inputs were completely colocalized within lysosomalcompartments (Figure 3.1C-E). There were rare instances in which engulfed RGC inputs didnot colocalize (Figure 3.1Ciii and E) and we suspect that these inputs are either in theprocess of being phagocytosed or are in phagosomal or endosomal compartments prior tolysosomal degradation. To further validate that microglia phagocytose RGC inputs, pHrodo-dextran, an anterograde tracer and pH-sensitive dye, was used to label RGC inputs (Figure3.2 A-B) (Deriy et al., 2009; Miksa et al., 2009). Because pHrodo only fluoresces once itenters acidic compartments of lysosomes, any pHrodo-positive fluorescence within amicroglia confirms phagocytosis of RGC inputs. Similar to previous experiments, pHrodo-positive RGC inputs were localized within microglia (Figure 3.2A-B). Furthermore, inaddition to anterograde tracing with CTB and pHrodo, RGC input engulfment was alsoassessed within the P5 dLGN using a genetic approach, double transgenic mice expressingtdTomato under the control of Chx10, a transcription factor expressed by RGCs (Chx10-cre/Rosa26-STOP-tdTomato) (Figure 3.2C-F). Similar to CTB experiments, we observedtdTomato-labeled RGC inputs within lysosomal compartments of microglia. Importantly,these experiments exclude the possibility that engulfment is due to injury secondary toocular injections. Together, we demonstrate that microglia phagocytose RGC inputs duringa peak period of synaptic pruning in the dLGN.
Microglia-mediated engulfment of RGC inputs is developmentally regulatedTo begin to address whether microglia-mediated engulfment of RGC inputscontributes to the normal process of synaptic pruning, we assessed the developmentalregulation of microglia phagocytic capacity. We first characterized microglia activationstate through development and observed a unique class of microglia in the early postnatal
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dLGN as compared to older ages (P30) (Figure 3.3). Microglia within the early postnataldLGN had characteristic features of more ‘activated’ cells traditionally associated withdisease including increased phagocytic capacity (assessed by morphology and CD68immunoreactivity; Figure 3.3C,D). Interestingly, early postnatal microglia also hadprocesses, a morphological characteristic of ‘resting’ microglia which are resident in thehealthy adult brain (Figure 3.3B) (Lynch, 2009; Ransohoff and Perry, 2009).To address whether engulfment of RGC inputs was developmentally regulated, wedeveloped an in vivo phagocytosis assay (Figure 3.4A). Using high resolution confocalmicroscopy followed by 3D reconstruction and surface rendering (Figure 3.4D),internalization of ipsilateral (CTB-647; blue) and contralateral (CTB-594; red) RGC inputswas quantified within the volume of each microglia (CX3CR1+/EGFP) throughout thedLGN.  To control for variation in microglia volume, the following calculation was used: %Engulfment = Volume of internalized RGC inputs (µm3)/Volume of microglia (µm3).Consistent with microglial involvement in normal developmental synaptic pruning,engulfment of RGC inputs was developmentally regulated. During a developmental periodof robust pruning (P5), engulfment was high (Figure 3.4B,Di). As few as 4 days later (P9),when much of the pruning is nearly complete, engulfment of RGC inputs was significantlyreduced (Figure 3.4B,Dii). Thus, microglia-mediated engulfment of RGC inputs istemporally correlated with a period of robust synaptic pruning within the developingdLGN. Importantly, similar to P5 dLGN, microglia within the P9 dLGN still retainedphagocytic capacity as assessed by morphology and CD68 expression (Figure 3.3C,D).
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Figure 3.3. ‘Activated,’ process-bearing microglia interact with RGC synaptic
inputs within the P5 dLGN. A, Representative image of a microglia (green,CX3CR1::EGFP) from a P5 dLGN. RGC inputs are labeled with the anterogradetracer CTB-594 (red) and RGC terminals are labeled with anti-VGlut2 (blue). Ai-ii,Enlarged regions from A demonstrating processes closely associated with andcontacting synaptic endings of RGCs (white arrow in Ai and yellow arrow in Aii). B,In P30 dLGN, resting microglia (green) processes associate but do not overlap withCTB-labeled ipsilateral (CTB-647, blue) and contralateral (CTB-594, red) RGCinputs. A,B, Scale bars = 10 µm. Ai-ii, Scale bar = 2 µm. C, Confocal images ofmicroglia immunolabeled for Iba-1 (green) and CD68 (red). The CD68 channel isvisualized alone in lower panel images. Arrows indicate position of cell soma. Scalebar = 10 µm. D, Quantification of microglia activation state in the developing dLGN.Microglia activation was assessed blind on a scale of 0-5 based on morphology andCD68 immunoreactivity. Microglia in P5 (black bars) and P9 (grey bars) dLGNwere consistently shifted toward increased activation state whereas cells sampledfrom older mice (P30, white bars) were consistently less activated (n=3 mice/age).Error bars represent s.e.m.
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Figure 3.4. Microglia-mediated engulfment of RGC inputs is developmentally
regulated. A, Schematic of retinogeniculate pruning and strategy used for assessingengulfment. Contralateral (red) and ipsilateral (blue) inputs overlap at earlypostnatal ages (P5). Inputs from both eyes prune throughout the dLGN during thefirst postnatal week and this is largely complete by P9/10. Engulfment was analyzedthroughout the dLGN. B, Engulfment of RGC inputs is significantly increased duringpeak pruning in the dLGN (P5). *P<0.001 by one-way ANOVA, n=3 mice/age. C,Engulfment in P5 dLGN occurs most significantly in synapse-enriched (contralateraland ipsilateral dLGN) versus non-synaptic (optic tract) regions. *P<0.01 by Student’s
t-test, n=3 P5 mice. All error bars represent s.e.m. D, Representative surfacerendered microglia from P5 (fluorescent image is shown in 1B), P9, and P30 mousedLGN. Engulfment of RGC inputs occurs during peak pruning (P5) versus older ages(P9 and P30). Enlarged insets denoted with a black dotted line. Grid line increments= 5 µm.
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These data suggest a more specific mechanism is driving engulfment specifically during thepeak pruning period in the P5 dLGN.
Microglia-mediated engulfment of RGC inputs is regulated by neural activitySynaptic pruning is thought to result from competition between neighboring axons forpostsynaptic territory based on differences in patterns or levels of activity (Hua and Smith, 2004;Katz and Shatz, 1996; Sanes and Lichtman, 1999). In the dLGN, it is thought that RGC inputscompete for territory such that those inputs which are less active or ‘weaker’ are prunedand lose territory as compared to those inputs that are ‘stronger’ or more active, whichelaborate and strengthen (Del Rio and Feller, 2006; Dhande et al., 2011; Huberman et al.,2008; Penn et al., 1998; Shatz, 1990; Torborg and Feller, 2005). This competition can occurbetween inputs from the same eye as well as between inputs from both eyes (Chen andRegehr, 2000; Hooks and Chen, 2006; Jaubert-Miazza et al., 2005; Ziburkus and Guido,2006). To determine whether microglia-mediated engulfment of RGC inputs is regulated byneural activity, P4 CX3CR1+/EGFP mice were injected with TTX (0.5 µM) to block RGCactivity or forskolin to increase activity (10 mM) (Cook et al., 1999; Dunn et al., 2006; Shatzand Stryker, 1988; Stellwagen and Shatz, 2002; Stellwagen et al., 1999) in the left eye andvehicle (saline or DMSO, respectively) in the right eye. In order to distinguish inputs fromeach eye, RGC inputs were anterogradely labeled with CTB-594 (TTX or forskolin inputs)and CTB 647 (vehicle inputs) following drug injection (Figure 3.5A,D). At P5, mice weresacrificed and engulfment was assessed in a region with a similar proportion of ipsilateraland contralateral eye inputs.
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Figure 3.5. Microglia-mediated engulfment of RGC inputs is regulated by
neural activity. A, D Schematic of strategies used for assessing microgliaengulfment following disruption of dLGN pruning by manipulation of neuronalactivity. B, Representative P5 microglia (green) surface rendered from the borderregion of ipsilateral and contralateral projections in which left and right eyes weretreated with TTX (red) and vehicle (blue), respectively. Inset is an enlarged regiondemonstrating the increase in engulfment of inputs from the ‘weaker’, TTX-treatedeye (red) as compared to those inputs derived from the ‘stronger’ vehicle-treatedeye (blue). Grid line increments = 5 µm. C, Significantly more TTX-treated inputs(black bar)  are engulfed as compared to vehicle-treated inputs (white bar).*P<0.04 by Student’s t-test, n=4 mice/treatment. E. Representative P5 microglia(green) surface rendered from the border region of ipsilateral and contralateralprojections in which left and right eyes were treated with forskolin (red) andvehicle (blue), respectively. Inset is an enlarged region demonstrating an increasein engulfment of inputs from the ‘weaker’, vehicle-treated eye (blue) as comparedto those inputs derived from the ‘stronger’ forskolin-treated eye (red). Grid lineincrements = 5 µm. F, Significantly more vehicle-treated inputs (white bar) areengulfed as compared to forskolin-treated inputs (black bar) within the samedLGN. *P<0.04 by Student’s t-test, n= 5 mice/treatment. All error bars represents.e.m.
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When mice were injected with TTX and vehicle in the left and right eyes,respectively, microglia phagocytosed significantly more inputs from the less active TTX-treated eye (CTB-594, red) as compared to the vehicle-treated eye (CTB-647, blue) (Figure3.5B,C). Likewise, mice injected with forskolin and vehicle engulfed significantly moreinputs from the vehicle-treated eye (CTB-647, blue) as compared to the more activeforskolin-treated eye (CTB-594, red) (Figure 3.5E,F). Importantly, this effect occurred inthe absence of any significant increase in RGC death (Figure 3.6). Taken together, thesedata demonstrate that microglia-mediated engulfment of RGC inputs is regulated byactivity such that microglia preferentially engulf inputs from the ‘weaker’ eye and suggestthat microglia are active participants in synaptic pruning.
Microglia engulf presynaptic elements specific to RGCsWhile it is clear that microglia engulf RGC inputs in a developmental and activity-dependent manner, it is unclear whether engulfed material is axonal and/or synaptic.Consistent with synaptic engulfment, significantly more RGC inputs were engulfed withinsynaptic-enriched of the P5 dLGN compared to a non-synaptic region, the optic tract(Figure 3.4C). To better determine the identity of engulfed material, electron microscopywas performed.Microglia were identified by EM using criteria previously described including asmall, irregular-shaped nucleus containing substantial amounts of coarse chromatin and acytoplasm rich in free ribosomes, vacuoles, and lysosomes (Mori and Leblond, 1969;Sturrock, 1981). Consistent with our confocal data, we observed several inclusionscompletely within the microglia cytoplasm including several double membrane-bound
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Figure 3.6. RGC death is not affected by TTX or forskolin treatment.WTmicewere treated with TTX (0.5 µm) or forskolin (10 mM) in the left eye and vehicle(saline or DMSO, respectively) into the right eye. RGC death was quantified bymeasuring the % of cleaved caspase-positive cells out of total DAPI-positive cellswithin the RGC layer of the retina. RGC death was not significantly differentbetween drug-treated (black bars) and vehicle-treated (white bars) eyes. Errorbars represent s.e.m. n = 16 fields of view.
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structures which contained 40 nm vesicles, data consistent with engulfment of presynapticterminals (Figure 3.7A,B and Figure 3.8). In a few instances, structures reminiscent ofjuxtaposed pre and postsynaptic structures were observed (Figure 3.7Aii).To further confirm microglia-mediated phagocytosis of synaptic elements,immunohistochemical electron microscopy (immunoEM) for the microglia marker Iba-1was performed and quantified in the P5 dLGN (Figure 3.7C) (Tremblay et al., 2010b).Consistent with EM data described above, we observed membrane-bound structurescontaining 40 nm presynaptic vesicles that were completely surrounded (Figure 3.7D) orenwrapped (Figure 3.7E) by DAB-positive microglial cytoplasm. To further support thatmicroglia engulf material specific to presynaptic terminals, 40 nm vesicles were enriched inpresynaptic terminals (Figure 3.7Bii,F) and very rarely visualized in cross or longitudinalsections of axons (Figure 3.7G). Indeed, presynaptic elements were observed within 35% ofthe microglia sampled (Figure 3.7I). Interestingly, several intact presynaptic terminals(Figure 3.7F) and all engulfed or enwrapped presynaptic inputs (Figure 3.7A,B,D,E) lackedmitochondria, a characteristic feature of presynaptic terminals. Previous work hassuggested that sensory deprivation or pharmacological blockade of neuronal activity (i.e.,TTX) results in reduced mitochondria in presynaptic terminals known to undergosubsequent elimination (Hevner and Wong-Riley, 1993; Tieman, 1984). Thus, we suspectthat these terminals deficient in mitochondria may be those destined for elimination.In addition to presynaptic element engulfment, 63% of the sampled cells containedstructurally unidentifiable membrane-bound inclusions within microglial lysosomal
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Figure 3.7. Microglia engulf presynaptic elements undergoing active synaptic
pruning. Ai, Bi. Low magnification EM of microglia. Asterisks denote the nucleusand the cytoplasm is pseudocolored green. Scale bar = 1 µm. Aii, Bii. Magnifiedregions of Ai and Bi (white boxes) demonstrating membrane-bound elementsengulfed by microglia. Arrows designate elements containing presynapticmachinery (40 nm vesicles). The arrowhead in Aii designates engulfed materialresembling juxtaposed postsynaptic elements. Scale bar = 100 nm. C, Lowmagnification EM of a microglia immunolabeled for Iba-1 in P5 dLGN (DAB-positive cell).  Red and blue boxes indicate enlarged regions in D and E,respectively. Scale bar = 2 µm. D, RGC input (A) localized within the Iba-1-positivemicroglia (M). Within the engulfed input, neurofilaments (arrows, enlarged in Diand Dii) and 40 nm vesicles (asterisks, enlarged in Dii) are indicative ofpresynaptic machinery.  D, Scale bar = 500 nm. E, RGC input (A) enwrapped by amicroglial process (M, arrowheads denote microglial process). 40 nm Vesicles arealso visible (asterisks, enlarged region in Ei). Another presynaptic element (a)containing 40 nm vesicles is surrounded by microglia cytoplasm (enlarged regionin Eii). Scale bars = 100 nm. F, An intact excitatory synapse in P5 dLGN in which thepresynaptic terminal (asterisk) contains 40 nm vesicles. Scale bar = 500 nm. G,Cross (asterisks) or longitudinal sections (pseudocolor) through axons arerelatively void of vesicles. Scale bars = 500 nm. H, A membrane-bound structure(arrowhead) completely within a microglial (M) lysosome (L). Scale bar = 500 nm.I, The frequency at which engulfed material was observed in microglia from P5dLGN, n=20 cells. Error bars represent s.e.m.
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Figure 3.8. Microglia engulf presynaptic elements within the P5 dLGN. Ai, Bi,Representative EM images of microglia. Asterisks denote the nucleus and thecytoplasm is pseudocolored green. Aii, Magnified region of Ai (white dotted line)demonstrating membrane-bound elements engulfed by microglia. The arrowdesignates elements containing presynaptic machinery (40 nm vesicle) and thearrowhead designates engulfed material that is not distinguishable by ultrastructure.Bii-iii, Magnified region of Bi (white dotted line) demonstrating membrane-boundelements enwrapped (Bii) or engulfed (Biii) by microglia. The arrow designateselements containing presynaptic machinery (40 nm vesicles) and the arrowheaddesignates engulfed material that is not distinguishable by ultrastructure. Ai, Scale bar= 1 µm. Bi, Scale bar = 500 nm. Aii, Bii-iii Scale bar = 100 nm.
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compartments (Figure 3.7H). We suspect that this membranous cellular material issynaptic material rapidly degraded in lysosomal compartments thereby rendering itundistinguishable by ultrastructure. Unlike presynaptic elements, engulfed materialresembling postsynaptic elements was very rarely observed (Figure 3.7Aii). However,rapid degradation of structural elements may preclude visualization of the postsynapticdensity. Importantly, there were rare instances in which no engulfed material wasobserved within microglia (Figure 3.7I, no inclusions, 10% of sampled cells).
To directly address whether microglia are engulfing RGC presynaptic terminals,immunohistochemistry in P5 dLGN for presynaptic machinery specific to RGCs (i.e., VGlut2)followed by high resolution imaging was performed. 3D structural illumination microscopy(3D-SIM), a technique enabling 2X the resolution of light microscopy (Gustafsson, 2000),was used to assess the P5 dLGN of CX3CR1+/EGFP mice immunolabeled for VGlut2. 3D-SIMdata revealed VGlut2 immunoreactivity within the EGFP-positive cytoplasm of microglialcells (Figure 3.9A-D). Consistent with previous confocal and ultrastructural data (Figures3.1-3.8), these data suggest that microglia are engulfing RGC presynaptic terminals.To further confirm that microglia were engulfing RGC presynaptic terminals, doubleimmunoEM in P5 dLGN for iba-1 (DAB) and a presynaptic marker specific to RGC terminals,VGlut2 (immunogold; Figure 3.9E-G) was performed. Consistent with 3D-SIM datapreviously described, we observed immunogold labeling for VGlut2 within the microgliacytoplasm and lysosomes (Figure 3.9F,G). Because immunogold was overexposed in orderto gain contrast against the DAB reactivity, vesicle membranes surrounding the VGlut2labeling were not observed within intact presynaptic terminals (Figure 3.9E) or microglia
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Figure 3.9. Microglia engulf presynaptic terminals specific to RGCs. A-D, 3D-SIM in P5 CX3CR1+/EGFP dLGN in which microglia are labeled with EGFP (green)and RGC presynaptic terminals are immunolabeled with anti-VGlut2 (red). A,Maximum intensity projection (MIP) of microglia and VGlut2 immunostaining in P5dLGN. B, MIP in which all VGlut2 fluorescence (red) that is not within the microglia(green) has been subtracted. Yellow arrow designates examples of engulfedVGlut2-positive elements, enlarged in inset. C,D Orthogonal views (C) and surfacerendering (D) of region in B (yellow arrow and inset). A-D, Scale bar = 5 µm. D, gridline increments = 2 µm. E-G, Double immunoEM in P5 dLGN for iba-1 (DAB) andVGlut2 (immunogold). E, RGC presynaptic terminals are enriched with VGlut2immunoreactivity (immunogold, yellow arrows). F,G, Similar to RGC terminals (E) ,microglial cytoplasm (DAB) and lysosomes contain VGlut2 immunogold labeling(yellow arrows). Asterisk in F denotes a VGlut2-positive presynaptic terminalwithin the same field of view as the microglia. Scale bars = 100nm. H, Cumulativeprobability demonstrates that there is increased probability of VGlut2 localizationto a RGC terminal (black solid line) or microglia (grey solid line) versus randomoccurrence throughout the neuropil (grey dotted line). For each structure, n=10.
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(Figure 3.9F,G). In addition, cumulative probability calculations demonstrated an increasedprobability of VGlut2 localized to an RGC terminal or microglia as compared to randomimmunoreactivity throughout the neuropil (Figure 3.9H). Similar to results from confocalmicroscopy experiments (Figures 3.1-3.5), these ultrastructural data reveal that microgliaengulf presynaptic terminals specific to RGCs.
Deletion of the CR3/C3-dependent phagocytic signaling decreases the capacity of microglia to
engulf RGC inputsWhat molecular mechanism(s) underlies microglia-mediated engulfment of synapticinputs? In the peripheral immune system, phagocytic cells can interact with severaldifferent immune-related signaling pathways to mediate clearance of cellular material.Included among these pathways are proteins belonging to the classical complementcascade, which bind surface receptors expressed by phagocytic cells. Given previous workdemonstrating that complement component C3 is enriched at synapses and is necessary forpruning of retinogeniculate synapses (Stevens et al., 2007), we hypothesized that C3ligand-receptor signaling may be one molecular mechanism by which microglia interactwith and engulf RGC synaptic inputs. Consistent with this hypothesis, CR3, a high affinityreceptor for activated C3 (Akiyama and McGeer, 1990; Perry et al., 1985), was specificallyupregulated in microglia in the P5 dLGN and downregulated at later developmental timepoints (Figure 3.10A). Importantly, other cell types known to express the surface receptorCR3 and/or have phagocytic capacity (i.e., infiltrating monocytes, macrophages, etc.) werecompletely absent from the P5 dLGN and surrounding brain tissue (Figure 3.11)
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Figure 3.10. CR3/C3-dependent signaling regulates engulfment of synaptic
inputs by microglia. A, Immunohistochemistry for the alpha subunit of CR3(CD11b) reveals that microglia express high levels of CR3/CD11b (left column) inthe P5 dLGN (top panels) versus older ages (P20, bottom panels). Total microgliaare visualized with GFP (CX3CR1+/EGFP, right column). Insets are magnifiedregions (red asterisks). Scale bar = 100 µm. B, Immunohistochemistry in thedeveloping dLGN for C3 (red). A single plane confocal image reveals that C3 levelsare increased in the P5 dLGN versus older ages (P9, P60). Scale bar = 10 µm. C,E,Representative surface rendered microglia (green) from P5 dLGN of WT (left) orKO (right) littermates in which RGC inputs were labeled with CTB-594 (red,contralateral) and CTB-647 (blue, ipsilateral). Insets are enlarged regionsdemonstrating reduced RGC input engulfment (red and blue) in CR3 (C) and C3 (E)KO mice. Grid line increments = 5 µm. D,F, P5 CR3 KO (D) and C3 KO (F) mice(black bars) engulf significantly fewer RGC inputs as compared to WT littermates(white bars). All data are normalized to WT control values. D, *P<0.04 by Student’s
t-test, n=3 mice/genotype. E, *P<0.01 Student’s t-test, n=4 mice/genotype. All errorbars represent s.e.m.
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Figure 3.11. CR3 expression is high and restricted to microglia in the P5 dLGN. A, Single planeconfocal images of dLGN immunostained for C3 (red) from P5 C3 WT (left) and KO (right) littermates.Signal for C3 is completely absent in C3 KO dLGN. Scale bar = 10 µm. B, Immunohistochemistry forCR3/CD11b in P5 CR3 WT (top panel) and KO (bottom panel) dLGN (outlined with white dotted line).The protein expression of the alpha subunit of CR3 is completely absent in the dLGN of CR3 KO mice.Scale bars = 100 µm. C, dLGN from P5 CX3CR1+/EGFP mice demonstrating complete colocalization ofEGFP (green; middle) with the microglia marker, Iba-1 (red; right). Di-ii, Single cell magnified from C(arrows). E, P5 CX3CR1+/EGFP CCR2+/RFP mice in which EGFP is expressed under the control of thefractalkine receptor, CX3CR1 to label microglia and RFP is expressed under the control of thechemokine receptor, CCR2 to label infiltrating monocytes/macrophages. All mice were heterozygous forCX3CR1 and CCR2. There is a complete absence of infiltrating monocytes/macrophages (red) within theP5 dLGN. The arrows denote a GFP/RFP-positive cell near the vLGN enlarged in F. Scale bar = 100 µm. F,Enlarged region from E denoted with arrows as either merged channels (i), EGFP alone (ii), or RFPalone ( iii). G. dLGN from a P5 CX3CR1-EGFP mouse in which resident microglia are labeled with EGFP(green), astrocytes are labeled with an anti-GFAP antibody (red), and total nuclei are labeled with DAPI(blue). At P5, astrocytes were frequent in vLGN but virtually absent from the dLGN.
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(Akiyama and McGeer, 1990; Perry et al., 1985). As a result, in the context of the P5 brain,genetic manipulation of CR3 is specific to microglial cells. Similar to CR3 and consistentwith our previous work, immunohistochemistry for CR3 ligand, C3 was enriched insynaptic regions of P5 dLGN and downregulated by P9, an age when pruning is largelycomplete (Figure 3.10B) (Stevens et al., 2007).  These data demonstrate that CR3 and itsligand, C3, are expressed at an appropriate age and location to mediate RGC inputengulfment.Using the in vivo phagocytosis assay previously described (Figure 3.4), engulfmentwas assessed in P5 mice lacking functional CR3 (CR3 KO) due to a genetic deletion of thealpha subunit, CD11b (Figure 3.11B) (Coxon et al., 1996) or mice deficient in CR3 ligand, C3(C3 KO) (Figure 3.11A). Microglia sampled from P5 CR3 or C3 KO mice had a statisticallysignificant decrease in capacity to engulf RGC inputs as compared to WT littermate controls(Figure 3.10C-F). Taken together, these data demonstrate that phagocytic signaling throughCR3 and its ligand C3 is one molecular mechanism by which microglia engulf RGC inputs.
Disruption of CR3 signaling in microglia results in sustained deficits in structural remodeling
of RGC inputsDuring the first postnatal week, overlapping inputs from both eyes segregate intoeye specific territories (i.e., eye-specific segregation) resulting in the termination ofipsilateral and contralateral inputs in distinct non-overlapping domains in the maturedLGN (see Figure 3.4A) (Godement et al., 1984; Guido, 2008; Huberman et al., 2008;Jaubert-Miazza et al., 2005; Sretavan and Shatz, 1986; Ziburkus and Guido, 2006).Consistent with our hypothesis that microglia play a role in synaptic pruning, C3 KO micehave previously been shown to have deficits in eye-specific segregation (Stevens et al.,
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2007). To determine whether microglia are mediators of C3-dependent synapticrefinement in the CNS, we quantified eye-specific segregation in CR3 KO mice. Ipsilateraland contralateral RGC inputs were labeled by intraocular injection of CTB-594 (red) andCTB-488 (green), respectively. Animals were subsequently sacrificed within 24 hrs of theinitial dye injection and overlap (yellow) between contralateral and ipsilateral RGCprojection territories was quantified.  In this experimental paradigm, an increase in the %overlap between the ipsilateral and contralateral projections within the dLGN is indicativeof a deficit in synaptic pruning (Bjartmar et al., 2006; Huh et al., 2000; Pham et al., 2001;Ravary et al., 2003; Stevens et al., 2007).Consistent with the hypothesis that microglia mediate complement-dependentsynaptic pruning, a statistically significant increase in ipsilateral and contralateral inputoverlap was observed in P10 and P30 CR3 KOs as compared to WT littermate controls(Figure 3.12A-C). This increase in overlap was attributed to a significantly broaderipsilateral projection territory (Figure 3.12D) and a small, but not significant, increase inthe contralateral projection territory (Figure 3.12E). Furthermore, at higher magnificationwe detected aberrant ipsilateral and contralateral RGC inputs within the inappropriatemonocular region (contralateral and ipsilateral, respectively) in mature CR3 KO dLGN(P30; Figure 3.12F,G). In addition to genetic manipulation of CR3, microglia involvement ineye-specific segregation was further validated by manipulating microglia functionpharmacologically using minocycline, an established inhibitor of microglial ‘activation’(Buller et al., 2009) (Figure 3.13A-E). Similar to CR3 KO data, minocycline (P4-P8; 75mg/kg) treatment during the peak of the pruning period resulted in reduced
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Figure 3.12. CR3 KO mice have sustained deficits in eye-specific segregation.A, Representative image of a P30 WT (left) demonstrates minimal overlap (yellow)between ipsilateral (red) and contralateral (green) RGC inputs. Indicative of asynaptic pruning deficit, CR3 KO mice (right) had increased overlap (yellow) ofipsilateral (red) and contralateral (green) RGC inputs. Scale bar = 100 µm. B-C, P10(B) and P30 (C) CR3 KO mice had statistically significant, threshold-independentdeficits in retinogeniculate pruning . D, The percentage of ipsilateral territory issignificantly increased in P30 CR3 KO mice as compared to WT littermate controls.E, Although trending toward an increase, there is no statistically significantdifference in percentage of contralateral territory. F,G dLGN from P30 CR3 WT (F)or KO (G) mice, dotted line boxes in lower magnification image (left panels)correspond to ipsilateral region magnified in middle panels (yellow i-ii) orcontralateral region magnified in far right panels (white i-ii). Bottom panels in F,G(ii) are contralateral (CTB-488, green, left panel) channel or ipsilateral (CTB-594,red, right panel) alone. G, There were increased aberrant contralateral projections(middle panel; i, green and ii) within the ipsilateral territory in P30 CR3 KO mice ascompared to WT littermates (F, middle panel). Similarly, there were aberrantipsilateral projections (right panel; i, red and ii) within contralateral regions of thedLGN in CR3 KO mice as compared to WT littermates (F, right panel). Left panels,scale bar = 100 µm. Middle and right panels, scale bar = 10 µm. B-C, *P<0.0001 byStudent’s t-test, n=6 (P10) or 4 (P30) mice/genotype. D, *P<0.03 by Student’s t-test, n=4 mice/genotype. All error bars represent s.e.m.
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Figure 3.13. Genetic or pharmacological disruption of microglial function results in abnormal
synaptic remodeling in the absence of RGC death or altered microglial density. A, Quantificationof microglia activation state in the developing dLGN following daily systemic treatment withminocycline during the peak of the pruning period. Microglia in P5 dLGN of vehicle-treated mice(white bars) were consistently shifted toward increased activation state as compared to minocycline-treated mice (black bars). B, Confocal images of microglia in P5 dLGN immunolabeled for Iba-1(green) and phagocytic receptor CR3 alpha subunit CD11b (red). CD11b immunoreactivity isdecreased following minocycline treatment (ii) compared to vehicle-treated littermates (i). Asterisksindicate position of cell soma. Scale bar = 10 µm. C, Microglia from P5 minocycline-treated mice (Min)engulf significantly fewer RGC inputs as compared to vehicle-treated littermates (Veh). Data arenormalized to control values. *P<0.04 by paired Student’s t-test. D, Representative images of a P10vehicle or minocycline-treated mouse. Indicative of a synaptic pruning deficit, there was increasedoverlap (yellow) of ipsilateral (red) and contralateral (green) territories. Scale bar = 100 µm. E,Deficits in eye-specific segregation in minocycline-treated mice were statistically significant andthreshold independent. *P<0.0001 by Student’s t-test. F, I, There is no significant difference betweendensity (mm2) of microglia in the dLGN of P5 CR3 KO (F) or minocycline-treated (I) mice. G,H,J,K, RGCcell number (G,J TUJ1-positive) and total DAPI-positive cells (H,K) are not significantly differentbetween P10 CR3 KO versus WT  mice (G,H) or minocycline versus vehicle-treated mice (J,K). For allexperiments, n=3 mice/genotype or treatment. All error bars represent s.e.m.
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microglial phagocytic function (i.e., reduced RGC input engulfment) at P5 and a statisticallysignificant deficit in eye-specific segregation at P10 (Figure 3.13C-E). Importantly, prior toany analyses we confirmed that any phenotype in KO or drug-treated mice was not due todifferences in total RGC number within the retina and/or density of microglia within thedLGN (Figure 3.13F-K).Taken together, disruption in microglia function by pharmacological (minocycline)or more specific genetic strategies (CR3 or C3 KOs) results in sustained deficits in eye-specific segregation within the dLGN. Furthermore, given that microglia are the only CNScell that express CR3 in the postnatal dLGN, these data suggest that microglia are mediatorsof synaptic remodeling in the retinogeniculate system and represent a key cellularmechanism underlying complement-dependent synaptic pruning (Stevens et al., 2007).
Disruption in CR3/C3-dependent signaling in microglia results in sustained deficits in synaptic
connectivityIf CR3/C3-dependent signaling in microglia is a mechanism underlyingdevelopmental synaptic pruning, then a sustained increase in synapse density would beexpected in the absence of these molecules. To test this possibility, retinogeniculatesynapse density was quantified in adult CR3 KOs (P32-35) using array tomography (AT), apowerful tool for high resolution imaging and quantification of synaptic density in vivo(Greer et al., 2010; Margolis et al., 2010; Micheva and Smith, 2007; Ross et al., 2010). RGCpresynaptic terminals within the dLGN were labeled with an antibody directed againstVGlut2 and postsynaptic excitatory sites were labeled with anti-GluR1. As suggested by theeye-specific segregation assay, there was a statistically significant increase (1.3-foldincrease) in RGC synapse density (i.e., juxtaposed GluR1 and VGlut2 puncta) in adult CR3
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Figure 3.14. CR3 KO mice have a sustained increase in synapse density. A,Single plane array tomography images for VGlut2 (green) to label RGC terminalsand GluR1 (purple) to label postsynaptic excitatory sites in P32-35 dLGN of CR3KO (right) and WT littermate controls (left). Yellow circles indicate synapsesdefined by VGlut2 and GluR1 immunoreactivity. Scale bar = 2 µm. B-D,Quantification of retinogeniculate synapse (B, VGlut2/GluR1-positive),postsynaptic (C, GluR1), and presynaptic/RGC terminal (D, VGlut2) densityindicates that there is a statistically significant increase in retinogeniculate synapsedensity and total RGC terminal density in CR3 KOs as compared to WT littermates.
*P<0.03 Man-Whitney U test, n=3 mice/genotype. Error bars represent s.e.m.
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KOs as compared to WT littermates (Figure 3.14A,B). Consistent with our previouslypublished work (Stevens et al., 2007), adult C3 KO mice had an identical 1.3-fold increase inVGlut2-containing synapses as compared to WT littermate controls (Figure 3.15).Interestingly, there was also a significant increase in the density of total (both synapseassociated and non-associated) VGlut2-positive puncta in CR3 KOs (1.8-fold increase) ascompared to WT littermates (Figure 3.14D). We hypothesize that these excess VGlut2-positive puncta represent residual immature synapses as well as retracted or unopposedimmature presynaptic terminals that were not eliminated by phagocytic microglia. Takentogether, these data implicate CR3/C3 signaling as a mechanism regulating synapticconnectivity.Because microglia are the only cell type within the P5 dLGN and surrounding braintissue to express CR3 (Figure 3.10; Figure 3.11) (Akiyama and McGeer, 1990), our datadirectly implicate microglia as mediators of anatomical pruning and identify CR3/C3-dependent signaling as an underlying molecular mechanism.
Discussion
In this study, we demonstrate that microglia are mediators of synaptic pruning inthe normal, developing brain and identify neural activity and CR3/C3-dependent signalingas underlying mechanisms. Specifically, we demonstrate that: 1) Microglia in the postnataldLGN engulf RGC presynaptic terminals during active synaptic remodeling. 2) Engulfmentof RGC inputs is regulated by neuronal activity. 3) Engulfment of RGC inputs is regulated byCR3/C3-dependent phagocytic signaling specific to microglia. 4) Genetic (CR3 and C3 KO)or pharmacological perturbations that disrupt microglia function result in deficits instructural remodeling of synapses. 5) Defects in synaptic circuitry are sustained into
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Figure 3.15. Array tomography in adult C3 KO dLGN and model of microglia-
mediated synaptic pruning. A, Single plane array tomography images for VGlut2(green) to label RGC terminals and GluR1 (purple) to label postsynaptic excitatorysites in P32-35 C3 KO and WT littermate controls. Yellow circles indicate bona fidesynapses defined by VGlut2 and GluR1 immunoreactivity. Scale bar = 2 µm. B,Quantification of synapse density indicates that there is a statistically significantincrease in RGC synapses (VGlut2/GluR1-positive) as compared to WT littermates.All data are normalized to WT control values. *P<0.03 by Mann-Whitney U test,n=3 mice/genotype. Error bars represent s.e.m. C, Model of microglia-mediatedsynaptic pruning illustrates that early in development the postsynaptic cell (darkblue) is innervated by exuberant presynaptic terminals. We propose that theactivated form of C3 (iC3b) “tags” weak or inappropriate synapses for selectiveremoval by phagocytic microglia expressing the C3 surface receptor, CR3. As aresult, only appropriate synapses remain and become strengthened.
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adulthood in CR3 and C3 KO mice. We propose a model in which neural activity andcomplement work cooperatively to mediate engulfment of RGC inputs, a process that mayunderlie synaptic pruning in the developing CNS (Figure 3.15).
Microglia engulf RGC presynaptic inputs during peak synaptic pruningOne question arising is whether engulfment of RGC inputs by microglia is an activeprocess. Particularly during CNS disease, microglia are known scavengers that phagocytosecellular debris (Hanisch and Kettenmann, 2007; Napoli and Neumann, 2009; Ransohoff andPerry, 2009). Furthermore, glia are known to engulf axonal material during large-scaledevelopmental pruning of axons in Drosophila and synaptic pruning at the mammalianneuromuscular junction (Bishop et al., 2004; Freeman, 2006; Rochefort et al., 2002). Whileour results do not rule out the possibility that axonal material may also be engulfed, ourdata suggest that microglia play an active role in the removal of transient, intactpresynaptic elements. Indeed, in comparison to large scale developmental axonal pruning,there is no evidence that local CNS synaptic pruning, such as in the case of theretinogeniculate system, involves classic  axonal  or synaptic degeneration (Dhande et al.,2011; Hahm et al., 1999; Snider et al., 1999; Sretavan and Shatz, 1984). Earlier EM work inthe developing mammalian dLGN demonstrated that RGCs transiently synapse within theinappropriate region of the dLGN (Campbell and Shatz, 1992; Campbell et al., 1984). Thesetransient synapses contained presynaptic machinery including a high density of vesicles,but were subsequently eliminated by an undetermined mechanism. Given our highresolution light microscopy and ultrastructure data, we suggest that microglia are activelypruning these transient synaptic connections via a phagocytic mechanism (Figure 3.15).
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We provide several lines of evidence implicating microglia in the local pruning oftransient, intact retinogeniculate synapses in the absence of axon debris or degeneration.First, in experiments involving anterograde tracing of RGCs (engulfment and eye-segregation assays), intraocular injections of dye occur less than 24 hrs prior to tissueharvesting and fixation. If neurons or axons were degenerating, we would not expecteffective dye uptake and tracing of the entire RGC projection. Furthermore, previous workhas demonstrated that RGC normal programmed cell death is essentially complete byP4/P5 (Farah and Easter, 2005). Taken together, any CTB labeling observed within thedLGN is, more likely, originating from a healthy RGC cell body and axon. Second, previouswork using dye tracing or fluorescent protein to label small subsets of RGC afferents in thedLGN demonstrate that RGC axons and arbors within the dLGN undergoing active pruningremain intact and unfragmented (Dhande et al., 2011; Hahm et al., 1999; Snider et al., 1999;Sretavan and Shatz, 1984). Consistent with these data, our EM experiments demonstratedthat engulfed material as well as surrounding dLGN neuropil did not appear to have classicsigns of axonal or synaptic degeneration such as multilamellar bodies, electron-densecytoplasm, lack of synaptic vesicles within presynaptic terminals, etc. (Hoopfer et al., 2006;Perry and O'Connor, 2010). Lastly, we observed sustained increases in the number ofintact, structural synapses by eye specific segregation and array tomography analyses inmice with disrupted microglia function (C3 KO, CR3 KO, and minocycline-treated mice). Ifsynapses degenerated prior to engulfment, we would not expect to observe increasednumbers of healthy, intact synapses in KO mice. Taken together, our data suggest thatengulfed presynaptic elements were healthy, intact, and specifically engulfed by microglia.
Engulfment of RGC inputs by microglia is an activity-dependent process
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Previous work has demonstrated that microglia have the capacity to interact withsynaptic elements in response to neurotransmitter release and/or sensory experience(Biber et al., 2007; Fontainhas et al., 2011; Nimmerjahn et al., 2005; Ransohoff and Perry,2009; Tremblay et al., 2010a; Wake et al., 2009). Furthermore, microglia can contribute tosynaptic plasticity in the adult CNS and, more recently, in the context of the normaldeveloping hippocampus (Paolicelli et al., 2011; Pascual et al., 2011; Roumier et al., 2008).Our data provide insight into mechanisms by which microglia may interact with synapsesand contribute to activity-dependent synaptic plasticity. When competition between inputsfrom the two eyes was enhanced by pharmacological manipulation (i.e., TTX or forskolin),we found that microglia preferentially engulfed inputs from the eye in which neuronalactivity was decreased or ‘weaker’. Although it is not yet known whether or how microgliatarget specific ‘weaker’ synapses, these data are consistent with previous workdemonstrating that such a competition results in decreased territory of the ‘weaker’ inputsand increased territory of ‘stronger’ inputs within the dLGN (Del Rio and Feller, 2006;Huberman et al., 2008; McLaughlin et al., 2003; Penn et al., 1998; Shatz, 1990; Shatz andStryker, 1988; Stellwagen and Shatz, 2002; Stellwagen et al., 1999; Torborg and Feller,2005). In the retina, spontaneous, correlated neuronal activity from both eyes (i.e., retinalwaves) drives the elimination of synapses and segregation of inputs into eye-specificterritories in the dLGN (Del Rio and Feller, 2006; Feller, 1999; Huberman et al., 2008;McLaughlin et al., 2003; Penn et al., 1998; Stellwagen and Shatz, 2002; Torborg and Feller,2005). Interestingly, complement and complement receptor-deficient mice have similarpruning deficits to mice in which this correlated firing has been disrupted (e.g., cAMP-
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analog injection, β2nAChR-/-mice, etc.) (Stevens et al., 2007), suggesting the intriguingpossibility that complement cascade activation and function is regulated by neural activity.Neural activity could also directly regulate microglia function (i.e., activation, recruitment,phagocytic capacity) through complement-independent mechanisms. Alternatively, neuralactivity may drive the elimination of synapses by other mechanisms which ultimately leadto complement activation and/or microglia-mediated engulfment. Future studies will aimto address how neural activity, complement, and microglia may interact to contribute todevelopmental synaptic pruning (Figure 3.15).
CR3/C3-dependent signaling: A molecular pathway underlying microglia-mediated synaptic
pruningSynaptic pruning likely involves several mechanisms that cooperatively interact toestablish precise synaptic circuits. We suggest that microglia may be a common link andidentify CR3/C3 signaling as one pathway underlying microglia-synapse interactions andmicroglia-dependent pruning in the developing CNS. One of the major questions raised bythese findings is precisely how secreted complement proteins mediate the selectiveelimination of synapses by microglia. In the immune system, C3 is cleaved into an activatedform, iC3b, which covalently binds to the surface of cells or debris and targets them forelimination by macrophages via specific phagocytic receptor signaling (e.g., CR3) (Lambrisand Tsokos, 1986; van Lookeren Campagne et al., 2007).  Similar to the immune system, wepropose that activated C3 (iC3b/C3b) could selectively ‘tag’ weak synapses (Figure 3.15).Consistent with C3 “tagging” subsets of RGC terminals, previous confocal analysis revealedcolocalization of C3 with pre and postsynaptic markers in the developing dLGN (Stevens etal., 2007). Furthermore, mice deficient in CR3, C3, and C1q, the initiating protein of the
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classical complement cascade, exhibit strikingly similar defects in developmental synapticpruning (Figure 3.12, 3.14 and Figure 3.15). Alternatively, other complement-dependentand/or independent mechanisms may be involved. For example, C3 could bind all synapsesand only those synapses that are ‘stronger’ or more active are selectively protected bymembrane-bound complement regulatory molecules (Kim and Song, 2006; Song, 2006).Another possibility is that ubiquitously expressed protective molecules, such as “don’t eatme” signals (Griffiths et al., 2007), could be lost from weaker synapses, enabling C3 topromote their removal. In contrast, selective, activity-dependent elimination of synapsescould be driven by a complement-independent mechanism which subsequently results incomplement binding and/or microglia-mediated engulfment. For example, MHC class Imolecules, another class of immune molecules demonstrated to play a role inretinogeniculate pruning, have been shown to be activity-dependent, localized to synapses,and co-localized with C1q leaving the possibility that MHC class I molecules may play anupstream role in microglia-mediated pruning of synapses (Corriveau et al., 1998; Datwaniet al., 2009; Goddard et al., 2007; Huh et al., 2000).While our data demonstrate that CR3/C3 signaling specific to microglia is involvedin the pruning of developing circuits and suggest that engulfment is the underlyingmechanism, CR3 and C3 may be acting through other pathways independent ofphagocytosis or may be downstream of other signaling pathways to mediate pruning. Inaddition, engulfment deficits in CR3 and C3 KO mice were reduced to approximately 50%of WT littermate control values suggesting that other complement receptor-dependent(e.g., CR4, CRig, etc.) and independent phagocytic mechanisms may also be involved.Moreover, these data may indicate that activated microglia engulf inputs in the absence of
93
“eat me” signals, suggesting a baseline level of phagocytic activity in need of regulation.Future studies will aim to address whether and how specific synapses are eliminated bycomplement and other microglia-dependent mechanisms and how neural activity plays arole in this process.
Complement-dependent engulfment of synaptic inputs: A more global mechanism underlying
remodeling of neural circuits in the healthy and diseased CNS?Our data raise the question as to whether complement and/or microglia-dependentengulfment of synaptic inputs represents a more global mechanism underlying CNS neuralcircuit plasticity. While in at least one other developing system local axonal retraction andsynapse elimination appear to occur independent of microglia (Cheng et al., 2010), recentwork describes a role for microglia at developing hippocampal synapses (Paolicelli et al.,2011). In addition, in vivo imaging studies in the cortex revealed that microglia dynamicsand interactions with neuronal compartments change in response to neural activity andexperience (Davalos et al., 2005; Nimmerjahn et al., 2005; Tremblay et al., 2010a; Wake etal., 2009). While these studies describe microglia dynamics at synapses, a precise functionand molecular mechanism(s) underlying microglia-synapse interactions in these brainregions was unknown. Our study provides mechanistic insight on the dynamic betweenmicroglia and developing synapses and provides complement-dependent signaling as apotential mechanism in other brain regions. Consistent with this idea, deficits incomplement component C1q results in an increase in the number of presynaptic boutonsand exuberant excitatory connectivity in the cortex (Chu et al., 2010). Future studies willaim to test the role of complement in microglia-synapse interactions in other CNS regionsknown to undergo activity-dependent synaptic remodeling.
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In addition to relevance in global remodeling of circuits in the healthy brain, ourfindings have important implications for understanding mechanisms underlying synapseelimination in the diseased brain.  Consistent with this idea, abnormal microglia functionand complement cascade activation have been associated with neurodegeneration of theCNS (Alexander et al., 2008; Beggs and Salter, 2010; Rosen and Stevens, 2010; Schafer andStevens, 2010). Indeed, in a mouse model of glaucoma, a neurodegenerative diseaseassociated with RGC loss and gliosis, C1q and C3 are highly upregulated and  deposited onretinal synapses and C1q deficiency or microglial ‘inactivation’ with minocycline providesignificant neuroprotection (Howell et al., 2011; Steele et al., 2006; Stevens et al., 2007). Inaddition to diseases associated with neurodegeneration, recent data from genome-wideassociation studies and analyses of postmortem human brain tissue have suggested thatmicroglia and/or the complement cascade may also be involved in the development andpathogenesis of neurodevelopmental and psychiatric disorders (e.g., autism, obsessivecompulsive disorder, schizophrenia, etc.) (Chen et al., 2010; Havik et al., 2011; Monji et al.,2009; Pardo et al., 2005; Vargas et al., 2005). Thus, an intriguing possibility remains thatmicroglia and/or complement dysfunction may be directly involved in diseases associatedwith synapse loss, dysfunction, and/or development.Together, our data offer insight into mechanisms underlying activity-dependentsynaptic pruning in the developing CNS, provide a role for microglia in the healthy brain,and provide important mechanistic insight into microglia-synapse interactions in thehealthy and diseased CNS.
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Chapter 4:
“Don’t Eat Me” Signals Prevent Excess Microglia-Mediated Retinogeniculate Pruning
Contributions: All experiments were designed by Emily Kate Lehrman and Beth Stevens.All experiments and data analysis were performed by Emily Kate Lehrman with theexception of the following:  SIM imaging and analysis and CD47 western blot analysis wereperformed by Daniel Wilton, in situ hybridization was performed by Arnaud Frouin, andCD200 engulfment analysis, CD200 and CD47 microglia activation assays, and CD200 andCD47 microglia cell density counts were performed by Stephen Chang. CD47 synaptosomefractionation data provided by Hisashi Umemori. RGCs provided by Allison Bialas.
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IntroductionOver the past decade, work from our lab and others has revealed that microglia areessential for normal brain development and function. We identified microglia as thecellular effectors mediating developmental retinogeniculate refinement and found thatthey remove synaptic inputs via complement-dependent phagocytosis (Schafer et al.,2012). However, despite this progress, we do not yet know how microglia target specificsynapses for removal.  Microglia must determine which inputs to engulf and which to avoidto create mature synaptic circuits, a crucial decision with potentially far-reachingfunctional and behavioral consequences. One possible mechanistic insight comes from acommon feature shared by molecules previously shown to regulate mouse retinogeniculaterefinement. These molecules, including class I major histocompatibility complex (MHCI)molecules, complement cascade components C1q and C3, and neuronal pentraxins 1 and 2(NP1, NP2), are all either immune molecules or homologs of immune molecules (Bjartmaret al., 2006; Datwani et al., 2009; Huh et al., 2000; Stevens et al., 2007).  While the initialdiscovery of immune molecules as regulators of retinogeniculate refinement came as asurprise, it fits nicely with the knowledge that microglia, the brain’s immune cells,phagocytose synaptic inputs.  Taken together, these data suggest that microglia maydetermine which synapses to engulf using mechanisms borrowed from the immune system.Indeed, some of the immune molecules required for proper refinement are bestknown for regulating phagocytosis of pathogens or debris, such as classical complementcascade proteins C1q and C3.  These molecules are canonical “eat me” signals, whichinstruct macrophages to engulf and clear apoptotic or non-self material by signaling toreceptors on phagocytes (Elward and Gasque, 2003; Grimsley and Ravichandran, 2003).
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We found that C3 functions similarly during brain development, directing microglia tophagocytose synaptic inputs during the retinogeniculate pruning period by engagingmicroglial C3 receptor CR3 (Chapter 3, Schafer et al., 2012). Mice deficient in C1q, C3, or theother aforementioned immune molecules exhibit a similar loss of function phenotype:failure to complete retinogeniculate refinement and, in most cases, maintenance of manyweak, supernumerary presynaptic inputs. These phenotypes indicate an inability toremove unnecessary connections during development, and suggest that these moleculeswork to promote the pruning process, potentially by identifying synaptic inputs in need ofremoval. Our data highlighting the importance of the C3-CR3 interaction for microglia-mediated pruning indicate that the signaling pathways and functions of these moleculesmay be conserved between the central nervous system (CNS) and the immune system. Yet,this does not address the question of how secreted molecules like C1q and C3 are capableof directing microglia to remove specific synapses.C1q and C3 can diffuse locally throughout the neuropil, and as we do not yet knowof a receptor or adaptor that recruits them to specific sites, it is possible that thesemolecules may bind to a variety of different synapses. Perhaps there is a yet-to-be-determined receptor that is specifically expressed by weak or inappropriately targetedsynapses, but, even so, given that microglial phagocytosis still occurs in the absence ofthese molecules and that excess pruning may be linked to disorders such as schizophrenia(Arnold, 1999; Keshavan et al., 1994; Woo and Crowell, 2005), it seems likely that a failsafewould be in place to prevent the inappropriate removal of necessary connections. Anotherkey feature of microglia-mediated retinogeniculate pruning is that it appears to involve theexclusive removal of presynaptic inputs, while axons and other cellular compartments
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remain intact (Chapter 3, Schafer et al., 2012).  This also hints at the existence of aprotective signal or inhibitory factor that would restrict microglial engulfment activity tosynaptic terminals. One such safeguard exists in the immune system to preventphagocytosis of “self” material by macrophages, which is especially important when thesecells are working to remove pathogenic substances during inflammation or injury.  Themolecules that perform this protective function in the immune system are called “don’t eatme” signals, and serve as identifiers of “self” that inhibit engulfment, either directly orindirectly, by engaging receptors on phagocytic cells (Gardai et al., 2006; Griffiths et al.,2007; Grimsley and Ravichandran, 2003).  These molecules include complement inhibitors,such as factor H and Decay accelerating factor (DAF/CD55), sialic acids, and cluster ofdifferentiation (CD) molecules CD31, CD47, and CD200. I hypothesize that “don’t eat me”signals serve a similar protective function during periods of heightened microglialphagocytosis and act to prevent the removal of excess synaptic connections during synapticrefinement. Given that synaptic refinement must be tightly regulated to enable the removalof supernumerary inputs without the elimination of necessary connections, I predict thatthe CNS, like the immune system, would employ more than one of these protective signalsto ensure that bystander damage in the form of inappropriate pruning does not occur.“Don’t eat me” signals, including DAF, sialic acids, CD47 and CD200 are indeedpresent in the developing CNS (Mi et al., 2000; Schnaar et al., 2014; Webb and Barclay,1984; Zhang et al., 1998), although their function during this period has not been wellexplored. To address whether these signals function analogously in the brain and protectretinogeniculate synapses from excess microglia-mediated pruning, I focused on two “don’teat me” signals, CD47 and CD200.  Although these molecules have not been well studied
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during brain development, they are both expressed in the developing CNS by neurons inaddition to other cell types and are both Ig superfamily proteins with microglial receptors,signal regulatory protein–alpha (SIRP) and CD200R, respectively (Matozaki et al., 2009;Walker and Lue, 2013). In the immune system, CD47 has been found to directly inhibitmacrophage phagocytosis via binding to SIRPα (Okazawa et al., 2005; Oldenborg et al.,2001).  Conversely, CD200 may affect phagocytosis indirectly via its inhibition ofmacrophage activation and inflammatory signaling (Minas and Liversidge, 2006), and micelacking CD200 have more activated microglia displaying increased Cd11b and CD45 (Hoeket al., 2000). Microglia activation is a broad term used to indicate a state in which microgliahave a more reactive phenotype, often characterized by an amoeboid morphology,increased phagocytic capacity, upregulation of specific cell surface markers, and secretionof pro-inflammatory cytokines (Ransohoff and Perry, 2009). CD200 may also inhibit excessmicroglial proliferation or infiltration into the CNS, as adult CD200KO brains and retinashave been reported to have increased numbers of these cells (Hoek et al., 2000). Bothmolecules have also been implicated in CNS disease, where the absence or blockade ofthese signals may lead to a worsening of disease severity and progression for a variety ofneurodegenerative diseases in humans and mouse models, including Multiple Sclerosis(MS), Alzheimer’s Disease (AD), and Parkinson’s Disease (PD) (Koning et al., 2007; Walkeret al., 2009; Wright et al., 2000; Zhang et al., 2011). These data suggest that “don't eat me”signals serve a protective function in the CNS, and that loss of these signals duringinflammatory diseases leads to the inappropriate removal of “self” material.  This couldinvolve a variety of targets, including myelin or synaptic connections, as increased myelinengulfment occurs with CD47 blockade in a model of traumatic axonal injury, and CD200
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downregulation has been proposed as a cause of chronic inflammation and microglialactivation in Alzheimer’s disease (AD), a disease in which inappropriate synapse loss isknown to occur (Gitik et al., 2011; Knobloch and Mansuy, 2008; Walker et al., 2009). Thesedisease studies bolster my hypothesis, and support the idea that these molecules functionsimilarly in the CNS to their immune system counterparts.Here, I demonstrate for the first time that protective signals are required to preventexcess microglia-mediated pruning during development. I show that CD47 and its receptor,SIRPα, are expressed in the right time and in the correct cell types and locations to servethis protective function during retinogeniculate refinement. I find that mice deficient ineither CD47 or CD200 exhibit decreased overlap between eye-specific territories in thedorsal lateral geniculate nucleus of the thalamus (dLGN), a phenotype that could indicateincreased pruning as territories cease to overlap when redundant left and right eye inputsare removed to ensure that each dLGN relay neuron receives input from only one eye. Thissimilar phenotype may arise in the two knockout mice via different mechanisms, asCD47KO microglia exhibit increased engulfment of synaptic inputs, which could lead toincreased or accelerated pruning, while CD200KO microglia have no engulfment defect,indicating that the CD200KO overpruning phenotype may have a separate cause. Myresults also indicate that microglial and neuronal SIRPα may be differentially regulated toperform specific functions in different cell types and brain regions during development.Taken together, these data suggest that “don’t eat me” signals serve an importantregulatory function during microglia-mediated pruning and that their absence alters thecourse of normal retinogeniculate refinement.
Results
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CD47 is enriched in the dLGN during peak pruningTo determine whether CD47 could regulate microglia-mediated pruning duringdevelopment, I first examined its localization and expression within the dLGN.Immunohistochemistry (IHC) for CD47 reveals punctate staining throughout the neuropilin all brain regions examined, as expected for a ubiquitous protective signal (Figure 4.1A,Figure 4.2, Figure 4.3A).  However, CD47 is highly localized to the dLGN during peakpruning (P5-P10), displaying a similar enrichment to that observed with vesicularglutamate transporter 2 (Vglut2), a marker of retinogeniculate synapses (Figure 4.1A-B).This enrichment is most noticeable at postnatal day (P5), which corresponds to the periodof peak microglial engulfment of synaptic inputs, and can still be observed at P10, when theformation of eye-specific territories is nearing completion (Guido, 2008; Hong and Chen,2011; Jaubert-Miazza et al., 2005).  CD47 levels increase in other brain regions duringdevelopment and decline slightly in the dLGN after P5 to reach a relatively uniformexpression pattern throughout the brain by P30, at which point dLGN pruning is nearingcompletion (Figure 4.1A, Figure 4.2A). High-resolution imaging using structuredillumination microscopy (SIM) reveals that CD47 colocalizes with both pre- andpostsynaptic markers in the dLGN (Figure 4.1C).  Moreover, western blot analysis ofsynaptosome fractions from P21 mouse cortex confirms this synaptic localization and alsodemonstrates that much of the CD47 protein in synaptosomes may be perisynaptic (Figure4.1D), similar to synaptic regulatory proteins such as cadherins and fibroblast growthfactors (FGFs). The unusual abundance of CD47 in the dLGN during the pruning period andits localization to synapses makes it well suited to regulate the pruning process.  CD47 may
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Figure 4.1. CD47 is developmentally regulated and synaptically localized in
the dLGN during the pruning period. A, Representative low magnificationmosaics of P5, P10, and P30 WT coronal sections. CD47 is enriched in the dLGN(arrow) during peak pruning at P5 and P10, but evenly distributed throughout thebrain at P30. Scale bar = 500m. B, CD47 (red) is highly enriched in the dLGNduring pruning, similar to Vglut2 (green), a marker of retinogeniculate synapses.Scale bar = 50m. C, SIM image of P5 dLGN (left), demonstrating that CD47 (red)colocalizes with both presynaptic (Vglut2, green, circles) and postsynaptic (Homer,blue, hexagons) puncta during peak pruning. Three-dimensional views of the entirez-stack (right) are provided for better visualization of colocalization of CD47 withsynaptic markers. Scale bar = 2m.  D, Western blot analysis of synaptosomefractions from P21 mouse cortex indicates that CD47 is enriched in the synapticmembrane and extra junctional fractions, but also present in the pre- and post-synaptic fractions.
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Figure 4.2. CD47 is developmentally regulated in the cerebellum and
localized to the optic tract. A, Images of CD47 staining in the cerebellum of WTmice. At P5, CD47 is localized to the purkinje cell layer, which is where climbingfiber synapses are located at that developmental time point. By P12 and P16, CD47moves to the molecular layer, coincident with the movement of climbing fibersynapses up purkinje cell dendrites that occurs during cerebellar pruning. Scalebar = 50m.  B, Confocal images of CD47 and Vglut2 in the P5 dLGN, dashed lineindicates the border of the dLGN and optic tract.  Vglut2 (green and middle panel)is confined to the dLGN, whereas CD47 (red and left panel) stains both regions.Scale bar = 10m.
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Figure 4.3. The CD47 antibody and in situ probe are specific. A, Representative10X images of dLGN from P5 CD47KO (right) and WT (left) littermatesdemonstrate that the antibody does not stain knockout tissue. B, Representative10X images of dLGN from P5 CD47KO (right) and WT (left) littermatesdemonstrate that the CD47 in situ probe does not label knockout tissue.  Scale bars= 50m
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also be upregulated in other brain regions, such as hippocampus and cerebellum,coincident with the onset of pruning in those regions (Figure 4.1A, Figure 4.2A).CD47 mRNA displays a similar pattern of expression, with heightened expression inthe dLGN during pruning prior to upregulation in other brain regions (Figure 4.4D, Figure4.3B).  Double fluorescent in situ hybridization (FISH) indicates that CD47 is produced byneurons in the dLGN at P5 and that this expression persists throughout the pruning periodand begins to decline at P30, while other regions initiate CD47 expression later (Figure4.4D).  Quantitative PCR (qPCR) using whole brain lysates demonstrates that CD47expression is relatively stable throughout development (Figure 4.4B), although thisobscures region-specific variability.  Consistent with presynaptic localization, CD47 is alsoproduced in the retina and message appears to be highest at P5, which may correspond tothe high level of CD47 protein in the P5 dLGN (Figure 4.4A). To determine whether CD47mRNA is made by retinal ganglion cells (RGCs), which serve as the object ofretinogeniculate refinement, I performed qPCR on acutely isolated RGCs from P5 mice andfound that they indeed make CD47, and that CD47 is more highly expressed in RGCs thanother cell types, such as acutely isolated P5 microglia (Figure 4.4C). These data indicatethat CD47 is well positioned to regulate microglia-mediated pruning in the dLGN.
CD47-deficient microglia exhibit increased engulfment of RGC inputsTo test the hypothesis that CD47 acts as a “don't eat me” signal to inhibit excessmicroglial phagocytosis of synaptic inputs during development, I turned to our in vivomicroglia engulfment assay (Chapter 3, Schafer et al., 2012).  For these experiments,intraocular injection of anterograde tracers (cholera toxin -subunit (CTB) conjugated toAlexa dyes) is performed to label presynaptic RGC inputs and microglia are visualized using
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Figure 4.4. CD47 is expressed more highly in the dLGN and retina during the
pruning period. A, CD47 is most highly expressed in the retina during peakpruning (P5) as measured by qPCR, n=3 mice per age. B, CD47 expression in wholebrain is relatively constant throughout development, n=3 mice per age. C, CD47 ismore highly expressed in acutely isolated P5 RGCs than acutely isolated P5microglia (MG) as measured by qPCR, n=2 RGC samples, 3 microglia samples. D,Representative double FISH images of dLGN (left) and hippocampus (right) fromWT mice.  CD47 (red) colocalizes with neuronal marker NSE (green) in bothregions, but appears more highly expressed in the dLGN than hippocampus duringpeak retinogeniculate pruning (P5) and declines in the dLGN after the pruningperiod (P30). Scale bar = 50m.  All error bars represent s.e.m.
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IHC for Iba-1.  Then, high-resolution imaging and three-dimensional (3D) reconstruction ofz-stack images are used to determine the volume of engulfed RGC inputs. I examinedCD47KO and WT littermates during peak pruning in the dLGN (P5) and found that CD47KOmicroglia engulfed approximately 1.5X the volume of inputs compared to that engulfed bytheir WT littermates (Figure 4.5A-B, p<.07 using Student’s t-test, n=6 WT, 6 CD47KO,analysis of additional litters in progress). This phenotype was not due to a uniformincrease in engulfment; instead, about half the cells in a CD47KO animal display wild typelevels of engulfment (inputs occupying 0-10% of the microglia cell volume), while the restof the cells engulf increased inputs.  Most of the remaining KO cells engulfed about 2X thewild type volume of inputs, and one or two cells per animal could typically be observedengulfing up to 3-4X wild type levels (inputs occupying 30-40% of the microglia cellvolume), something never observed in WT animals (Figure 4.5C).  The variability in theknockout suggests that other factors may also work to prevent excess engulfment, and thatmicroglia may be a heterogeneous population of cells.Further examination of microglia in CD47KO and WT littermates yielded noadditional abnormalities in morphology or markers representing phagocytic capacity. Iused our microglia activation assay (Figure 3.3), in which scores are assigned based onlysosome abundance, as measured by CD68 immunoreactivity, and cell morphology, asdetermined by counting branches on Iba-1 stained microglial cells, to assess these twoproperties in fixed tissue. CD47KO microglia exhibited a comparable level of activation inthe dLGN to their wild type littermates at P5 and P10, with a similar percentage of cellsfrom each animal being assigned a particular score (Figure 4.6A-B). The numbers ofmicroglia within the dLGN were also similar between CD47KO and WT littermates (Figure
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Figure 4.5. CD47-deficient microglia exhibit increased engulfment. A,Representative images of CD47KO (right) and WT (left) littermate microglia(green) with internalized CTB-labeled inputs (red and blue). Grid line increments =5m. B, CD47KO microglia engulf more CTB-labeled inputs than WT littermatemicroglia, n=6 mice per genotype, p<.07 using Student’s t-test. C, Binning cells bypercent engulfment shows that the CD47 distribution is shifted to the right,indicating that, although some cells still exhibit WT levels of engulfment, there aremany cells that engulf at higher than WT levels.  All error bars represent s.e.m.
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Figure 4.6. CD47KO mice do not exhibit alterations in microglia activation,
cell density, or input innervation. A, Representative images of P5 (top) and P10(bottom) CD47KO and WT littermate dLGN microglia stained for Iba-1 (green) andCD68 (red) to label microglia and lysosomes, respectively. Scale bars = 10μm. B,Results of the microglia activation assay for P5 (top) and P10 (bottom) CD47KOand WT littermates.  Microglia activation is similar for the two genotypes, n=3 miceper age per genotype. C, Quantification of microglia cell density in CD47KO and WTlittermates indicates that there is no difference in cell density, n=3mice per age pergenotype.  D, Quantification of the volume of CTB-labeled inputs within the P5dLGN as measured using Imaris software (volume of inputs/volume of dLGN fieldanalyzed).  CD47KO mice do not appear to have reduced innervation into the dLGN,n=6 mice per genotype. All error bars represent s.e.m.
118
4.6C), and KO and WT microglia were indistinguishable based on their average three-dimensional cell volume (data not shown). These data indicate that CD47KO microgliaengulf more retinogeniculate inputs during peak pruning, despite cell-to-cell variability,and that this phenotype is not due to changes in microglia activation. This suggests thatCD47 is required to inhibit excess microglia-mediated pruning, and that once the “brakes”on pruning are removed, microglia can consume additional synapses.
CD47KO mice display increased or accelerated pruningTo address the functional consequences of excess microglial engulfment of RGCinputs, I investigated whether this increased pruning could impact retinogeniculaterefinement. During typical refinement, there is a great deal of overlap between inputs fromthe left and right eyes when pruning is initiated at P5, yet distinct eye-specific territoriescan be observed with minimal overlap at the border of the ipsilateral and contralateralregions only five days later at P10 (Guido, 2008; Jaubert-Miazza et al., 2005; Sretavan andShatz, 1986; Ziburkus and Guido, 2006). Given our findings that decreased microglialengulfment during peak pruning led to decreased retinogeniculate refinement in CR3knockout mice (Chapter 3, Schafer et al., 2012), I hypothesized that increased engulfmentwould produce the opposite result, or overpruning. Performing eye-specific segregationanalysis on P10 CD47KO and WT littermates revealed significantly less overlap betweeneye-specific territories in KOs compared to WT littermate controls (Figure 4.7A-C).  Thissuggests that increased microglial engulfment of RGC inputs leads to overpruning in thedLGN.  Retinal neuron numbers were comparable between KOs and WTs, indicating thatthe decrease in overlap does not result from loss of retinal neurons in CD47KOs (Figure4.8C). This phenotype could also result if outgrowth is impaired in CD47KO animals,
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Figure 4.7. CD47KO mice have an overpruning defect. A, Representative imagesof CD47KO (right) and WT littermate (left) P10 dLGN contralateral (green) andipsilateral (red) territories.  CD47KOs exhibit less overlap (yellow) between thetwo territories, indicating increased pruning, n=8KO, 7WT, Scale bar = 10m. B,CD47KOs have a significant reduction in overlap, *p<.05, Student’s t-test.  C, Thedifference in overlap diminishes as thresholding becomes more conservative,*p<.05, Student’s t-test. D, Representative western blot for synaptic markers from 3month-old striatum. CD47KO mice have lower levels of presynaptic marker Vglut2,but postsynaptic Homer appears unchanged. Quantification below.  All error barsrepresent s.e.m.
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Figure 4.8. CD47KO mice exhibit accelerated pruning that is not caused by
loss of retinal cells. A, Quantification of P7 eye-specific segregation data.CD47KO and WT littermates do not have a statistically significant difference inoverlap, but there is a trend toward increased pruning in P7 CD47KOs, n=9WT,7KO. B, Quantification of P30 eye-specific segregation data. CD47KO and WTlittermates do not exhibit differences in percent overlap at this age, n=3WT, 6KO. C,Quantification of cell numbers in the retina.  CD47KO and WT littermates do notexhibit alterations in the number of total cells (DAPI, right) or the number ofretinal neurons (Tuj1, left) at P10, n=3 mice per genotype. All error bars represents.e.m.
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a phenotype that has been described in cultured hippocampal neurons (Murata et al.,2006). I used 3D reconstruction of CTB-labeled inputs in the dLGN to assess outgrowthwhile performing microglia engulfment analysis, and found equivalent innervation in KOand WT littermates (Figure 4.6D), suggesting that this is not responsible for the phenotype.As this period of refinement involves both a reduction in inappropriately targeted inputsand the arborization of those inputs that remain (Dhande et al., 2011; Snider et al., 1999), itis possible that decreased overlap could result from a failure to properly elaborate arbors.To address this, I am performing single RGC arbor tracing experiments in CD47KO and WTlittermates carrying an RGC-specific tamoxifen inducible Cre and a Thy1-STOP-YFPtransgene.  Low doses of tamoxifen will allow me to visualize individual YFP-labeled arborsin sagittal dLGN sections that I can reconstruct and trace using Imaris software todetermine whether arbor sizes are reduced in CD47KOs.One question raised by this phenotype is whether the pruning process begins earlierin CD47KO mice or is accelerated compared to the normal timeline.  When I imaged dLGNsat P5 for the microglia engulfment assay, CD47KO and WT littermates appearedindistinguishable, and pruning did not appear to have been initiated.  However, by P7, thedecrease in overlap between eye-specific territories in CD47KO versus WT littermates canbe visualized, although this is variable and not seen in every litter examined (Figure 4.8A).This suggests that increased microglial phagocytosis may accelerate the pruning process,and it is possible that the variability in engulfment at P5 could lead to the variable levels ofoverlap observed at P7.Another important question is whether this increase in pruning is sustained intoadulthood.  To address questions of phenotype maintenance in this system, we typically
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perform the eye-specific segregation assay again at P30, which is near the end of theretinogeniculate refinement period (Hong and Chen, 2011; Huberman et al., 2008).  At thistime point, CD47KO and WT littermates display similar levels of overlap between eye-specific territories (Figure 4.8B), however, it is somewhat difficult to interpret this result asthis assay is not designed to discern overpruning (for further explanation, see discussion).To better address this question, I am performing quantification of structural synapses inP60 CD47KO and WT littermates, an age chosen to ensure that pruning and arborizationchanges should be completed.Intriguingly, this overpruning may also occur in other brain regions, as western blotanalysis of synaptic proteins in the striatum revealed lower Vglut2 levels in three month-old CD47KO mice, while levels of postsynaptic marker Homer were unchanged (Figure4.7D).  While these data are preliminary, they suggest that overpruning may lead to areduction in synapse numbers that persists into adulthood, and that CD47 may be utilizedas a protective signal throughout the brain.
CD47 receptor SIRPα is developmentally regulated in microglia during the pruning periodTo determine whether the protective function of CD47 in the developing dLGN is infact due to direct inhibition of microglial phagocytosis, I sought to examine the expressionand localization of its known microglial receptor, SIRPα. SIRPα (SHPS-1/CD172a/P84/BIT/ MyD-1) is an Ig superfamily protein expressed by microglia and othercell types in the brain, including neurons (Adams et al., 1998; Chuang and Lagenaur, 1990;Comu et al., 1997; Ohnishi et al., 2005).  Work in the immune system has shown thatbinding of CD47 to SIRPα on macrophages induces receptor tyrosine phosphorylation,followed by binding of SHP2 or SHP1 to the SIRPα cytoplasmic tail to inhibit phagocytosis
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(Barclay and Van den Berg, 2014; Matozaki et al., 2009). Although microglial SIRPα has notbeen studied in the context of normal brain development, the CD47-SIRPα interaction hasbeen shown to play a role in phagocytosis of myelin after traumatic axonal injury, withblockade of SIRPα preventing binding to CD47 on myelin and enabling increased microglialphagocytosis (Gitik et al., 2011).  This interaction mirrors CD47-SIRPα function in theimmune system, and represents the inhibitory interaction between presynaptic CD47 andmicroglial SIRPα that I hypothesize is a mechanism for synaptic protection duringdevelopmental microglia-mediated pruning in the dLGN.For SIRPα to regulate retinogeniculate refinement, it would have to be present onmicroglia in the dLGN during the pruning period.  To assess SIRPα localization, I performedimmunohistochemical analysis on the developing brain. SIRPα appears broadly expressedthroughout the brain and increases during development (Figure 4.9A).  Highermagnification images reveal that SIRPα staining exhibits a punctate pattern, similar to thatof synaptic staining.  Intriguingly, neuropil staining for SIRPα is lower in the dLGN duringthe pruning period, and higher magnification images of P5 dLGN reveal SIRPα-stainedmicroglia (Figure 4.9B).  Microglia staining can be observed in other brain regions as wellat P5, but is no longer visible in older mice, although this could be due to either a decreasein microglial SIRPα or an increase in neuronal SIRPα that occludes microglial staining.To visualize microglial and neuronal SIRPα expression throughout development, weused double fluorescence in situ hybridization (Figure 4.10A).  These data mimic the IHCdata in that neuronal SIRPα expression is lower in dLGN than in other brain regions, butreveal a microglia-specific expression pattern in the dLGN during peak pruning.  At
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Figure 4.9. SIRP is more highly localized to microglia than neurons during
peak pruning. A, Representative low magnification mosaics of P5, P10, and P30WT coronal sections. SIRP is slightly lower in the dLGN (arrow) versus otherregions at P5, and SIRP levels increase with age. Inset is a higher magnificationimage of the dLGN from each mosaic. Scale bar = 500m. B, SIRP (red) is highlycolocalized to Iba-1 positive microglia (blue) in the P5 dLGN, but this is notobserved at P10.  Scale bar = 10m.
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P5 and P10, SIRPα expression appears to be primarily microglial in the dLGN and co-localizes with IHC for microglia marker Iba-1.  There is some co-localization between SIRPαand Iba-1 in other brain regions at P5, but, unlike in the dLGN, SIRPα colocalizes primarilywith neuronal marker NSE in all other regions examined at P10.  By P30, SIRPα appearsonly to be made by neurons in the dLGN and throughout the brain. I have also observedthe P5 microglial enrichment and the downregulation of microglial SIRPα after completionof the anatomical pruning period using acutely isolated microglia from whole brain (Pinoand Cardona, 2011). Compared to acutely isolated RGCs, SIRPα is expressed approximatelysix-fold more by microglia at P5 as measured by qPCR (Figure 4.10B).  Microglial SIRPα isexpressed at similar levels in acutely isolated microglia from P5 and P10 brains, butdeclines dramatically by P20 (Figure 4.10C). In contrast, SIRPα qPCR performed on wholebrain samples indicates that global SIRPα levels are stable and may increase slightly overdevelopment, which parallels the neuronal staining results (Figure 4.10D).  Taken together,these data indicate that microglial and neuronal SIRPα are differentially regulated, and thehigh levels of microglial SIRPα expression during early development suggest a need for theinhibition of phagocytosis during this period. The unique expression pattern of SIRPα inthe dLGN during the pruning period supports the hypothesis that the CD47-SIRPαinteraction serves to inhibit excess pruning during retinogeniculate refinement.To investigate the role of SIRPα in microglia-mediated pruning, we are collaboratingwith Dr. Hisashi Umemori and obtained his conditional SIRPα mice. His lab recently usedthese mice to demonstrate that SIRPα regulates synaptic maturation in the hippocampus,as a decrease in presynaptic marker staining intensity is only observed if SIRPα is knocked
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Figure 4.10. SIRP is highly expressed by microglia in the dLGN during the
pruning period. A, Representative 20X images of FISH (SIRP, red and neuronalmarker NSE, green) combined with IHC (microglial marker  Iba-1, blue) in thedLGN and hippocampus.  SIRP is primarily expressed by microglia in both regionsat P5, but is expressed by neurons in the P10 hippocampus while still beingexpressed by microglia in the P10 dLGN. SIRP is expressed by neurons in bothregions at P30.  Arrows indicate microglia shown in enlarged images on the right tobetter display colocalization.  Scale bar = 50m. B, Acutely isolated microglia (MG)express approximately 6-fold more SIRP than acutely isolated RGCs as measuredby qPCR, n=2 RGC samples, 3 microglia samples.  C, SIRP declines in acutelyisolated microglia as the pruning period nears completion (P20), n=3 samples perage.  D, SIRP slightly increases throughout development in whole brain lysates asmeasured by qPCR, n=3 samples per age.  All error bars represent s.e.m.
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down starting at P15, coincident with the period of hippocampal synaptic refinement (Tothet al., 2013).  Although this study employed a global actin-CreER driver to excise floxedSIRPα, the observed synapse loss occurs concurrently with the hippocampal period ofmicroglia-dependent maturation and engulfment (Paolicelli et al., 2011), raising theintriguing possibility that microglial SIRPα may be involved in mediating the observedsynaptic changes. I have used tamoxifen delivery with this driver line to create a germlineknockout and am currently breeding up a colony to investigate whether microglia-mediated pruning is uninhibited in SIRPαKO mice. Unfortunately, this experiment will notrule out the possibility that neuronal SIRPα also participates in pruning, however, theexpression pattern of SIRPα in the P5 and P10 dLGN increases the likelihood that a dLGNphenotype will be linked to loss of microglial, and not neuronal, SIRPα.  Microglial SIRPαfunction can also be studied by isolating microglia from global SIRPα knockout mice andexamining their phagocytic behavior in culture, which is an experiment I plan to conduct tosupport in vivo results obtained using the germline KO.
CD200-deficient mice exhibit alterations in retinogeniculate refinementIn the immune system, a variety of “don’t eat me” signals are employed to confer“self” protection, although they achieve this protective effect via different mechanisms(Barclay et al., 2002; Griffiths et al., 2007).  Given the many apparent similarities betweenretinogeniculate refinement and self versus non-self discrimination in the immune system,I hypothesized that this could be the case in the developing CNS as well.  In this way, ratherthan functioning redundantly, “don’t eat me” signals could work together to promotesynaptic protection by independently inhibiting different aspects of microglial behavior.CD200 is another well known “don’t eat me” signal expressed in the developing brain, and
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its mediation of self protection in the immune system is thought to be due to regulation ofmacrophage activation, inflammatory signaling, and cell numbers (Hoek et al., 2000; Minasand Liversidge, 2006; Walker and Lue, 2013; Wright et al., 2000). As these properties arealso likely to affect CNS pruning, CD200 may be a “don’t eat me” signal that works in adifferent, but complementary, manner to CD47.To determine whether CD200 could serve as a “don’t eat me” signal to regulatemicroglia-mediated pruning during development, I examined its localization in thedeveloping brain.  Immunohistochemistry for CD200 reveals punctate staining similar tothat of CD47, although CD200 is broadly expressed throughout the brain and does notappear to be enriched in any particular region at P5. Interestingly, CD200 protein appearsto decrease with age in the dLGN and is nearly absent by P30 when retinogeniculaterefinement is nearly complete (Figure 4.11A).  High-resolution SIM images demonstratethat CD200 also colocalizes with pre- and postsynaptic markers, however, unlike CD47,CD200 appears to be more highly localized to postsynaptic Homer-positive puncta in thedLGN (Figure 4.11B).To determine whether CD200 also acts as a “don’t eat me” signal to preventoverpruning in the retinogeniculate system, I examined overlap between ipsilateral andcontralateral territories in the dLGN using the eye-specific segregation assay describedearlier. Similar to CD47KO mice, CD200KO mice exhibit significantly decreased overlapbetween emerging eye-specific territories in the dLGN at P10 (Figure 4.12A-B).  I amcurrently in the process of quantifying retinal cell numbers to confirm that this decrease inoverlap is not due to a reduction in the number of healthy retinal neurons, and will assessearlier time points to investigate whether pruning is accelerated in CD200KOs as well.
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Figure 4.11. CD200 is localized throughout the brain during peak pruning
before declining in the dLGN. A, Representative 10X images of CD200 in WTdLGN (arrow).  CD200 is localized to the dLGN at P5, but begins to decline relativeto other areas at P10 and is nearly absent by P30.  Scale bar = 50m. B, SIM imagesof CD200 (red) indicating that it primarily colocalizes with postsynaptic Homer(blue, hexagons) rather than presynaptic Vglut2 (green, circles).  Three-dimensional images of the z-stack are provided for another view of colocalization(right).  Scale bar = 2m.
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Given the similarities of this phenotype to that of the CD47KO mice (Figure 4.7A-C),I next used our engulfment assay to evaluate whether it might be caused by increasedphagocytosis of RGC inputs during peak pruning.  However, unlike CD47KO microglia,CD200KO microglia do not engulf more inputs in the P5 dLGN than WT littermate microglia(Figure 4.12C). At the time of engulfment analysis (P5), microglia cell density andactivation state also do not appear to be different in CD200KO and WT littermates (Figure4.12D-E). This suggests that CD200 deficiency may give rise to increased or acceleratedretinogeniculate pruning via a different mechanism than CD47, which is consistent withwhat is known about these molecules from the immune system (Barclay et al., 2002;Griffiths et al., 2007).  Whether this could be caused by increased microglia numbers afterP5 or increased inflammatory signaling, two commonly described features of CD200KOmice (Broderick et al., 2002; Hoek et al., 2000; Walker and Lue, 2013), is a matter I amcurrently investigating by assessing microglia numbers at the time of the eye-specificsegregation analysis (P10) and measuring cytokine levels in CD200KO mice. Thisphenotype could also occur if CD200KO microglia do not exhibit the normal developmentaldecrease in engulfment, and I will address this possibility by conducting engulfmentanalysis after peak pruning (P9) in CD200KO mice.
DiscussionMy results demonstrate for the first time that protective signals are required toprevent excess microglia-mediated pruning during development.  I identified CD47 andCD200, two classical “don’t eat me” signals, as regulators of retinogeniculate refinement inthe developing dLGN.  Both molecules are expressed in the dLGN during the pruning period
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Figure 4.12. CD200-deficient mice exhibit overpruning at P10 without
changes in microglial engulfment, activation, or density. A, Representativeimages of CD200KO (right) and WT littermate (left) P10 dLGN contralateral(green) and ipsilateral (red) territories.  CD200KOs exhibit less overlap (yellow)between the two territories, indicating increased pruning, n=3KO, 4WT, Scale bar =10m. B, CD200KOs have a significant reduction in overlap, *p<.02, Student’s t-test.C, CD200KO microglia engulf approximately the same amount of inputs as WTlittermate microglia, n=7KO, 5WT.  D, CD200KO microglia activation is notdifferent from WT at P5, n=3 mice per genotype. E, CD200KO microglia cell densityis not different from WT at P5, n=3 mice per genotype. All error bars represents.e.m.
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(Figure 4.1, 4.11), however, CD47 exhibits striking regional specificity during this time.Loss of CD47 leads to increased microglial engulfment of retinogeniculate inputs duringpeak pruning as well as decreased overlap between eye-specific territories in the dLGN atP10 (Figure 4.5, 4.7).  This could indicate increased pruning or an acceleration of thenormal pruning process.  Preliminary data from adult mice demonstrating a reduction insynaptic markers suggest that this is, in fact, an overpruning phenotype that leads to aprolonged decrease in synapses (Figure 4.7).  I also found that CD47 receptor SIRPα isprimarily expressed by microglia in the dLGN during the pruning period, and thatmicroglial SIRPα expression declines with age while neuronal expression is relativelyconstant (Figure 4.10).  CD200 deficiency also leads to a decrease in overlap between eye-specific territories in the dLGN at P10, but does not appear to alter microglial engulfment atP5 (Figure 4.12).  Together, these data reveal that mechanisms used to identify and protectself cells in the immune system are similarly utilized to protect necessary synapticconnections during CNS development, and future experiments will further elucidate themechanisms underlying this function.My results raise several important questions that I am currently investigating.  First,is whether the CD47KO overpruning phenotype extends into adulthood or has behavioralconsequences.  Second, is if the CD47KO phenotype is mediated by its interaction withmicroglial SIRPα.  Next, I plan to further investigate the CD200 overpruning phenotype todetermine its underlying cause. I will also examine whether loss of both CD47 and CD200has a synergistic effect on pruning. Finally, I would like to investigate whether loss ofprotective signals allows microglia to engulf non-synaptic material or other cellularcompartments, such as axons. Answers to these questions will provide a more complete
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understanding of CD47 and CD200 function and the role of protective signals inretinogeniculate pruning.A major open question that has been difficult to resolve is whether the CD47 andCD200 knockout eye-segregation phenotypes represent a true overpruning or anacceleration of development that simply reaches its normal endpoint earlier.  One reasonthis has been challenging is due to limitations of the eye-specific segregation assay. Whilethe eye-specific segregation assay provides information about synaptic refinement and theremoval of inappropriately targeted inputs (Huberman et al., 2008; Jaubert-Miazza et al.,2005), it may not be sensitive enough to detect overpruning or excess elimination of inputsonce eye-specific territories have formed. As shown in Figure 4.7, I found that CD47KOmice were hyper-refined, or had less overlap between left and right eye inputs at P10 ascompared to littermate controls.  This result, paired with the increased engulfmentexhibited by CD47KO microglia (Figure 4.5), strongly suggests overpruning.  However, themajor type of pruning that occurs after P10 involves the removal of supernumerary inputsfrom monocularly innervated relay neurons, which is not something the eye-specificsegregation assay is designed to measure (Chen and Regehr, 2000; Hong and Chen, 2011;Hooks and Chen, 2006; Ziburkus and Guido, 2006).  To address whether there isoverpruning in the adult, I am instead conducting structural synapse quantification in thedLGN using high-resolution microscopy and performing western blot analysis for synapticproteins from whole brain and microdissected regions of interest. In future studies, weplan to use electrophysiology to address whether there is enhanced functional eliminationof retinogeniculate inputs in CD47 KOs in the postnatal and adult brain.
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Regardless of the answer to the above question, I still plan to investigate whetherthe observed changes in pruning have behavioral consequences.  Visual systemdevelopment is a precisely timed process, and an acceleration of dLGN pruning is likely tohave consequences that affect other visual areas. I plan to perform behavioral assays toevaluate visual function, such as the optomotor task and the visual water maze, todetermine whether increased pruning or accelerated development affects normal visualprocessing.  If future experiments substantiate preliminary data that CD47KOs havereduced synapse numbers in non-visual areas, such as striatum, other behavioral functionsrelevant to those regions can be assessed as well. Interestingly, a recent reportdemonstrated that CD47KOs have defects in behavioral assays related to schizophrenia,including prepulse inhibition and social interactions (Koshimizu et al., 2014). Asschizophrenia is a disorder characterized by circuit disconnectivity (Schmitt et al., 2011),these data suggest that CD47 deficiency may lead to overpruning in brain regions andcircuits beyond the retinogeniculate system.  I am planning to conduct further behavioralanalysis and examine pruning in other brain regions with the help of collaborators, which Iwill discuss in more detail in the next chapter.As mentioned in the main text, I am pursuing the hypothesis that the CD47KOoverpruning phenotype is due to impairment of CD47 signaling to microglial SIRPα.  Thisinteraction has been shown to underlie phagocytosis in both the immune and nervoussystems (Gitik et al., 2011; Okazawa et al., 2005; Oldenborg et al., 2001), however, CD47does have other binding partners, such as Thrombospondin-1 and Integrinv3, as well asneuronal SIRPα (Brown and Frazier, 2001; Matozaki et al., 2009).  I will performengulfment and eye-specific segregation analyses using global SIRPα knockout mice to
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determine whether they phenocopy the CD47KO defects.  While neuronal SIRPα could stillbe playing a role, the in situ hybridization data suggest that a P5 or P10 dLGN phenotypecould be attributed to microglial SIRPα (Figure 4.10).  Experiments addressingphagocytosis in cultured microglia isolated from SIRPαKO mice can also be performed tosupplement in vivo data.One additional question is whether this has implications beyond the synapse.  Ourprevious work demonstrated that microglia perform most of their engulfment in synapticregions, and our electron microscopy analysis of the material engulfed in the dLGN by wildtype microglia indicated that it most likely represents presynaptic terminals (Chapter 3,Schafer et al., 2012). However, we do not know what keeps microglial engulfment confinedto the synapse and prevents engulfment of other parts of the cell. It could be due to specificsynaptic localization of “eat me” signals, but it is possible that “don't eat me” signals couldplay a role in restricting microglia to synapses as well. CD47 appears to be expressed inboth synaptic regions and non-synaptic regions like the optic tract (Figure 4.2B), and liveimmunostaining of cultured hippocampal neurons reveals it to be on the surface of theentire cell (data not shown). One possibility is that the broad localization of CD47throughout the neuron prevents microglial engulfment of other parts of the cell. In orderto test whether CD47 prevents engulfment of axons or other cellular compartments inaddition to synapses, I am examining engulfment in the optic tract and plan to conduct EMon CD47KO microglia to visualize the ultrastructure of the material they engulf.  If CD47KOmicroglia are also engulfing axons, this could have far-reaching implications for regionalconnectivity and circuit development.
Immune molecules tightly regulate retinogeniculate refinement
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Previous work from our lab and others has implicated a number of immunemolecules and their homologs in retinogeniculate refinement (Boulanger, 2009; Hubermanet al., 2008; Shatz, 2009).  All of these molecules have been found to promote pruning, andloss of these signals produces a similar under-pruning phenotype, or a lack of normalrefinement and formation of eye-specific territories (Huberman et al., 2008).  CD47 andCD200 are the first immune molecules shown to yield the opposite phenotype, that ofoverpruning, or more “mature” eye-specific territories. Mice carrying a mutation in theDown Syndrome critical region (DSCR) are the only other mice known to have anexcessively refined dLGN, although, due to the roles of DSCAM in cell spacing andfasciculation, this most likely represents anatomical abnormalities and not overpruning(Blank et al., 2011). The identification of CD47 and CD200 as molecules critical fordevelopmental synaptic pruning further promotes the idea that CNS refinement isanalogous to the immune system process of self versus non-self recognition.  Complementmolecules C1q and C3 are well known “eat me” signals that opsonize material in need ofremoval from the body.  “Don’t eat me” signals, such as CD47 and CD200, keep the immunesystem from generating too strong a reaction and removing self cells.  Using what is knownfrom the immune system, one can imagine that CD47 and CD200 are present on synapsesthat form appropriate connections, while C1q and C3 identify synapses in need of removal.Both sets of molecules signal to microglial receptors, much like they do to macrophages inthe immune system, and regulate their phagocytic behavior. This model is supported by in
vitro data demonstrating that sialic acid, another immune “don’t eat me” signal, preventscomplement binding and microglial removal of neurites in culture (Linnartz et al., 2012). Itis not yet clear whether neuronal pentraxins and MHCI molecules are repurposing their
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immune system functions to promote the pruning of unneeded synaptic connections, but asNP1 and NP2 are homologs of PTX3, a C1q regulatory protein, this may be a possibility.
Potential mechanisms underlying activity-dependent synaptic pruning by microgliaAnother open question raised by this work is why specific synapses would betargeted for protection or removal. The answer to this mystery of specific synaptictargeting may lie in neuronal activity. Studies of synapse elimination performed at theneuromuscular junction indicate that stronger synaptic inputs “win” the competition forpostsynaptic territory, and many studies in the retinogeniculate system demonstrate thatspontaneous activity is necessary for the formation of eye-specific territories (McLaughlinet al., 2003; Penn et al., 1998; Sanes and Lichtman, 1999; Shatz and Stryker, 1988;Stellwagen and Shatz, 2002; Torborg and Feller, 2005). We found that microgliapreferentially engulf weaker inputs in the dLGN, suggesting that there must be a neuronalactivity signal that they can identify (Chapter 3, Schafer et al., 2012). While CD47 andCD200 have never been linked to neuronal activity, unpublished work from our labindicates that C1q undergoes activity-dependent transcription (Rosen and Stevens, 2011).If C1q is secreted from strong synapses, it may be able to diffuse to and “opsonize” nearbyweaker synapses.There are then two possible ways in which the system can achieve specificity(Figure 4.13).  One model relies on C1q and C3 for specificity, in that CD47 and CD200would be ubiquitously expressed while C1q and C3 would recognize and bind to weaksynapses that would then be eliminated by microglia.  There is some indication that thismay be a prospective mechanism, as data from our lab demonstrate that C1q localizes toless active retinogeniculate synapses in an in vitro system for studying activity-dependent
138
Figure 4.13. Two possible models for specific synapse removal. In the specifictagging model (left), complement (red and orange) opsonizes only those synapsesin need of removal, while “don’t eat me signals” (pink and yellow) are ubiquitouslyexpressed. Microglia (green) would evaluate levels of complement and “don’t eatme signals” using receptors for both types of molecules in deciding which synapsesto engulf.  In the specific protection model (right) complement contacts manysynapses, and only those that do not have a “don’t eat me” signal are engulfed.  Inthis model, microglial phagocytosis is inhibited by the presence of “don’t eat me”signals.
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retinogeniculate refinement (Koyama et al., 2013). This model would require the existenceof a receptor or adaptor on weak synapses to localize C1q and C3, and microglia wouldthen have to read out the relative abundance of “eat me” and “don’t eat me” signals todetermine which synapses to engulf.  The other model is based on the idea that, as secretedproteins, C1q and C3 diffuse broadly throughout the neuropil, which would require specificprotection of the synapses that must be maintained.  How “don’t eat me” signals wouldachieve synaptic specificity is unknown, but as CD47 is lost from membrane subdomainsduring apoptosis (Gardai et al., 2005), similar signaling mechanisms at weak orinappropriate synapses could lead to selective downregulation or re-localization of CD47.Furthermore, these models are not mutually exclusive, and it is possible that both specificopsonization and specific protection may occur.
Microglial phagocytosis is increased in the absence of molecular “brakes”Previous work from our lab identified C1q and C3 as positive regulators ofmicroglial phagocytosis in the developing brain, as loss of these molecules reducesmicroglial engulfment, consistent with their function as “eat me” signals (Bialas andStevens, 2013; Schafer et al., 2012).  However, C1q and C3-deficient microglia still engulfsome RGC inputs during the pruning period, indicating that they are not solely responsiblefor directing microglial phagocytic activity.  Continued engulfment in knockouts couldsuggest the existence of other unidentified “eat me” signals, or indicate that, during thisperiod of development in which microglia are more activated, some element ofphagocytosis is constitutive.  If activated microglia exhibit a high basal level of non-specificphagocytic activity, mechanisms would be required to ensure they do not blindly engulf
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material in their environment, but such mechanisms have not been established during CNSdevelopment.I propose that CD47 serves as a “brake” on excessive phagocytosis.  In the absence ofCD47, microglia engulf increased RGC inputs during peak pruning (Figure 4.5).  Previousstudies have shown that CD47KO mice exhibit increased microglial engulfment of materialin the CNS, but this has always been observed in the context of disease or injury, in whichmicroglia are known to behave pathologically in other ways (Gitik et al., 2011;Koenigsknecht and Landreth, 2004).  This is the first indication that removing the brakeson microglial phagocytosis can alter engulfment in the healthy brain.CD200 also appears to be a “break” on some aspects of microglial behavior.  Whileloss of CD200 does not produce increased engulfment at P5 (Figure 4.12), it likely regulatesmicroglia in other ways that produce excess pruning, as CD200KOs are known to haveincreased microglia numbers, microglia activation, and pro-inflammatory signaling (Hoeket al., 2000; Walker and Lue, 2013; Wright et al., 2000).  Alterations in these propertiescould also be pathological during brain development, and future experiments willdetermine if these abnormalities are observed in CD200KO mice during the pruning period.Microglia are known to have both beneficial and harmful effects during disease, and mydata suggest that, while microglia are required for normal CNS development, they cancause harm if their phagocytic behavior is not properly controlled by endogenousinhibitory signals.
CD47 and CD200 may yield the same phenotype via non-redundant mechanismsCD47 and CD200 are often grouped together as “don’t eat me” signals and regardedas functionally similar. However, based on their use of different receptors and the immune
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system abnormalities observed in knockout animals, they likely arrive at a similarphenotype via different routes.  CD47 is a classic example of a “don’t eat me” signal, as itdirectly inhibits macrophage phagocytosis upon binding to SIRPα (Okazawa et al., 2005;Oldenborg et al., 2001).  CD47KO RBCs are rapidly cleared as macrophages no longeridentify them as “self” and attempt to remove them from the body (Oldenborg et al., 2000).Unchallenged knockout mice are healthy, and do not exhibit gross alterations ininflammatory or other immune signaling molecules.  Alterations in macrophage ormicroglia number or activation state have not been reported in these mice.  In contrast,CD200KO mice exhibit increased expression of pro-inflammatory cytokines as well asincreased numbers and activation of microglia (Hoek et al., 2000).  Unlike CD47 mice,which are refractory to EAE (Han et al., 2012), CD200KO mice exhibit increased diseaseseverity (Wright et al., 2000). Increased phagocytosis in CD200KO mice has not often beenreported, and is likely to be an indirect effect of increased inflammation, rather than directregulation of microglia.These differences may influence how CD47 and CD200 regulate synaptic refinementduring brain development.  The enrichment of CD47 in the dLGN during the pruning periodis suggestive of a direct role in phagocytosis (Figure 4.1), indicating that it may bind SIRPαand inhibit engulfment in that specific region during that specific time period.  CD200 doesnot display enrichment, and is instead similarly abundant throughout the brain during thepruning period (Figure 4.11). Additionally, while a deficiency in either molecule producesa similar decrease in overlap between eye-specific territories (Figure 4.7, 4.12), theirmicroglia do not appear to behave in the same way. This suggests that CD200 likelyregulates synaptic refinement though a different mechanism than CD47, as microglial
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engulfment of RGC inputs was not altered in P5 CD200KO mice (Figure 4.12), in contrast tothe increase in engulfment observed in CD47KO microglia (Figure 4.5).There are several potential mechanisms that could underlie the CD200KOoverpruning phenotype and must be explored. First, it will be important to assess cellnumbers in these mice, as loss of “don’t eat me” signals could lead to excessive self cellremoval (Griffiths et al., 2009).  If retinal numbers are normal, CD200KO microglia willhave to be analyzed closer to when the overpruning phenotype is observed at P10 todetermine if engulfment exhibits the expected developmental downregulation at this timeand if microglia numbers or activation have changed.  CD200 is known to inhibit microglia-derived inflammatory signaling via its binding to CD200R, which promotes CD200Rinteraction with Dok2, activation of RasGap, and inhibition of downstream Ras activationand inflammatory signaling (Walker and Lue, 2013).  I will therefore examine the levels ofpro-inflammatory cytokines and chemokines in CD200KO and WT littermates to assessinflammatory signaling in these mice.  Recent work indicates that astrocytes are alsocapable of engulfing RGC inputs during the pruning period in the dLGN (Chung et al., 2013),so I can also investigate whether dysregulated signaling in CD200KOs affects astrocyte-mediated pruning.  Regardless of the outcome, it is clear that CD47 and CD200 havedifferent mechanisms of action, and I am currently examining double knockout mice todetermine whether the overpruning phenotype is exacerbated by loss of multiple non-redundant protective mechanisms. If loss of both genes has a synergistic effect, it couldsupport the idea that more than one protective mechanism is used to prevent majordisruptions to circuit remodeling, and that combined immune dysregulation and increasedengulfment produces a more severe phenotype. My work promotes the idea that
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protective molecules regulate the removal of “self” material, however, it challenges thenotion that these molecules perform this function redundantly.
The CD47-SIRPα interaction may prevent excess engulfment during developmentThe binding of CD47 to SIRPα on macrophages in the immune system is known toinhibit phagocytosis (Okazawa et al., 2005).  Given the similar functions of immunemolecules in retinogeniculate refinement and self versus non-self discrimination, Ianticipate that CD47 binding to microglial SIRPα inhibits the removal of necessaryconnections during development.  My data indicate that SIRPα is highly expressed inmicroglia during the pruning period in the dLGN and that microglial SIRPα levels decline aspruning nears completion (Figure 4.10).  These results suggest that microglial SIRPα isexpressed at the right time and place to inhibit excessive pruning, and future engulfmentand eye-segregation experiments with the germline SIRPα knockout mouse will be used toinvestigate this possibility.One factor that may complicate these findings is that SIRPα is also expressed byneurons.  Previous studies on SIRPα in the CNS have shown that it has the capacity toregulate behavior, in that SIRPα tyrosine phosphorylation affects body temperatureregulation and circadian patterns of locomotion in mice (Maruyama et al., 2012; Nakahataet al., 2003).  Recent work by our collaborator, Dr. Hisashi Umemori, indicates that SIRPαregulates synaptic maturation in the hippocampus and that impairments occur when it isremoved from the brain starting at P15 (Toth et al., 2013).  All of these findings have reliedon whole brain samples or genetic mouse models in which both microglial and neuronalSIRPα were affected.  These studies have made the assumption that neuronal SIRPα isresponsible for these effects, however, that is not a foregone conclusion given the role of
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microglia in hippocampal engulfment at P15 and the recent studies showing that changesin microglial genes can affect behavior (Chen et al., 2010; Paolicelli et al., 2011; Parkhurstet al., 2013; Rogers et al., 2011; Zhan et al., 2014).Unfortunately, creating a microglia-specific SIRPα knockout mouse has provenchallenging.  I obtained the conditional SIRPα floxed mouse from Dr. Umemori and plannedto use the recently published CX3CR1-CreER line to excise SIRPα specifically in microgliaduring the pruning period.  Based on his suggestions, I administered tamoxifen to P0 pups,but found that this did not effectively eliminate SIRPα from microglia by P5, and thattamoxifen negatively affected microglia cell health and integrity.  More recently, we learnedthat CX3CR1 is also expressed in a subset of neurons during brain development, and whilethis is still under investigation, it makes the CX3CR1-CreER line unsuitable for investigatingmicroglia-specific SIRPα function.To avoid having to use tamoxifen in my experiments, I administered tamoxifen toSIRPα conditional mice crossed to the actin-CreER driver line to remove SIRPα globally andcreate a germline knockout.  While experiments conducted with these mice cannot be usedto prove that findings are due to microglial SIRPα, the microglial expression andlocalization of SIRPα in the dLGN during the time I assay engulfment and eye-specificsegregation make it a more likely possibility (Figure 4.9, 4.10).  I will also examinemicroglia in SIRPα KO mice for changes in activation state or cell numbers, which couldalso affect pruning.  Additionally, I can isolate microglia from the global SIRPαKO andexamine their phagocytic behavior in culture.  Microglial SIRPα has never been studied inthe developing brain.  Determining that the CD47-SIRPα interaction regulates microglia-
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mediated pruning would not only be a novel finding, but would strengthen the ties betweenimmune and nervous system protective mechanisms.My work demonstrates that immune protective signals are required to preventexcess pruning in the developing retinogeniculate system.  Further experimentation isnecessary to understand the overpruning phenotypes in mice deficient in “don’t eat me”signals CD47 and CD200, however, the identification of these molecules as criticalregulators of synaptic refinement and microglial function represents a paradigm shift andmay have broad implications.  These data indicate that the developing CNS utilizes immunemechanisms to shape neural circuits, and therefore may provide a hint as to othercandidate molecules to investigate for involvement in pruning.  Additionally,understanding how these and other immune mechanisms shape neural circuit refinementmay yield insight into the circuit alterations that occur in disorders characterized byimmune dysregulation, such as ASD and schizophrenia. Therefore, future workinvestigating these and other immune protective signals in the developing CNS may offernot only a more complete picture of synaptic refinement but also therapeutic potential.
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Synaptic refinement has long been recognized as a critical developmental processrequired for the removal of unnecessary or inappropriate connections and theestablishment of mature neural circuitry. In the past decade, molecules required forrefinement have begun to be identified and, surprisingly, given the immune privilegedstatus of the brain, many of them are immune or immune-related molecules (Boulanger,2009; Hong and Chen, 2011; Shatz, 2009). To determine how molecules involved in innateand adaptive immunity could regulate synaptic circuit development, we turned to thebrain’s immune cells: microglia.  Study of these cells had been restricted to disease orinjury models for many years; however, new findings were beginning to demonstrate thatmicroglia play an important role in the development and function of the healthy brain(Hanisch and Kettenmann, 2007; Paolicelli et al., 2011; Ransohoff and Perry, 2009). Myfindings further emphasize the necessity of microglia for normal brain development andprovide a more complete picture of synaptic refinement as well as a new way ofconceptualizing brain development.The data presented in this dissertation indicate that microglial engulfment ofsynaptic inputs is essential for normal refinement in the retinogeniculate system.  Immunemolecules communicate with microglia to regulate this process, and deficiencies inmicroglia-mediated pruning lead to lasting defects in the formation of eye-specificterritories and the removal of excess synapses.  Importantly, microglial phagocytosis isboth developmentally regulated and activity-dependent, which is consistent with thecurrent understanding of pruning (Hua and Smith, 2004; Huberman et al., 2008; Katz andShatz, 1996; Sanes and Lichtman, 1999).  My findings also demonstrate that “don’t eat me”signals are required to protect the developing CNS from excess or accelerated pruning, and
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indicate that these molecular brakes restrict microglial engulfment and may prevent theirbehavior from becoming pathological.  My work in this area is still ongoing, and I plan toconduct additional experiments to better understand the mechanisms by which “don’t eatme” signals impact refinement as well as if the overpruning that results from loss of thesesignals has behavioral consequences. Many open questions remain, including whether “eatme” and “don’t eat me” signals direct pruning throughout the brain and if they are relevantto the immune dysfunction observed in neurodevelopmental or neuropsychiatric diseases.Although we do not yet have all the answers, the data presented in this dissertationindicate that brain development involves a delicate balance between synaptic protectionand synaptic pruning, and demonstrate that it shares many similarities with self versusnon-self discrimination in the immune system.
Microglia shape synaptic circuits in the normal, healthy brainOur work defines a critical role for microglia in synaptic circuit refinement in thedeveloping visual system. I found that microglial engulfment of retinal ganglion cell (RGC)inputs is developmentally regulated and occurs during the peak of the pruning period inthe dorsal lateral geniculate nucleus of the thalamus (dLGN). Engulfment tapers off as theformation of eye-specific territories nears completion at P9, even though at that timemicroglia are still relatively activated and capable of phagocytosis. I also observed thatmicroglia preferentially engulf inputs in synaptic regions versus regions containing axontracts, which suggests that the CTB-labeled material they engulf represents synapses, andthat they must be capable of discerning synapses from axons when deciding what to engulf.We also found that microglia are capable of distinguishing weak inputs from strong, andalthough they will engulf both types of inputs, they display a significant preference for
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weak synapses.  When microglia are quieted by administration of anti-inflammatoryantibiotic minocycline, engulfment is reduced and eye-specific territories fail to form,indicating the importance of microglia-mediated pruning for retinogeniculate refinement.These studies also identified immune molecules as key regulators of microglialengulfment during development.  We identified “eat me” signal C3, a member of theclassical complement cascade, and its microglia-specific receptor, CR3, as molecules thatpromote microglial phagocytosis of synaptic inputs in the dLGN. C3 is localized to thedLGN during peak pruning and reduced by P9, and microglial CR3 is also expressed duringearly postnatal development and greatly reduced by P20. Mice lacking these moleculesexhibit decreased engulfment as well as increased overlap between eye-specific territoriesin the dLGN and increased numbers of synapses, suggesting that loss of signals thatpromote phagocytosis leads to incomplete synaptic pruning.  I then identified moleculesrequired to protect against excess pruning, “don’t eat me” signals CD47 and CD200.  In micedeficient in these molecules, eye-specific territories exhibit less overlap than what isnormally observed during developmental retinogeniculate refinement, suggestingincreased or accelerated pruning.  This phenotype appears to result from increasedmicroglial engulfment in CD47KO mice; however, more work is necessary to determine theunderlying cause of the phenotype in CD200 deficient animals. The CD47 receptor, SIRPα ,is developmentally regulated in microglia in the dLGN during peak pruning, and my futurework will investigate whether inhibition of phagocytosis via SIRP signaling is part of thesynaptic protection mechanism. This is the first demonstration that protective signals arerequired for proper circuit refinement, and together, these studies provide a wealth of newknowledge about microglial function and regulation in the healthy, developing brain.
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Do immune molecules and microglia regulate pruning throughout the brain?While our work identifies microglia as critical cellular mediators of synaptic circuitrefinement in the retinogeniculate system, we do not yet know if this extends to pruning inother brain regions.  Interestingly, recent studies from other groups suggest that circuitrefinement by microglia may indeed be a broadly utilized strategy for circuit maturationand modification. Microglia have been directly observed engulfing synaptic material in thehippocampus during the time associated with refinement and maturation in this region,and mice lacking microglia-specific fractalkine receptor CX3CR1 have fewer microglia inthe hippocampus during development and delayed synaptic maturation (Paolicelli et al.,2011). The mechanism underlying hippocampal synaptic engulfment is not yet known, andone possibility is that complement and fractalkine work together, with fractalkinerecruiting microglia through CX3CR1 and complement binding to synapses in need ofremoval. SIRPα was also shown to be required for hippocampal synapse maturation duringthis same developmental window (Toth et al., 2013).  Although this defect is assumed toresult from loss of neuronal SIRPα, contributions from microglia cannot be ruled out sincea global actin-CreER driver line was used to remove this gene. If my experiments using theglobal SIRPα knockout mouse reveal increased phagocytosis of RGC inputs during peakpruning, future collaborative work with Dr. Umemori can focus on separating the effects ofneuronal and microglial SIRPα in the hippocampus.The hippocampus is not the only other region in which microglia regulate synapsematuration.  Defects in synapse maturation in the CX3CR1 knockout mouse have also beenobserved in the barrel cortex (Hoshiko et al., 2012).  Similar to observations in thehippocampus, loss of CX3CR1 delays microglial recruitment to this region, which in turn,
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seems to impair functional maturation of postsynaptic glutamate receptors. Whether ornot this phenotype is related to alterations in phagocytosis remains to be explored.Another stereotyped pruning process occurs in the cerebellum at the climbing fiber-purkinje cell synapse (Hashimoto and Kano, 2005).  Microglia have not yet been implicatedin pruning in this region, but the striking, developmentally regulated localization of CD47in the cerebellum, which parallels the movement of climbing fiber synapses as they travelfrom purkinje cell bodies to dendrites, suggests that this may be a possibility (Figure4.2A).I am currently examining cerebellar pruning in CD47KO animals.  If CD47 appears toregulate pruning in this region, it would indicate that microglial phagocytosis andprotective signals may be hallmarks of normal brain development.
Microglia as activity sensorsWe now know that microglia are capable of sensing and responding to neuralactivity during development, in that they display preferential engulfment of weak synapsesduring peak pruning.  However, neural activity underlies a multitude of circuit-levelchanges that occur throughout the brain, including synaptic plasticity and homeostasis(Greer and Greenberg, 2008). The ability of microglia to alter their behavior in response toneural activity could place them at the center of a variety of processes, and it is clear thatmicroglia retain their sensor ability in the adult brain, where they continuously monitortheir environment with active filopodial movement that is reduced by TTX application andlowered body temperature (Davalos et al., 2005; Nimmerjahn et al., 2005; Wake et al.,2009). Microglia also transiently contact spines and synapses, and although the function ofthis spine contact is not yet clear, it does appear to be activity dependent. If young, lightreared mice are placed into the dark during the visual critical period, microglial contact
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with spines is altered in V1, in that microglia appear to contact larger spines and contactinterfaces cover more area (Tremblay et al., 2010).  If mice are then re-exposed to light fortwo days, microglia exhibit more phagocytic inclusions, which may represent engulfment ofsynaptic material. This indicates that microglia, and potentially microglial engulfment, mayplay a role in activity dependent synaptic remodeling throughout the brain.The activity sensor properties of microglia may not always lead to engulfment. Asimmune cells, microglia are also capable of secreting cytokines and chemokines andinitiating an inflammatory response (Ben Achour and Pascual, 2010; Wyss-Coray andRogers, 2012). Glial-derived TNF- has been shown to be required for homeostaticsynaptic scaling, although this cytokine can be secreted from both astrocytes and microgliaand more needs to be done to identify the source (Beattie et al., 2002; Stellwagen andMalenka, 2006). Work using cultured microglia has demonstrated that they can affectneural activity, and that they do so by secreting glycine and L-serine into the culturemedium (Hayashi et al., 2006; Moriguchi et al., 2003).  Additionally, activation of culturedmicroglia with lipopolysaccharide (LPS) has been shown to indirectly increase AMPAR-mediated spontaneous EPSCs in the CA1 of hippocampal acute slice via astrocyteintermediaries (Pascual et al., 2011), although it is unclear if this occurs in a non-inflammatory context.Microglia clearly sense and respond to neural activity, however, the mechanismsemployed to communicate activity-related signals to microglia are not yet known.  Forsurveillance functions or the modulation of neural activity via secreted signals, microgliamay make use of the many receptors they express to respond directly to neurotransmittersor neuromodulators (Kettenmann et al., 2011). Recent work from our lab indicates that
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visually-evoked activity can also regulate microglial gene expression, including genesinvolved in motility and the cellular mechanics of engulfment (Schafer et al., 2013).However, for functions involving phagocytosis, their more macrophage-like behaviorswould need to be engaged, suggesting that some pro- or anti-phagocytosis cues must beactivity regulated to direct activity-dependent engulfment behavior, such as the engulfmentof weaker synapses during retinogeniculate refinement. One possibility is that pro-phagocytosis signals like “eat me” signals might specifically bind to weak synapses.Alternatively, anti-phagocytosis “don’t eat me” signals could be specifically downregulatedby or re-localized away from weak synapses, or upregulated by or more highlyconcentrated on strong synapses. Then again, local activity changes could regulatereceptors on nearby microglial processes, and thereby affect phagocytosis. The regulationof these molecules could resemble that described in the punishment model (Figure 1.1,Lichtman and Colman, 2000), with complement molecules serving as the secretedpunishment signals that bind weak or asynchronously firing synapses.  “Don’t eat me”signals could then act as the local protective mechanism, and could either be lost fromweak synapses or increased on strong synapses to regulate refinement.Future work can be directed toward determining whether the “eat me” and “don’teat me” signals identified as regulators of microglial engulfment during developmentinstruct microglia to prune weaker synapses.  The in vivo competition assay we used todetermine that microglia preferentially phagocytose weaker synapses in the dLGN can beperformed in knockout mice to investigate whether microglia retain that preference. Ifthey do not, the missing signal may be critical for microglia to discern neural activity levels.Our lab has also developed a co-culture model of the retinogeniculate system to better
161
visualize and study the molecular mechanisms regulating activity-dependent synapticrefinement (Koyama et al., 2013).  I plan to use this system to determine whether CD47 isspecifically down- or upregulated on individual synapses known to be weak or strong,respectively. Microglia-spine contact can also be assessed after dark adaptation in micedeficient in “eat me” or “don’t eat me” signals to determine whether the presumablyactivity-dependent contacts reported in the cortex are altered in the absence of thesemolecules (Tremblay et al., 2010).  Identifying the molecules that transmit phagocytosis-related neural activity information to microglia will provide additional insight intomechanisms underlying microglia-mediated pruning during development, and intoconditions in which pathological neural activity may be involved, such asneurodegenerative disease.
Microglia and astrocytes: partners in pruning?Recent work indicates that microglia are not the only cells capable of engulfing RGCinputs during the retinogeniculate pruning period. A new study from the Barres labdemonstrates that immature astrocytes also engulf synaptic inputs in an activity-dependent manner, and that genetic disruption of this function has lasting consequencesfor retinogeniculate refinement (Chung et al., 2013). Astrocytes are not motile and do notengulf as much material as microglia when examined on a cell-to-cell level, but as there aremore immature astrocytes than microglia during the pruning period, they may still make asubstantial contribution to pruning. Interestingly, astrocytes rely on conserved phagocyticreceptors to engulf RGC inputs, MERTK and MEGF10, and orthologs of MEGF10 have beenshown to regulate axon pruning by Drosophila glial cells (Draper) and phagocytosis ofapoptotic cells in C. elegans (CED-1) (MacDonald et al., 2006; Zhou et al., 2001; Ziegenfuss
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et al., 2008). This mechanism is complement independent, suggesting that distinctmechanisms regulate pruning in astrocytes and microglia. However, what is not yetestablished is whether microglia and astrocytes work together to shape synaptic circuitsand whether one type of cell can compensate if pruning by the other is impaired.The astrocyte pruning study provides a small hint that pruning between the twocells may be coordinated, in that microglial pruning is transiently increased in P5 Mertk-/-mice that have reduced astrocyte engulfment (Chung et al., 2013). MERTK is expressed byboth cell types, and how MERTK-deficiency could produce different effects in these twotypes of cells is still unknown. Although this observation requires further substantiation,coordinated pruning between microglia and astrocytes could be responsible for therelatively small magnitude of the overpruning defect in mice deficient in “don’t eat mesignals.”  An intriguing question for future investigation is whether astrocyte pruning isreduced when microglial pruning is increased in CD47KO mice. Additionally, given thatastrocyte phagocytosis has been reported to increase with inflammatory stimuli or ininflammatory diseases (Kalmar et al., 2001; Morcos et al., 2003), it is also possible thatastrocyte engulfment may be altered in CD200KO mice if they have enhanced pro-inflammatory signaling, which is one of the mechanisms I plan to explore as a possiblecause of CD200KO overpruning.
Parallels between nervous system and immune system functionThe vast majority of molecules recently identified as regulators of developmentalsynaptic pruning have been immune or immune-related, including members of the classicalcomplement cascade (Boulanger and Shatz, 2004; Hong and Chen, 2011; Shatz, 2009).  Allof these molecules have a similar role in promoting normal pruning, and loss of these
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molecules impedes removal of overlapping and supernumerary connections in the dLGN(Bjartmar et al., 2006; Datwani et al., 2009; Huberman et al., 2008; Huh et al., 2000; Stevenset al., 2007). In this study, I have, for the first time, identified immune molecules requiredto inhibit pruning, “don’t eat me signals” CD47 and CD200, that appear to serve asmolecular brakes to prevent pruning from proceeding too quickly or removing too manyinputs.  This discovery enhances our understanding of brain development, and suggeststhat protective mechanisms are required to ensure that circuits form normally. Thesemolecules, as well as “eat me” signals C1q and C3, regulate microglia, the myeloid-derivedimmune cells of the brain, by binding microglial receptors, including SIRPα and CR3(Griffiths et al., 2007). Taken together, these findings present a new model of synapticrefinement, one that shares many common mechanisms with self versus non-selfdiscrimination in the immune system.The major task facing the immune system is the removal or destruction of apoptoticcells and pathogenic or non-self material to prevent harm to the body.  However, theimmune system has to complete this task while avoiding two potential negativeconsequences: the accidental removal of self material and an excessive inflammatoryresponse (Elward and Gasque, 2003; Grimsley and Ravichandran, 2003). To successfullyachieve this balance, two types of molecular cues are needed.  “Eat me” signals areexpressed by or bound to only the cells or debris in need of removal.  Phagocytes possessreceptors for these signals, which can be membrane bound or secreted, and use them toidentify material that must be engulfed (Hochreiter-Hufford and Ravichandran, 2013).“Don’t eat me” signals are markers of self, and are ubiquitously expressed by self cells andnot pathogens, and downregulated or lost from cells once they become apoptotic or
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unhealthy (Gardai et al., 2006; Griffiths et al., 2007).  Not only do these signals inhibitinappropriate removal by communicating with receptors on phagocytes, some of them alsonegatively regulate the inflammatory response (Walker and Lue, 2013). Failure of “eat me”signals can lead to illness, while deficiencies in “don’t eat me” signals can cause increasedsusceptibility to autoimmune diseases (Wright et al., 2000).We have now identified classic “eat me” and “don’t eat me” signals as key regulatorsof microglia-mediated pruning. Their function appears to be highly conserved, and if weconsider inappropriate connections analogous to non-self and necessary connectionssimilar to self, we see that microglia are performing the same discrimination task as theirimmune system counterparts.  My discovery of the involvement of “don’t eat me” signalsprovides a key missing piece necessary to complete this analogy, and paves the way forfurther exploration of the role of immune molecules in synaptic refinement.  The moleculeswe have identified are only a subset of those involved in the self versus non-selfdiscrimination task in the immune system (Griffiths et al., 2007; Hochreiter-Hufford andRavichandran, 2013), and a major open question is whether other immune molecules alsoregulate microglia-mediated pruning.
Do other immune and immune regulatory molecules influence pruning?The immune system employs a large number of cellular signaling mechanisms toensure that the removal of harmful material occurs with minimal non-specific removal ofself cells (Elward and Gasque, 2003).  Given the striking similarities between this processand microglia-mediated synaptic refinement in the dLGN, it seems likely that other immunemolecules may also regulate pruning during brain development. Identifying suchmolecules may seem like a daunting task in light of the complexity of the immune system,
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but candidates can be chosen based on the “eat me” and “don’t eat me” model of microgliaregulation. To qualify as a good candidate, an immune molecule must function within thecontext of the signals and cells we have already identified as mediators of phagocytosis.Two classes of molecules emerge as sources of candidates: complement regulators and“find me” signals.The complement cascade functions as part of the innate immune system to targetpathogens or debris for cell lysis or removal by phagocytes. A variety of molecules act toeither enhance or inhibit the complement cascade during apoptosis and the elimination ofnon-self material (Kim and Song, 2006).  Of these, a subset are expressed in the CNS andmay serve as candidates to regulate microglia-mediated pruning.  One such candidate isCD55 or Decay accelerating factor (DAF), a GPI-linked complement inhibitor that acts at thelevel of C3.  Expressed by neurons, DAF has been shown to be upregulated in diseasesassociated with complement activation, such as experimental autoimmuneencephalomyelitis (EAE), and can protect against complement opsonization whenectopically expressed (van Beek et al., 2005). DAF upregulation has also been observed inneural crest-derived cell lines during pathfinding and axon outgrowth and shown toprotect against complement-mediated lysis (Zhang et al., 1998). While it has not beenstudied in vivo during brain development, its neuronal localization and inhibition of C3make it an interesting candidate. Another interesting complement regulatory molecule isthe recently identified CSMD1 (Lau and Scholnick, 2003).  CSMD1 is highly expressed in thedeveloping CNS and appears to inhibit the classical complement cascade by preventing C3deposition and causing degradation of its proteolytic product, C3b.  This makes it aninteresting candidate protective signal as it could prevent “eat me signal” opsonization
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(Escudero-Esparza et al., 2013; Kraus et al., 2006).  Finally, there is some evidence tosuggest that well-known neural adhesion and recognition molecules may also behave asimmune regulatory molecules (Tian et al., 2009). For instance, Sema-7A has been shown toplay an important role in the negative regulation of T cell activation (Czopik et al., 2006),further supporting the idea that the CNS and immune system share molecules andsuggesting that perhaps canonical neuronal signaling mechanisms can have immune-likefunctions. The fact that semaphorins have been implicated in axonal pruning in thehippocampus (Bagri et al., 2003), a region in which microglial engulfment has also beendemonstrated (Paolicelli et al., 2011), makes this an intriguing possibility.Another interesting, but poorly understood, class of molecules is the “find me” or“come get me” signals. These molecules are thought to be secreted from apoptotic cells toattract macrophages (Grimsley and Ravichandran, 2003; Ravichandran, 2011), and giventhe similarities of macrophage engulfment of dying cells to microglial engulfment ofinappropriate synapses, it would be interesting to see if these molecules functionanalogously in the developing CNS. Thus far, only a handful of molecules have beendescribed as “find me” signals in mammalian cells: lysophosphatidylcholine (LPC),sphingosine 1-phosphate (S1P), a fragment of fractalkine, and ATP, all of which are foundin the CNS. Interestingly, fractalkine and ATP may exert some “find me” like effects onmicroglia, as fractalkine receptor knockouts have fewer microglia during development andATP is necessary for microglia to extend processes and move toward sites of injury(Davalos et al., 2005; Hoshiko et al., 2012; Paolicelli et al., 2011). Additionally, an S1Preceptor modulator that reduces microglial activation is used as a treatment for relapsing
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Multiple Sclerosis (MS), although it is unclear if its effects are due to blockade of S1P “findme” signaling (Jackson et al., 2011; Noda et al., 2013).If we extend the analogy of microglia-mediated pruning of inappropriateconnections to the removal of apoptotic cells, another interesting candidate comes to thefore. Phosphatidylserine (PS) is exposed on the outer surface of apoptotic cells, and allowsfor identification by phagocytes (Grimsley and Ravichandran, 2003).  In the immunesystem, CD47 normally covers the entire cell surface, but, during apoptosis, its expressionis reduced or re-localized into patches, revealing PS in CD47-negative regions (Gardai et al.,2005). However, the mechanism underlying this interesting re-localization behavior is notyet known. One area for future study in our system is whether PS exposure is increased inCD47KOs, or whether weaker synapses in either our in vitro or in vivo competition assaylose CD47 and are associated with PS externalization (Koyama et al., 2013; Schafer et al.,2012). A better understanding of the interaction between these two molecules could shedlight on CD47 function and regulation during the pruning period.
Consequences of microglial dysfunction in the normal and inflamed brainAs interest has grown in understanding microglial function in the healthy brain,microglia have been implicated in what seems like an ever-increasing number of processes.Therefore, it is unsurprising that disruption of these cells, which we have already shownhas consequences for circuit refinement, also produces behavioral alterations.Furthermore, there is a growing body of evidence linking microglia to bothneurodegenerative diseases and neurodevelopmental disorders, and microglialabnormalities may be related to the inflammation or other immune-related changes thatoccur in the brain during these diseases (Frick et al., 2013; Wyss-Coray and Rogers, 2012).
168
Thus, as we learn more about the immune molecules regulating microglia-mediatedpruning, we are likely to uncover molecular mechanisms that are also disrupted in disease.
Defects in microglial function influence behaviorGiven that microglia are now recognized as participants in neural circuit formationand modulation, it follows that mice harboring microglial alterations display abnormalbehavior.  Normal microglial function may be required for proper learning, as micecarrying only a single copy of microglial receptor CX3CR1 exhibit deficiencies in memory,motor learning, and contextual fear conditioning (Rogers et al., 2011).  However, this mayvary based on experimental paradigm as improved learning has also been observed usingthis strain (Maggi et al., 2011).  Mice in which microglia have been completely eliminatedusing genetic ablation also display defects in motor learning (Parkhurst et al., 2013).Excessive grooming has been observed in mice carrying microglia-specific genetic lesionsand mice missing both copies of CX3CR1 display reductions in functional connectivitybetween brain regions and impaired social interactions (Chen et al., 2010; Zhan et al.,2014).  Microglia may also play a role in establishing baseline sex-specific behavior, asmicroglia in male and female rats display different levels of activation, and alteringactivation levels pharmacologically produces behavior more typical of the opposite sex(Lenz et al., 2013; Schwarz et al., 2012).  Of the microglial genes that have been linked tobehavior, CX3CR1 has direct ties to engulfment, suggesting that behavioral changes inknockout mice may result from reduced microglia-mediated refinement or maturation.There may even be some evidence linking “eat me” and “don’t eat me” signals tobehavioral changes.  C1q knockout mice have been found to have seizures, a result that mayimply the presence of excess synapses in other brain regions (Chu et al., 2010).  This result
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suggests that “eat me” signals could be required to promote microglial engulfment ofunnecessary synaptic connections throughout the brain. Moreover, aged C1q and C3knockouts perform better than aged WT mice in certain cognitive and memory tasks, apossible indication that reduced engulfment could lead to less synapse loss orneurocognitive decline later in life (Shi et al., 2012; Stephan et al., 2013). Additionally,“don’t eat me” signal CD47 may be required for normal learning.  A series of studiesindicated that CD47 is upregulated in the hippocampus during memory consolidation, andthat blocking CD47 with antibody or complimentary antisense oligonucleotide injectioninto the dentate gyrus impairs memory retention in a one-way inhibitory avoidancelearning task (Chang et al., 2001; Huang et al., 1998; Lee et al., 2000).  While these resultsdo not necessarily implicate microglia in this process, especially since CD47 is known tobind neuronal SIRPα as well as other ligands (Brown and Frazier, 2001), it is possible tospeculate that the CD47 upregulation that occurs during memory consolidation helpsprotect newly formed connections from microglial removal.To better understand how loss of CD47-dependent synaptic protection affectsbehavior, studies would have to be performed either very early, at a time point in whichSIRPα is primarily microglial, or based on visual system function, as this is a system inwhich CD47 signaling to microglia appears critical.  I plan to perform behavioral analysison CD47KO mice, and appropriate tests given the aforementioned stipulations includemeasuring ultrasonic vocalizations (USVs) in young pups and examining visual function viathe optomotor and visual water maze assays in adults.  While defects in these behavioralassays would not conclusively prove that it is the protective function of CD47 that isrequired for normal behavior, they could suggest that excessive or accelerated pruning
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influences behavioral output.  This possibility could be investigated by examining the samebehaviors in other mice with similar overpruning phenotypes, like CD200KOs, andpotentially the global SIRPα knockout mouse.  Given the behavioral changes observed inmice lacking other microglia-pruning related genes, it seems likely that the excess pruningobserved in CD47KO mice would have behavioral consequences.
What are the consequences of an overpruned brain?Most of the studies described in the previous section depict behavioral alterationsthat occur when microglia are not doing their job, either due to their absence or due to lossof function in genes known to drive normal microglial function. One major open question iswhat happens when microglia are doing their job a little too well?  This appears to be thecase in CD47KO mice, as microglial engulfment of synaptic inputs is increased in theabsence of the necessary molecular “brakes”.  This indicates that continuous inhibitory“self” signaling is required to ensure proper circuit formation, and that, in its absence,microglia may not be able to correctly differentiate appropriate versus inappropriatesynaptic connections. Additionally, as CD47 appears to be localized along the entire cellmembrane, loss of these signals may lead to the engulfment of more than just synapses,such as microglial phagocytosis of axons.  I am currently examining phagocytosis in theCD47 knockout optic tract, a non-synaptic region bordering the dLGN, to determinewhether microglia engulf more material in this region.  Our data demonstrate thatmicroglia phagocytose far less material in this region in wild type mice (Chapter 3, Schaferet al., 2012), however, my preliminary observations indicate that this may not hold true inCD47 knockouts. Inappropriate engulfment of axons could have far-reaching effects onneural circuitry, particularly if it occurs in a relay center like the thalamus.
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My results indicate that loss of protective signals leads to increased pruning oraccelerated development in the retinogeniculate system, and future experiments willdetermine whether this applies more globally.  If these protective mechanisms are broadlyemployed by a variety of brain regions to prevent excess synapse removal, as ourpreliminary data from the striatum suggest, then loss of these molecules could haveextensive consequences for circuit formation.  Furthermore, many events in circuitdevelopment are precisely timed with critical developmental windows (Hensch, 2004;LeBlanc and Fagiolini, 2011), so if increased pruning causes a circuit to reach its maturestate prematurely, this could affect function and influence the development of connectedcircuits in other brain regions.  Whether loss of protective signals affects regionalconnectivity or overall brain function is a major open question for future study.While the effects of loss of “don’t eat me” signals on brain function remain to beexplored, studies in mouse models and human patients indicate that altered connectivitymay play a role in neurodevelopmental and neuropsychiatric disorders. Studies on autismspectrum disorder (ASD) have yielded mixed findings, with some indicating hypo-connectivity in fMRI studies or mouse models, while others suggest hyper-connectivity(Belmonte et al., 2004; Tye and Bolton, 2013).  Still other studies propose an initialovergrowth of connections followed by a period of pruning back (Courchesne et al., 2007).The data on schizophrenia are more cohesive, with many groups characterizing the diseaseas one of disconnectivity (Keshavan et al., 1994; Schmitt et al., 2011).  I plan to determinewhether increased pruning could lead to autistic or schizophrenic-like behaviors in CD47or CD200 knockout mice by performing behavioral testing.  Interestingly, a very recentstudy characterized CD47KO mouse behavior and demonstrated that knockouts display
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defects associated with schizophrenia, including impaired prepulse inhibition and socialinteractions (Koshimizu et al., 2014).  While the authors do not propose a mechanism toexplain these defects, it is possible that loss of protective signals and increased pruningcould be an underlying cause. Further behavioral analysis of these mice and mice withrelated overpruning defects is required to determine whether loss of “don’t eat me” signalscould be a possible mechanism underlying ASD or schizophrenia.
Immune dysregulation and neurodevelopmental disordersIn support of a potential role for “don’t eat me signals” in these disorders, recentstudies indicate that immune dysregulation may be a key feature of autism andschizophrenia (Goines and Van de Water, 2010; Vargas et al., 2005).  Microarray analyses ofpostmortem ASD tissue samples revealed an enrichment of genes related to immunity andinflammation as well as to microglia activation (Voineagu et al., 2011). Additionally,unpublished data from the same group indicate that “don’t eat me” signals, includingCD200 and its receptor CD200R, are significantly downregulated in ASD brains (DanGeschwind, personal communication) and that “eat me” signals, such as C1q, areupregulated. We plan to collaborate with the Geschwind lab to examine CD47 and CD200localization in control and ASD human tissue.  Many studies of schizophrenia have alsorevealed an increase in inflammatory cytokines as well as microglial activation, and someantipsychotics have been suggested in in vitro studies to have anti-inflammatory effects(Frick et al., 2013; Kneeland and Fatemi, 2013; Monji et al., 2013).  Minocycline, a broadanti-inflammatory agent, has even shown some success as a treatment for schizophrenia(Dean et al., 2012).  Intriguingly, CD200 and CD47 were altered in a recent study that usedthe maternal immune challenge model (MIA) of schizophrenia, in which pregnant dams are
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prenatally injected with Poly IC, a synthetic double stranded RNA analog that mimics viralinfection, to produce offspring with ASD and schizophrenia-relevant behavioralphenotypes (Meyer, 2013).  The data from this study suggest that CD47, CD200, and theirreceptors may be dsyregulated in Poly IC treated mice and that stress can further alter theexpression of these molecules (Giovanoli et al., 2013).  Prenatal inflammation aloneappears to increase the expression of these genes, while the addition of peripubertal stressdecreases the expression of CD47, CD200, and their receptors.  While it is unclear whatoverexpression of “don’t eat me” signals could represent, data from cancer studies indicatethat ectopic expression of CD47 by cancer cells prevents removal by phagocytes (Jaiswal etal., 2009), so perhaps increased expression of “don’t eat me” signals in the CNS couldinhibit normal pruning.This intriguing finding lends itself to the idea that a “double hit” of geneticsusceptibility plus environmental insult may underlie the development ofneurodevelopmental or neuropsychiatric disorders (Eapen, 2011; Goines and Ashwood,2013).  Using CD47 as an example, this model would suggest that loss of this moleculecauses alterations in brain development that may not produce recognizable behavioraldefects on their own, but that, combined with prenatal inflammation or postnatal stress,would synergize with the dysregulation of other immune molecules to produce moresevere defects.  This hypothesis is easily testable by performing MIA on CD47 or CD200KOsor exposing these animals to postnatal stress and assessing behavior compared to naïveknockout animals.  If these treatments lead to behavioral defects, treated animals can beexamined for changes in microglia-mediated pruning as well as for other microglial
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alterations to determine whether immune dysregulation leads to additional engulfment ormicroglia activation in these “unprotected” mice.However, it is also possible that loss of protective signals may lead to immunedysregulation directly, as these signals normally prevent the release of pro-inflammatorycytokines by microglia (Barclay et al., 2002; Walker and Lue, 2013).  I plan to examine thelevels of cytokines, complement, and other pro-inflammatory molecules in CD47 andCD200 knockout brains to determine whether inflammation is altered compared to wildtype.  This could underlie changes in microglial phagocytosis and could be related to theimmune dysregulation often observed in autism and schizophrenia.There is already some data to suggest that dysregulation of immune moleculesregulating complement or microglia may lead to autistic or schizophrenic-like symptoms.Mice lacking CSMD1, a likely inhibitor of the classical complement cascade, displaybehavioral alterations consistent with neuropsychiatric disorders (Steen et al., 2013).  AsCSMD1 was identified as a susceptibility gene in a genome wide association study (GWAS)study of schizophrenic patients (Havik et al., 2011), these data suggest that loss of immuneregulatory signals that inhibit “eat me signals” implicated in microglia-mediated pruningcould lead to schizophrenia.  Furthermore, mice lacking the fractalkine receptor, whichhave been previously found to have microglial pruning defects, also appear to exhibitchanges in functional brain connectivity and autistic-like behaviors (Zhan et al., 2014).This study also implicates disrupted pruning in autism, and identifies the brain’s immunecells, microglia, as key players.  Taken together, these data suggest that immunedysregulation that affects microglial pruning may underlie the development ofneurodevelopmental or neuropsychiatric disorders.
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Microglia-mediated pruning may be aberrantly reactivated in neurodegenerative diseaseOne interesting commonality among the “eat me” and “don’t eat me” signals we haveidentified as regulators of microglia-mediated pruning during development is the growingevidence of their involvement in neurodegenerative disease.  “Eat me” signals, includingC1q and C3, are known to be upregulated in the late stage of various diseases, includingAlzheimer’s disease (Afagh et al., 1996; Gasque et al., 2000; Stephan et al., 2012).Inflammation is also increased during these diseases, although it is currently unclearwhether the increase in complement levels is a cause or consequence of inflammation.Conversely, “don’t eat me” signals, including CD47 and CD200, are reduced in a variety ofneurodegenerative diseases, including Multiple Sclerosis (MS) and Parkinson’s disease(PD) (Koning et al., 2007; Zhang et al., 2011).  CD200 is known for its role as an inhibitor ofinflammation, so loss of this molecule may play a part in the initiation or continuation ofinflammation in disease.  Finally, microglial activation has been observed in these diseasesas well (Dheen et al., 2007; Perry et al., 2010), meaning the cells are more phagocytic andlikely secreting pro-inflammatory cytokines.  The combined dysregulation of “eat me” and“don’t eat me” signals would facilitate a favorable environment for phagocytosis.The concomitant upregulation of “eat me” signals and downregulation of “don’t eatme” signals alongside growing evidence that synapse loss is one of the earliest events inmany neurodegenerative diseases, such as Alzheimer’s (AD) and Huntington’s disease(HD), leads to an interesting hypothesis (DiProspero et al., 2004; Scheff and Price, 2003).Perhaps a shared mechanism among these diseases is an aberrant reactivation of thedevelopmental pruning program in the absence of molecular brakes (Stephan et al., 2012).It is unclear whether “eat me” signal upregulation or “don’t eat me” signal downregulation
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occurs first, but it would be possible to determine the order of these events by examiningthe expression and localization of these molecules in mouse models of AD and HD early indisease progression.  Given that loss of “don’t eat me” signals would remove theconstitutive inhibition of inflammation, it seems reasonable that loss of these signals wouldoccur first.  Once this protective shield has been removed, inappropriate opsonization ofneurons, myelin, or synapses by complement could lead to phagocytosis by microglia.This model yields testable therapeutic possibilities.  If loss of “don’t eat me” signalsappears to be one of the earliest pathological events in mouse models of AD or HD, we canattempt to restore these molecules via viral delivery and assess whether synapse loss ordisease progression is improved.  Alternatively, if “eat me” signal upregulation appears tobe the initiating factor, we can attempt to lessen complement in disease models by crossingmice to complement knockouts or administering secreted complement inhibitorymolecules, such as factor H.  We can then perform similar analysis of synapse numbers anddisease progression to determine whether decreasing “eat me” signals might havetherapeutic potential.  Finally, we can target microglia themselves using minocyclineinjection, which will reduce microglial activation, but can also have broad anti-inflammatory effects in the CNS and throughout the body.  Interestingly, minocycline hasbeen reported to have a beneficial effect on some neurodegenerative diseases, such as HDand AD, although it is unclear whether this is due to a decrease in microglial phagocytosis(Kim and Suh, 2009).  Employing our engulfment assay to investigate the effects ofminocycline on phagocytosis in mouse models of these diseases would be a good first stepin determining whether inappropriate microglial “pruning” contributes to pathology,
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although better tools need to be developed to more specifically inhibit microglialphagocytosis for future experiments.
ConclusionMy work adds to the growing body of evidence demonstrating that microgliadynamically regulate synaptic circuit formation in the developing brain (Schafer andStevens, 2013; Wake et al., 2013).  Their phagocytic function plays a critical role in synapticrefinement, indicating that engulfment of material in the CNS is a feature of normal braindevelopment and not restricted to injury or disease, although it may bear some mechanisticsimilarities to more pathological phagocytosis.  Importantly, my identification of “don’t eatme” signals CD47 and CD200 as protective molecules that prevent excess pruning addsdepth to our understanding of both retinogeniculate refinement and microglial regulation.These studies highlight the notion that synapse refinement is not only about the removal ofinappropriate connections, but also about the protection of necessary connections that areto be maintained. This appears to be accomplished by a system of molecular checks andbalances in which well-known immune molecules guide microglial engulfment.  In this way,synaptic refinement bears a striking resemblance to self versus non-self discrimination byphagocytes in the immune system, and conceptualizing this developmental process as animmune system analog may lead to the identification of additional immune regulatorymolecules involved in pruning.These molecules converge on microglia to either encourage or discourage theirengulfment of synaptic material.  While this is essential for proper pruning, my resultsdemonstrate that, if left unchecked, phagocytosis during development can easily becomepathological. Therefore, “don’t eat me” signals serve as necessary molecular brakes to
178
prevent uncontrolled microglial engulfment, similar to the prevention of bystander damagein the immune system.  As these signals are also known for their inhibition of microglialinflammatory signaling, it is possible that they also prevent cytokine release during braindevelopment, and my future studies will examine whether knockout brains exhibitincreased inflammation.  This could potentially create a positive feedback loop that shiftsthe balance in favor of phagocytosis if “eat me” signals are among the moleculesupregulated when “don’t eat me” signals are lost.  Investigating the relationship betweenthese signals will enhance our understanding of the regulation of microglia-mediatedpruning.A major open question left unanswered by this work is how “eat me” and “don’t eatme” signals correctly identify synapses in need of removal and those that must bemaintained. This is a challenging question, and one that hinges upon determining whether“eat me” or “don’t eat me” signals are activity regulated, and thereby capable of beinglocalized to or lost from weak synapses.  Another important issue in need of resolution toanswer this question is whether microglial phagocytosis is based on the relative abundanceof “eat me” and “don’t eat me” signals expressed on a cellular target, or whether thepresence of any “don’t eat me” signals serves as a molecular override.  Studies usingcultured cells and phagocytes indicate that the former may be the case (Oldenborg et al.,2001), which suggests that microglia may be capable of making fairly complex decisions.Given the repeated appearance of microglia and “eat me” and “don’t eat me” signals innumerous disease models and patient samples, determining the answers to these questionswill greatly enhance our understanding of CNS development and may have therapeutic
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potential for a variety of neurodevelopmental, neuropsychiatric, and neurodegenerativediseases.
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